>> --PART OF THE NATIONAL INSTITUTES OF HEALTH AND PART OF THE LARGER DEPARTMENT OF HEALTH AND HUMAN SERVICES. WE APPRECIATE YOU HANGING IN THERE. THIS REPRESENTS THE FIRST OF 2 MEETINGS THAT WE'RE HAVING DURING THE YEAR 2020. WE HAVE THE ADVISORY BOARD THEMSELVES AVAILABLE HERE ONLINE AND WE HAVE QUITE A FEW SUPPORTERS, ADVOCATES, RESEARCHERS AND OTHER MEMBERS OF THE COMMUNITY AVAILABLE THROUGH VIRTUAL CONNECTIONS AND WE APPRECIATE YOUR TUNING INTO THIS MEETING. I'M GOING TO NOW GET THINGS START, TURN IT OVER TO OUR CHAIR. EDE TO DO ROLE CALL, APPROVAL AND MINUTES AND GET THINGS START. >> GOOD MORNING EVERYONE. I HOPE EVERYONE IS DOING WELL IN THESE UNCHARTED TIMES. YOU SHOULD HAVE RECEIVED SEVERAL DOCUMENTS FROM RALPH INCLUDING CLEARANCE DOCUMENTS AND THE AGENDA SOIME GOING TO BEGIN BY GOING LIEU THE ROLL CALL FOR THE MEMBERS. >> I GOT AN E-MAIL FROM ABBIE, SO I THINK HE'S ON HIS WAY. >> OKAY, THANK YOU RALPH. >> STEPHANIE DELUCA? >> HERE. >> [INDISCERNIBLE]. >> I'M HERE, CAN YOU HEAR ME? >> YES, THANK YOU, WELCOME. >> ARTHUR ENGLISH. >> HERE. >> JUDY [INDISCERNIBLE]. >> I'M HERE. >> BARBARA [INDISCERNIBLE]. >> HERE, SORRY. >> CRAIG MCDONALD. >> HERE. >> [INDISCERNIBLE]. >> YES, I'M HERE, CAN YOU HEAR ME? >> YEAH, YOU GOT IN, GOOD. >> WELL, I'M IN BUT I'M IN JUST ON THE PHONE, I CAN'T GET ON IN MY COMPUTER, IT KEEPS BLOCKING ME. I THINK IT'S OUR SECURITY SOFTWARE, I HAVEN'T FIGURED IT OUT YET, I WILL KEEP WORKING ON IT. >> AND WE ALSO HAVE A BREAK, IF YOU NEED TO RUN FOR HELP, AT 11:45. EXCUSE ME. ERIC [INDISCERNIBLE]? >> HERE. >> DAVID [INDISCERNIBLE]. >> HAVEN'T SEEN HIM YET. >> BRIAN [INDISCERNIBLE]. >> IS BRIAN ON? >> BRIAN AND UNMUTE AND SAY HELLO IF YOU CAN. >> OH THERE'S BRIAN. HI, BRIAN. >> CAN YOU WAVE, THAT WILL BE OFFICIAL. [LAUGHTER] >> LESTER, [INDISCERNIBLE] >> JENNIFER STEVENS-[INDISCERNIBLE]. I DON'T SEE JENNIFER ON MY LIST HERE. >> SHE'S COMING IN NOW. I SEE HER SHOWING UP. >> OKAY. >> OKAY, PLEASE MUTE YOUR PHONES IF YOU ARE NOT SPEAKING. SO THAT WE MINIMIZE THE BACKGROUND NOISE. I WILL GO THROUGH THE EXOFICIOs ARE-- >> THEY'RE WATCHING BUT THEY'RE NOT-- >> THANK YOU FOR THAT RALPH. THE NEXT ITEM IS-- >> THIS IS [INDISCERNIBLE], I'M NOT SURE I HEARD MY NAME? >> I GOT KICKED OFF. >> YOU WERE RIGHT UNDER THE DATE AND I GOT YOU INTO--MIXED UP IN THE DATE. THANK YOU FOR SPEAKING UP, ALL. >> NEXT ORDER OF BUSINESS-- >> BY THE WAY,. >> --SORRY, ROB, DID I MISS YOU TOO? SORRY, GLAD TO HAVE YOU, THANKS FOR JOINING US. SO THE NEXT ITEM OF BUSINESS IS TO APPROV THE MINUTES FROM THE DECEMBER MEETING WHICH SEEMS LIKE FOREVER AGO. AND DO I HAVE A MOTION TO APPROVE THE MINUTES? >> SO MOVED. >> SO MOVED. >> THANK YOU. I BELIEVE MINUTES OF APPROVAL DOES NOT NEED A SECOND. SO ALL IN FAVOR OF APPROVING THE MINUTES, SAY AYE. >> AYE. >> AYE. >> AYE. >> AYE. >> ANY OPPOSED? OR ANY EDITS THEY WOULD LIKE TO SUGGEST? ALL RIGHT, THE MINUTES ARE APPROVED. BEFORE WE GO AHEAD AND JUST MOVE INTO THE AGENDA, IS THERE ANYTHING THAT TERESA OR OR RALPH YOU WOULD LIKE TO SAY OR CLARIFY AS WE MOVE INTO THE AGENDA ITEMS? OKAY, HEARING NONE--ALL RIGHT, HEARING NONE THEN OUR FIRST ORDER OF BUSINESS, I WOULD LIKE TO INTRODUCE DR. DIANNA BIANC, I, WITH THE NATIONAL INSTITUTE OF CHILD AND HUMAN HEALTH DEVELOPMENT FOR AN UPDATE, THANK BIANCHI? >> THANK YOU EDE, WILL LIZA BRING UP MY SLIDES? GREAT. THANK YOU IF WE COULD HAVE THE FULL SCREEN SHOT VIEW, EXCELLENT. >> LGOOD --WELL, GOOD MORNING AND THANK YOU FIRST OF ALL IN YOUR FLEXIBILITY FOR THE DATE REARRANGEMENT, MOST OF YOU ARE SIGNING IN FROM YOUR HOMES SO WE REALLY APPRECIATE THAT, I'M KMING FROM MY PERMANENT HOME IN BOSTON. SO IF WE'RE IN GROUP C AT THE NIH, WE ARE PREDOMINANTLY WORKING FROM HOME RIGHT NOW AND WE'VE BEEN TOLD THAT WE WILL BE WORKING FROM HOME UNTIL AT THE EARLIEST OCTOBER 9th. SO LET'S GET STARTED. I'M HAPPY TO SPEAK WITH YOU TODAY, MAY I HAVE THE NEXT SLIDE, PLEASE. SO, THE VERY FIRST THING WE WILL DO IN THE NEXT SLIDE IS CELEBRATE OUR NEW DIRECTOR OF THE MCMRR AND I UPON HOPEFULLY GIVE YOU THINGS YOU DON'T ALREADY KNOW ABOUT HER AND THEN WE WILL TALK ABOUT THE BUDGET SITUATION AND THEN, IMPORTANTLY, WHAT NICHD AND THE NIH AND DOING TO ADDRESS THE SCIENTIFIC ASPECTS OF THE PANDEMIC THAT WE'RE ALL LIVING THROUGH RIGHT NOW. I'LL GIVE YOU A COUPLE OF SLIDES UPDATING YOU ON WHAT'S HAPPENING WITH THE INCLUDE INITIATIVE, WHICH IS INVESTIGATORRING CO-OCCURRING CONDITIONS ACROSS THE LIFE SPAN TO UNDERSTAND DOWN SYNDROME AND AS A BRIEF UPDATE AS I DO WITH EACH OF MY PRESENTATIONS IN TERM OF WHERE WE ARE IN TERMS OF OUR STRATEGIC PLAN IMPLEMENTATION AND THEN UPDATES WITH REGARD TOEUR STAFF. SO MAY I HAVE THE NEXT SLIDE PLEASE. WELL, THERESA HAS BEEN DOING A FANTASTIC JOB AS ACTING DIRECTOR OF THE NCMRR, AND THROUGH THE PROCESS FOR WHICH WE HAD OUTSTANDING CANDIDATES, THERESA ROSE TO THE TOP AND WAS OFFICIALLY NAMED AS OUR NEW DIRECTOR OF THE NCMRR EFFECTIVE MONDAY. SO SHE'S BEEN IN THE JOB PERMANENTLY FOR THE LAST 2 DAYS ANDY WOO WILL HEAR FROM HER SHORTLY. SO YES, WE CAN GIVE A ROUND OF APPLAUSE--[ APPLAUSE ] --FOR THE GREAT JOB SHE'S DONE AND GREATER JOB SHE WILL DO IN THE FUTURE. BUT I KNOW YOU'VE ALL BEEN WORKING WITH THERESA. SOME NOISE? DID SOMEBODY HAVE A COMMENT? OKAY, I KNOW YOU'VE ALL BEEN WORKING WITH THERESA BUT YOU MAY NOT KNOW SPECIFIC DETAILHER BACKGROUND. SO SHE EARNED A BACHELOR OF SCIENCE IN BIOMEDICAL ENGINEERING WITH HIGHES HONORS FROM RUTGERS, AND SHE RECEIVED HER M. S. AND Ph.D. DEGREES IN BIOMEDICAL ENGINEER FREE RADICALS GENERATED NORTHWESTERN. FROM THERE, IN CHICAGO SHE DID REHABILITATION RESEARCH AT THE REHABILITATION INSTITUTE OF CHICAGO AND FOCUSED ON MOTOR CONTROL AND GAIT IMPARTMENTS OF THE LOWER LIMB FOLLOWING STROKE. SHE CAME TO NIH AND THE NCMRR IN 2009, INITIALLY MANAGING GRANTS IN THE DEVICES AND TECHNOLOGY DEVELOPMENT AND REHABILITATION DIAGNOSTICS AND INTERVENTIONS PROGRAMS AS WELL AS SBIR/STTR AWARDS IN MEDICAL REHABILITATION. SHE ALSO DID A RESEARCH DETAIL AT THE FUNCTIONAL AND APPLIED BIOMECHANICS LABORATORY IN THE REHABILITATION MEDICINE DEPARTMENT OF THE CLINICAL CENTER AT THE NIH IN 2015. AND MORE RECENTLY SHE HAS BEEN THE KEY LEAD IN THE BRAIN INITIATIVE CO HAD BEEN PORTFOLIO IN NEUROTECHNOLOGY DEVELOPMENT. SO YOU WILL BE HEARING FROM HER SHORTLY ABOUT HER VISION BUT WE ARE JUST THRILLED TO HAVE FINALIZED HER SELECTION. MAY I HAVE THE NEXT SLIDE, PLEASE? NEXT SLIDE. MONEY. THE FEDERAL GOVERNMENT IS FUNDED THROUGH THE END OF THE FISCAL YEAR WHICH IS SEPTEMBER 30th OF THIS YEAR AND AS YOU KNOW, IF YOU'VE BEEN FOLLOWING THE NEWS, CONGRESS DID PROVIDE SUPPLEMENTAL FUNDS TO THE FISCAL YEAR 2020 BUDGET IN TERMS OF THE CARES ACT AND IN THAT ACT 945 PLUS MILLION DOLLARS WAS GIVEN TO NIH, EXCUSE ME, TO PREVENT, PREPARE FOR OR RESPOND TO CORONAVIRUS DOMESTICALLY OR INTERNATIONALLY. NOW THIS IS BACK IN MARCH, I BELIEVE, IT COULD HAVE BEEN APRIL BUT FAIRLY EARLY IN THE SPRING AND IT INCLUDED SPECIFIC FUNDING FOR NIAID, NHLBI, NIBIB, NCATS, NLM, AND THE OFFICE OF THE DIRECTOR. YOU'LL BE HEARING ABOUT SOME OF THE MONEY WE HAVE RECEIVED FROM THE OFFICE OF THE DIRECTOR BUT BASICALLY THE POINT OF THE SLIDE WAS TO SAY THAT NICHD DID NOT RECEIVE--PEOPLE WITH DISABILITIES OR PREGNANT WOMEN. WE'VE TRIED TO ADDRESS THAT AND HAVE GIVEN PROPOSED YOU KNOW INFORMATION THAT CONVERSATION HAS REACHED OUT TO US FOR A PROPOSED ADDITIONAL SUPPLEMENT BUT AS YOU PROBABLY KNOW THAT HASN'T HAPPENED YET AND IN FACT, THE SENATE WENT OFF ON THEIR VACATION WITHOUT COMING TO INTEREST SORT OF CONCLUSION IN TERMS OF NEGOTIATING WITH THE HOUSE. IN ADDITION, NOW THAT'S JUST HER FISCAL YEAR 2020 AND THAT IS FOR ADDITIONAL RELIEF MONEY FOR PEOPLE WHO ARE PERSONALLY IMPACTED BY ECONOMIC ISSUES OR HEALTH ISSUES RELATED TO COVID-19 BUT IN ADDITION TO THAT STIMULUS OUT OF THIS FISCAL YEAR, THERE'S ALSO AN IMPASSE FOR THE NEXT FISCAL YEAR. SO IT SEEMS LIKE A LONG TIME AGO BUT ON MARCH 4th, I WAS 1 OF SEVERAL INSTITUTE DIRECTOR WHO IS TESTIFIED AT THE HOUSE SUBCOMMITTEE ON LABOR, HHS WHO ACTUALLY PROASHT OUR BUDGET AND AT THE TIME WHILE THE MAJORITY OF QUESTIONS WERE FOR TONY FAUCI, THEY WEREN'T ALL FOR TONY FAUCI, AND WE DID HAVE AN OPPORTUNITY TO ANSWER QUESTIONS THAT SPECIFICALLY RELATE TO OUR RESEARCH FORT FOLIO OR OR POPULATION. THE FISCAL YEAR 2021 APPROPRIATIONS HAVE PASSED IN THE HOUSE BUT THERE'S BEEN NO ACTION YET IN THE SENATE. AS THEY SAID THEY'VE GONE OFF ON RECESS, SO THERE IS I POSSIBILITY THAT THERE WILL BE A CONTINUING RESOLUTION FROM OCTOBER 1st UNTIL AFTER THE ELECTION. SO WE DON'T REALLY KNOW WHAT'S GOING TO HAPPEN WITH FISCAL YEAR 21, SO FROM'S A LOT OF UNCERTAINTY RIGHT NOW AND I WILL EXPLAIN HOW WE WERE ABLE TO GET SOME FUNDS THAT WE DID FOR COVID-19 RELATED RESEARCH. NEXT SLIDE. NEXT SLIDE. I WANTED TO MAKE YOU AWARE, FIRST OF 2 LARGE TRANSNIH EFFORTS. THERE IS THE ACTIVE INITIATIVE WHICH STANDS FOR ACCELERATING COVID-19 THERAPEUTIC INTERVENTIONS AND VACCINES WHICH IS BASICALLY A PUBLIC-PRIVATE PARTNERSHIP. THE UPPER LEFT PANEL IS FROM A PAPER THAT DR. COLLINS WROTE WITH PAUL STOFFELS, WHO IS FROM JOHNSON & JOHNSON, PUBLISHED IN JAMA AND IT REALLY DETAILS THE DIFFERENT GROUPS WAYS THAT PHARMA CAN ESSENTIALLY CAN ACCELERATE BOTH TESTING, DEVELOPMENT, TESTING AND TRANSLATION OF THERAPEUTICS AND VACCINES INTO CLINICAL CARE. IT'S BEEN A MASSIVE EFFORT. IT'S REALLY TAKEN UP MOST OF DR. COLLYNN'S TIME BUT THEY'RE MAKING TREMENDOUS AMOUNT OF PROGRESS. NEXT SLIDE. THE OTHER LARGE TRANSNIH EFFORT IS SOMETHING CALLED RADX. WHICH IS THE NIH RAPID ACCELERATION OF DIAGNOSTICS INITIATIVE FOR COVID-19. IT CONSISTS OF 4 DIFFERENT SUBPROGECS. THERE'S THE RADX TECH WHICH IS SHOWN IN THE GRAPHIC. THAT IS A SHARK TANK LIKE INITIATIVE WHERE THERE WAS BACK IN APRIL A NATIONAL CALL FOR INNOVATIVE TECHNOLOGIES. THEY RECEIVED SEVERAL THOUSANDS OF APPLICATIONS OR INDICATIONS OF INTEREST, THOSE WERE ALL RAPIDLY EVALUATED AND ARE GOING THROUGH A PIPELINE WHERE THEY ARE BEING REVIEWED BY EXTERNAL COMMITTEES AND SOME ARE NOW TRANSLATING INTO CLINICAL TRIALS. THE RADX ATP WHICH IS A DIFFERENT PART OF THE RADX INITIATIVE IS DEVOTED TO ACCELERATING TECHNOLOGIES, SO THE RAD X ATP IS TAKING TECHNOLOGIES THAT ALREADY EXIST WHEREAS RADX TECH IS DEVELOPING NEW TECHNOLOGIES NAMELY ASSOCIATED WITH TRYING TO BETTER DEVELOP RAPID DIAGNOSTIC TESTS FOR SARS-COV2. RADX-ATP IS A SCALE UP THAT ARE DEVELOPED AND MAKING THEM AVAILABLE SO THAT HUNDREDS OF THOUSANDS OF--THEY WANT TO GO TO MAINE SO THEY HAD TO GET EVIDENCE OF NEGATIVE TESTS AND 2 MEMBERS OF THE FAMILY HAD POSITIVE RAPID TESTS BUT THEN NEGATIVE TESTS WITH 2 OTHER ECNOLOGYS, SO IT'S--OTHER TECH FOLGS, NOBODY WOULD WAS SICK OR SYMPTOMATIC, SOME OF THE DISCREPANCIES BETWEEN OF THE TESTING. SO RADX-TECH AND RADX-ATP HAD THE GOAL OF DEVELOPING THE MOST ACCURATE TESTS THAT CAN BE DEPLOYED RAPIDLY AND IN HUGE SCALE AND AS YOU KNOW ALL THE ISSUES RELATED TO RETURN TO COLLEGES, RETURNING TO SCHOOLS, THE NEED FOR TESTING IS ENORMOUS. NOW RADX-UP, STANDS FOR UNDERSERVED POPULATIONS WHICH IT HAS THE GOAL OF HOW DO WE PROVIDE TESTING TO PEOPLE AND COMMUNITIES THAT ARE RURAL THAT DON'T HAVE ACCESS TO HEALTHCARE THAT MAY HAVE OTHER CHALLENGES AND VERY IMPORTANTLY FOR PEOPLE WITH PHYSICAL DISABILITIES TO CANNOT GET TO TESTING SITES, HOW DO WE GET THE TESTING OUT TO THEM. AND THEN RADX-RAD IS KIND OF A SMORG AS BOARD OF DIFFERENT THINGS, THE RAD STANDS FOR RADICAL IDEAS, IT'S REALLY LOOKING AT OUT OF THE BOX TECHNOLOGY BUT IT'S ALSO LOOKING AT APPLICATION OF TECHNOLOGIES TO MOVE ACROSS POPULATIONS AND WE HAVE BEEN ABLE TO RECEIVE $20 MILLION FROM THIS LARGE TRANSNIH EFFORT TO BE ABLE TO TEST CHILDREN AS A POPULATION THAT'S NOT GETTING ENOUGH TESTING. NEXT SLIDE. IF YOU WANT TO KNOW MORE ABOUT THE RADX INITIATIVE, THERE WAS AN ARTICLE WRITTEN BY DR. COLLYNNS AND SEVERAL OF MY COLLEAGUES WHO ARE INSTITUTE DIRECTOR WHO IS ARE EXPLAINING WHO APPLIED FOR SOME OF THESE INIT WHYATIVES AS WELL AS DIFFERENT SAMPLE TYPES THAT ARE GOING TO BE EVALUATED, NEXT SLIDE. SO AGAIN, AS I MENTIONED WE DIDN'T NEARLY GET MUCH BUDGETARY ATTENTION FROM CONGRESS BACK IN MARCH BECAUSE AT THAT TIME IT WAS THOUGHT THAT CHILDREN DIDN'T REALLY GET COVID OR IF THEY DID IT WAS SO MILD IT WASN'T A BIG DEAL AND THEN IN MIDMAY, WE BECAME AWARE OF SOMETHING THAT WAS LATER--THAT WAS NAMED ALSO IN MIDMAY BY THE CDC AS MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN AND A CLUSTER OF ARTICLES BEGAN APPEARING IN LATE APRIL, EARLY IN MIDMAY ABOUT THIS SPIKE IN KAWASAKI-LIKE DISEASE OR CHILDREN WHO WERE HAVING VERY SERIOUS COMPILATION OF SYMPTOMS ABOUT A MONTH AFTER THEY HAD A MILD CASE OF COVID . NEXT SLIDE. SO THE CDC ALSO CAME OUT WITH A DEFINITION OF WHAT IS MIS-C. AND SOME OF THE HALLMARKS ENCLUED DEATHS IN CHILDREN AND THE DEFINITION OF CHILD DIFFERS FROM STATE TO STATE BUT FUNDAMENTALLY SOMEONE WHO'S UNDER 18 OR 19 YEARS OLD WHO PERHAPS HAD SARS-COV-2 THAT--OR WAS EXPOSED TO SARS-COV-24 WEEKS PRIOR TO THIS CLINICAL PRESENTATION WHICH INCLUDES PROLONGED FEVER, BLOOD LABORATORY EVIDENCE OF INFLAMMATION AND A CLINICALLY SEVERE OWENESS THAT REQUIRES HOSPITALIZATION WITH MULTISYSTEM ORGAN INVOLVEMENT, MOST OFTEN INCLUDING THE HEART WHICH IS WHY YOU SEE A PATIENTS IN THE CLINIC URT - -A PICTURE OF THE HEART THERE WITH DILATION, CORONARY ARTERY AND EFFECTED CHILDREN CAN GET SERIOUS MY O CARDITEIS, THEY CAN HAVE HEART FAILURE. AFTER THE HEART, THE GI TRACT SEEMS TO BE 1 OF THE BIGGEST AREAS THAT AFFECTS CHILDREN, CHILDREN OFTEN PRESENT WITH SEVERE ABDOMINAL PAIN, NAUSEA, VOMITING, DIARRHEA, THEY CAN HAVE SKIN RASHES, THE RESPIRATORY COMPONENT OF MIS-C IS 1 OF THE MILDER AREAS AND THAT'S WHAT MAKE ITS SO CONFUSING, IT'S A VERY DIFFERENT PRESENTATION. AND THERE ARE DIFFERENT VARIATIONS OF THIS SO THE CHILDREN WHO HAVE THE TRUE MIS-C, AND BY THE WAY, THERE WAS A RECENT--AN UPDATED REPORT FROM THE CDC THAT DESCRIBES 570 CASES, MOST CHILDREN DO RECOVER BUT CHILDREN DO DIE FROM THIS. THERE ARE APPROXIMATELY 90 CHILDREN IN THE U.S. WHO HAVE DIED FROM COVID-19 TO DATE. BUT THERE'S ALSO A MILDER VERSION OF MIS-C, WHO ARE NOT IN THE ICU, BUT THEN PRESENT WITH PESPIRATTORY INVOLVEMENT, BUT THOSE THAT HAVE THE MISC-HAVE THE FULL BLOWN MIS-C. SO NEXT SLIDE. SO WE WERE A LITTLE BIT LATE TO GETTING INVOLVED BECAUSE HONESTLY WE DIDN'T HAVE FUNDING. WE WERE THINKING A LOT ABOUT WHAT WE COULD DO WITH EXISTING FUNDS IN OUR BUDGET THAT'S JUST HAPPENING WELL INTO THE FISCAL YEAR WHERE WE HAVE COMMITMENTS TO EVERYTHING ELSE, SO DR. COLLINS ASKED DR. GARY GIBBONS AND MYSELF TO CO-LEAD AN NIH WIDE COLLABORATION IN PARTNERSHIP WITH NIAID TO UNDERSTAND WHAT'S HAPPENING IN CHILDREN AND OVER TIME WHAT WE'VE DONE IS KNIT TOGETHER 3 SEPARATE PROGRAMS WHICH IT STILL DOESN'T HAVE A NAME BUT SORT OF THE NIH ATTEMPT TO UNDERSTAND MISC. AND NICHD IS THE LEADONTHE UPPER LEFT PROGRAM WHICH IS PREVAIL-KIDS WHICH IS--I WILL TELL YOU MORE ABOUT IT IN A MOMENT BUT IT'S THE AT-RISK COHORT. SO A KEY ISSUE IS LOTS OF CHILDREN ARE GETTING COVID, THE NUMBERS ARE INCREASING OF THE TOTAL CASES OF COVID IN THE COUNTRY. BACK IN APRIL IT WAS ONLY 2 PERCENT WERE CHILDREN BUT NOW, ALMOST 9% ARE CHILDREN AND 97,000 CHILDREN WERE DIAGNOSED WITH SARS-COV-2 INFECTIONS JUST IN THE LAST 2 WEEKS OF JANUARY, SO THE CASES ARE INCREASING IN CHILDREN AND CERTAINLY AS THERE ARE MORE CASES.CHOOL,- SO WE ARE TRYING TO ADVANCE UNDERSTANDING OF WHO IS AT RISK TO DEVELOP MIS-C. WE'RE WORKING WITH NHLBI, NHLBI IS LEADING SOMETHING THAT I BELIEVE THEY ARE GOING TO CALL THE MUSIC INITIATIVE WHICH IS A COMPREHENSIVE UNDERSTANDING OF PHENOTYPE, NATURAL HISTORY OUTCOMES IN THE PATHOBIOLOGY OF MIS-C WITH A FOCUS ON THE HEART AND THEN NIAID IS VERY INTERESTED IN THE IMMUNE ASPECTS AND THE LONG-TERM FOLLOW UP OF CHILDREN WHO DEVELOP MISC. SO WE'RE WORKING TOGETHER WITH A STREAMLINE COMMON DATA PROTEIN COMPLEX COL. COMMON DATA ELEMENTS, SHARING BIOSPECIMENS, AS WELL AS CLOUD-BASED DATA SHARING. NEXT SLIDE. SO IN THE MUSIC OR THE CORE COHORT OF THE HOSPITALIZED CHILDREN AS IT SAYS, THE FOCUS IS LARGELY ON THE HEART. ALL OF THESE CHILDREN WILL HAVE VERY SOPHISTICATED CARDIAC--ECHO CARDIO GRAMS. THEY WILL BE ANALYZE INDEED A CENTRAL SITE, BLOOD WILL BE COLLECTED FOR WHOLE GENOME SEQUENCING, RNA-SEQ AND VARIOUS IMMUNE TESTS AND THERE'S THE OPPORTUNITY TO DO ADAPTIVE DESIGN TRIALS TO ENHANCE TREATMENTS. CURRENTLY THESE CHILDREN ARE BEING TREATED WITH INTRAVENOUS IMMUNE GLOBUE LYNN, STEROIDS AND ANTIINFLAMMATORY MEDICATIONS AND AS I SAID THEY'RE GENERALLY DOING WELL, THE MAJORITY OF CHILDREN DO GO HOME IN ABOUT A WEEK. NEXT SLIDE. SO OUR PREVAIL KIDS COHORT, WE'RE HOPING TO STUDY AROUND 10,000 CHILDREN WHO ARE NO 1 TO BE SARS-COV-2 POSITIVE. THIS ALSO INCLUDES ADOLESCENTS WE ARE USING OUR CLINICAL TRIALS INFRASTRUCTURE, USING ELECTRONIC RECORDS, FORMS, COLLECTING SPECIMENS AND THE GOAL IS TO RETROSPECTIVELY LOOK AT THE CHILDREN WHO DEVELOP MIS-C TO DETERMINE WHAT IS IT ABOUT THEIR GENOME, WHAT IS IT ABOUT THEIR IMMUNE PROFILE THAT WOULD BE BIOMARKERS TO INDICATE THEIR AT-RISK FOR MIS-C. ONLY .5% OF ALL OF THE CHILDREN WHO GET COVID-19 WILL DEVELOP MIS-C, SO WHO ARE THEY? THEY ARE GENERALLY CHILDREN THAT--OBESITY IS A RISK FACTOR ACCORDING TO THE CDC, BUT IN GENERAL THESE ARE NOT CHILDREN WITH ASTHMA OR CHRONIC LUNG DISEASE. THEY'RE NOT NECESSARILY FORMER PREMIES, AND WE NEED TO SEE WHAT IS PUTTING THEM AT RISK AND THE JUST RECENTLY THE PREVAIL FOR KIDS ANNOUNCEMENT WAS JUST RELEASED AND SO WE'RE LOOKING FOR COHORTS OF CHILDREN, THIS WILL INCLUDE CHILDREN WITH DISABILITIES. WE DON'T KNOW ENOUGH ABOUT THOSE CHILDREN. NEXT SLIDE. AND THEN THE LONG-TERM FOLLOW UP FOLLOW UP STUDY, WE KNOW FROM THE LONG HAULERS IN ADULT THERE ARE LONG-TERM EFFECTS WHEREAS THE NHLBI ARE FOCUSED ON THE HEART, WE ARE MORE FOCUSED ON THE WHOLE CHILD. WE'RE VERY INTERESTED IN WHAT MI S-C DOES LONG-TERM TO THE HEART, GI TRACT AS WELL AS DEVELOPMENT AND WHETHER THERE ARE INTELLECTUAL CONSEQUENCES OF INFECTION. THE OTHER THING THAT'S VERY IMPORTANT IS THE PATHOPHYSIOLOGY OF MIS-C AT THE PRESENT TIME IS CONSIDERED TO BE SOME SORT OF IMMUNE OVERRESPONSE TO THE PRIOR INFECTION. SO WHAT DOES THIS MEAN FOR BOTH VACCINES FOR SARS-COV-2 AS WELL AS OTHER CHILDHOOD VACCINES. SO WE REALLY NEED TO KNOW THAT BEFORE WE GIVE THESE INFECTED CHILDREN ANOTHER VACCINE. NEXT SLIDE. SO HOW ARE WE GOING TO DO THIS AND OTHER STUDIES? WELL WE'RE GOING TO MAKE USE OF OUR PEDIATRIC TRIALS NETWORK. IT'S A CONTRACT MECHANISM WHICH ALLOWS US TO VERY QUICKLY GO INTO SITES THAT ARE HOT SPOTS WHERE WE KNOW THERE ARE LOTS OF EFFECTED CHILDREN AND WE WOULD PREDICT THAT IN A FEW WEEKS WE WILL BEGENERATD TO SEE MIS-C IN THAT AREA. IN ADDITION WE'RE ALREADY USING THE PEDIATRIC TRIALS NETWORK TO GATHER INFORMATION ON PHARMA CO KIN ETICSICS AND SAFETY OF DRUGS THAT ARE NOT TYPICALLY USED IN CHILDREN TO DEFINE THE APPROPRIATE DOSING OF THESE DRUGS FOR CHILDREN WITH COVID-19. THIS IS AN EXISTING NETWORK AND ITS PURPOSE IS TO PROVIDE DATA OF DOSING OF THEM FOR OTHER DRUGS. SO CURRENTLY CHILDREN WHO ARE GETDING REMDESIVIR, OR ANY OF THE OTHER DRUGS THAT ARE LISTED HERE ARE BEING ENROLLED AND WE'RE USING ARCHIVED BLOOD SAMPLES BASICALLY TO LOOK AT HOW THE DOSING AFFECTS DRUG LEVELS IN THESE CHILDREN. SO WE ALREADY HAVE 50 STUDY SITES THAT ARE PARTICIPATING IN THE DRUG ASPECT OF THIS. THIS IS 1 OF THE EXAMPLES OF HOW WE PIVOTED VERY QUICKLY WITH EXISTING RESOURCES TO BEGIN TO ADDRESS ISSUES RELATED TO COVID IN OUR POPULATION, SO WE'RE IN ADDITION USING THIS NETWORK TO JUMP START THE PREVAIL KIDS STUDY. NEXT SLIDE. PREGNANT WOMEN ARE ANOTHER BIG PART OF OUR POPULATION AND WE HAVE AN EXISTING MATERNAL-FETAL MEDICINE USE NETWORK AND IS AN OPPORTUNITY TO STUDY PREGNANT WOMEN WHO HAVE COVID-19 SO THAT NETWORK IS ENROLLING THOUSANDS OF PREGNANT WOMEN AT 12 DIFFERENT SITES ACROSS THE UNITED STATES AND THE GOAL IS TO COMPARE ESSENTIALLY MORBIDITY AND MORTALITY IN THE PREAND POST COVID-19 ERAS. SO PREGNANT WOMEN WHO HAVE COVID-19 HAVE AN INCREASED INCIDENCE OF PRETERM BIRTH, THEY HAVE INCREASED INCIDENCE OF GETTING SICK, AND INCREASED INCIDENCE OF SESARRIAN SECTION, SO THE GOAL TO COMPARE. WE WON'T KNOW THAT ALL THE WOMEN ACTUALLY HAVE HAD COVID, WE'RE TRYING TO GET A SENSE OF WHAT IS THE DIFFERENCE BETWEEN THEN AND NOW. NOT ALL PREGNANT WOMEN ARE TESTED UPON ARRIVAL AT LABOR AND DELIVERY AND SOME INSTITUTIONS THEY ARE AND EMBEDDED WITHIN THAT STUDY IS A STUDY OF 1500 COVID-19 POSITIVE PREGNANT WOMEN AND WE ARE ATTEMPTING TO PARTNER WITH OTHER REGISTRIES AS WELL. IN ADDITION IT'S VERY IMPORTANT, HUGE DISCUSSION ONGOING AS TO WHY PREGNANT WOMEN ARE NOT BEING INCLUDED IN THE VACCINE TRIALS THAT ARE ONGOING RIGHT NOW. THE MAJORITY OF COMPANIES HAVE SAID THAT THEY ARE NOT GOING TO INCLUDE PREGNANT WOMEN. --AT RISK FOR GETTING SICK, BUT ALSO HEALTHCARE WORKER IS A HUGE NUMBER OF WOMEN IN THE HEALTHCARE FIELD WHO ARE OF REPRODUCTIVE AGE AND AT HIRISK. SO WE NEED TO KNOW MORE ABOUT THE VACCINE AND PREGNANT WOMEN, NEXT SLIDE. AGAIN PIVOTING TO WHAT WE CAN DO WITH WHAT WE HAVE, IN ADDITION WE'RE DOING A STUDY WITH OUR EXISTING GLOBAL NETWORK FOR WOMEN IN CHILDREN'S RESEARCH, THAT NETWORK IS CONSISTS OF 8 SITES IN 7 COUNTRIES AND IN THAT STUDY, THEY'RE USING ANTIBODY TESTING OF DELIVERY TO ESSENTIALLY DO A DESCRIPTIVE STUDY OF THE MATERNAL, FETAL ANDNYONATAL OUTCOMES AND COMPARE THEM IN THE INFECTED WOMEN TO BE NONINFECTED WOMEN. NEXT SLIDE, A BIG ISSUE FOR US IS WHETHER OR NOT THERE IS VERTICAL TRANSMISSION OF THE VIRUS. IT'S NOTE A STRAIGHT FORWARD ISSUE, THE ANGIO TENSEN CONVERSION RECEPTOR 2 OR THE ACE 2 RECEPTOR WHICH GRABS ON TO THE VIRUS AND BRINGS IT INTO THE TISSUE THERE ARE ACTUALLY CONFLICTING REPORTS AS TO WHETHER THERE ARE ACE 2 RECEPTORS IN THE PLACENTA. OUR OWN INVESTIGATORS DR. ROBERTO ROMERO, AT THE PERIINATOLOGY RESEARCH BRANCH THAT NICHD SPONSORS IN DETROIT HAS SAID THAT THE PLACENTA DOES NOT EXPRESS ACE 2 RECEPTORS. THERE'S AN ADDITIONAL STUDY RIGHT BELOW IT IN PLUS 1 THAT BASICALLY SAID, THE OPPOSITE AND THEY ACTUALLY WERE USING THE SAME PUBLICLY AVAILABLE DATA SET AND THEY INTERPRET THE DATA DIFFERENTLY. IF YOU ARE INTERESTED IN THIS TOPIC, I WOULD RECOMMEND LOOKING AT THE NATURE COMMUNICATION PAPER WHICH I THINK HAS THE MOST CONCLUSIVE EVIDENCE FOR TRANSPLACENTA TRANSMISSION SHOWING THE VIRUS ACTUALLY IN THE PLACENTA, SHOWING A BABY THAT WAS QUITE ILL AND HAD EVIDENCE OF INCREASING INFECTION OVER THE FIRST FEW WEEKS OF LIFE, THIS BABY ALSO HAD NEUROLOGIC COMPLICATIONS AND THERE ARE INDIVIDUAL CASE REPORTS BUT THEY DO SEEM TO BE RARE. NEXT SLIDE. AND THEN WHAT ABOUT THE REASON WE'RE HERE NOW, WHAT ABOUT POPULATIONS OF DISABILITIES. THERE WAS RECENTLY A PAPER ADDRESSING SOME OF THE CONSIDERATIONS FOR PEOPLE WITH DISABILITIES THAT WAS PUBLISHED IN THE AMERICAN JOURNAL OF PSYCHIATRY, SOME OF OUR INVESTIGATORS FROM OUR NETWORK OF INTELLECTUAL AND DEVELOPED MENTAL DISABILITY RESEARCH CENTER WROTE THIS AND I BELIEVE THAT THERESA WILL SPEAK MORE ABOUT THIS BUT YOU KNOW SOME OF THE CONSIDERATIONS FROM PEOPLE WITH DISABILITIES HAVE BEEN JUST TRYING TO RESTRUCTURE FACILITIES TO KEEP THEM SAFE, BUT BEYOND THAT, PEOPLE WITH DISABILITIES HAVE SUFFERED TREMENDOUSLY FROM NOT BEING ABLE TO HAVE IN-PERSON SUPPORT SERVICES AND BECAUSE THEY ARE RELIANT ON PHYSICAL HELP FROM OTHERS, SOCIAL DISTANCING HAS HAD A DISPROPORTIONATE IMPACT ON THIS POPULATION. FOR INTELLECTUAL DISABILITIES WE'RE CONCERNED ABOUT ALL CHILDREN BUT PARTICULARLY CHILDREN WHO HAVE A TYPICAL NEURODEVELOPMENT AND WHAT THAT MEANS TO NOT HAVE THE SUPPORT SERVICES THAT ARE TYPICALLY PROVIDED BY THE SCHOOL SYSTEM. SO FROM A CHILD PERSPECTIVE, IT'S VERY CLEAR THAT CHILDREN NEED TO BE IN SCHOOL, IT'S OBVIOUSLY A VERY COMPLEX ISSUE AND THE INITIAL RETURN OF POPULATIONS TO SCHOOL HAVE BEEN VERY DISCONCERTING BECAUSE OF THE RAPID SPREAD OF CORONA CORONAVIRUS. ON THE OTHER HANDLE IT HEALTH PRACTICE AND I THINK THERE ARE TELEHEALTH OPPORTUNITIES FOR RESEARCH, THAT MAY BE AN OPPORTUNITY AND MAYBE A POSITIVE THING THAT COMES OUT OF THAT. CLEARLY NOT BEING ABLE TO GO IN PERSON TO MEDICAL CARE SETTINGS CERTAINLY HAS AN ISSUE FOR PEOPLE WITH PHYSICAL AND INTELLECTUAL DISABILITIES. NEXT SLIDE. AND JUST QUICKLY WE HAVE SOME MAJOR EFFORT ON DOWN SYNDROME AND THE INCLUDE PROJECT. THERE WAS A SURVEY FROM THE TRI--[INDISCERNIBLE]--OR THEIR FAMILIES AND WHAT THEY SHOWED WAS THAT THE YOUNGER INDIVIDUALS DID NOT PRESENT WITH SEVERE DISEASE WHICH IS THE SAME AS PEOPLE WHO DON'T HAVE DOWNS SYNDROME BUT THE RISK FOR FATALITY WAS OCCURRING AT A YOUNGER AGE. PEOPLE WITH DOWN SYNDROME DO AGE PREMATURELY AND THAT IS BEING SEEN IN THE DEATHS. WE ARE PARTICULARLY INTERESTED IN COVID-19 AFFECTS INDIVIDUALS WITH DOWN SYNDROME AND WE DO HAVE AN OPPORTUNITY FOR ADMINISTRATIVE SUPPLEMENTS COMING UP. NEXT SLIDE. AND THEN WE ALSO HAD A VIRTUAL TRIALS WORKSHOP THAT WAS HELD IN EARLY MAY AND 1 OF THE THINGS THAT WAS PRESENTED WAS THE FACT THAT PEOPLE WHO HAVE DOWN SYNDROME HAVE 3 COPIES OF INTERFERON GENES THAT MAP TO CHROMOSOME 21. SO IF THEY ESSENTIALLY HAVE AN INTERFERON OPATHY, ARE THEY MORE AT RISK FOR AN EXUBERANT OVERACTIVE IMMUNE RESPONSE LIKE MIS-C, SO THAT IS A RESEARCH QUESTION THAT'S CURRENTLY PROPOSED FOR STUDY. THERE ARE CLINICAL TRIAL WORKSHOP WENT VERY WELL. WE HEARD A LOT OF CO OCCURRING CONDITIONS THAT ARE LISTED ON THIS SLIDE. I THINK, WHAT I TOOK AWAY FROM THIS WAS THAT HEARING FROM THE SELF-ADVOCATES AND THE PARENTS HOW ACTUALLY TELEHEALTH HAS BEEN A GREAT OPPORTUNITY AND FAMILIES ARE VERY, VERY WILLING TO PARTICIPATE IN RESEARCH THROUGH A TELEMECHANISM. SO I THINK THERE WILL BE OPPORTUNITIES FOR THE FUTURE. NEXT SLIDE, PLEASE. NEXT SLIDE. SO AS MOST OF YOU KNOW, WE PRESENTED OUR STRATEGIC PLAN FOR THE NEXT 5 YEARS JUST ABOUT A YEAR AGO NOW, AND NOW WE ARE WORKING ON IMPLEMENTATION OF THE PLAN, FOR 3 FOCUS AREAS, SCIENTIFIC RESEARCH THEME, SCIENTFIC STEWARDSHIP AND MANAGEMENT AND ACCOUNTABILITY. NEXT SLIDE, PLEASE. SO WE'RE WORKING WITH THE NICHD STAFF TO CONSIDER HOW TO MAKE PROGRESS TOWARDS EACH GOAL. WE HAVE ALREADY REFRESHED THE EXTRA MURAL BRANCH PRIORITIES, THEY HAVE BEEN FINALIZED AND THEY'RE QUITE UP TO DATE, I CHECKED OVER THE WEEKEND BEFORE I ACTUALLY WAS GOING TO SAY THIS AND THEY ARE THERE. SO IF YOU WANT TO THINK ABOUT WHAT THE BRANCHES ARE PRIORITIZING, YOU CAN GO DIRECTLY TO THE DIVISION OF EXTRA MURAL RESEARCH BRANCHES ON THE WEBSITE. NEXT SLIDE. HOWEVER, AS WE CERTAINLY LEARN FROM THIS EXPERIENCE, THIS YEAR, THAT WE NEED TO HAVE FLEXIBILITY. SO HERE'S COVID-19 THAT'S COMING RIGHT IN THE MIDDLE OF THE FISCAL YEAR WHILE FUNDS ARE PRETTY MUCH COMMITTED FOR MOST OF THE YEAR, AND YOU KNOW WE NEED TO BE ABLE TO RAPIDLY PIVOT TOWARDS SO MANY OF THE QUESTIONS THAT NEED TO BE ADDRESSED IN PARTICULAR FOR OUR POPULATION. SO, THE PRIORITIES ARE NOT WRITTEN IN STONE BUT WE NEED TO HAVE FLEXIBILITY TO ADJUST AS WE MOVE THROUGHOUT EACH YEAR. NEXT SLIDE. SO YOU WANT TO JUST GO THROUGH THE NEXT BULLET, PLEASE. SO WHAT HAVE WE ACCOMPLISHED IN--YEAH, THERE ARE 5 THINGS. THANK YOU. --WHAT HAVE WE ACCOMPLISHED SO FAR IN TERMS OF THE DIFFERENT SCIENTIFIC THEMES? SO WITH REGARD OF THEME 1 OF THE STRATEGIC PLAN, WE HAVE REISSUED FUNDING OPPORTUNITY ANNOUNCEMENTS. FOUR, THE INTELLECTUAL AND DEVELOPMENTAL DISABILITIES RESEARCH CENTER. WITH ARE REGARD TO 2, WE ESTABLISHED INTRAMURAL ADOLESCENT AND PEDIATRIC GYNECOLOGY PROGRAM AT THE CLINICAL CENTER, WITH TEAM 3, WE'VE HELD THE MATERNAL MORTALITY AND CO MORBIDITY WORKSHOP, WE'VE ALSO FUNDED SUPPLEMENTS FOR A NEW TRANSNIH INITIATIVE AT THE ETERNAL MORBIDITY AND MORTALITY KNOWN AS IMPROVE. WITH THEME 4 IN A FEW WEEKS, WE WILL BE HAVING A WORKSHOP ON NAVIGATING PEDIATRIC TO ADULT HEALTHCARE AND I THINK THIS IS SOMETHING THAT IS OF INTEREST TO THIS ADVISORY BOARD BECAUSE LET'S JUST SAY CHILDREN CHALLENGES IN NEGOTIATING OR NAVIGATING THAT TRANSITION TO AN ADULT CARE SETTING SO THAT IS GOING TO BE ADDRESSED IN A WORKSHOP AND OF COURSE IT'S FREE TO ATTEND THAT. SO IF THAT'S OF INTEREST WE CAN MAKE THE REGISTRATION INFORMATION AVAILABLE TO YOU. AND LASTLY, BEING THEME 5 WHICH HAS TO DO WITH DEVELOPING DRUGS AND DEVICES FOR OUR POPULATIONS WE'RE FINIZING THE IMPLEMENTATION PLAN FOR THE TASK FORCE ON RESEARCH SPECIFIC TO PREGNANT WOMEN AND LACTATING WOMEN ALSO KNOWN AS PRGLAC, I THINK WE FINALIZED IT. WE'RE DAYS AWAY FROM SUBMITTING IT TO SECRETARY AZAR AND AND IT'S VERY IMPORTANT THAT THOSE RECOMMENDATIONS ARE IMPLEMENTED, IT COMES TO HEAD WITH THE WHOLE ISSUE OF VACCINES IN PREGNANT WOMEN. HERE WE ARE, WE ARE SAYING IN THIS REPORT THAT PREGNANT WOMEN SHOULD BE INCLUDED IN TRIALS OF VACCINES FOR COVID,OT OTHER HAND WE HEAR THE MAJORITY OF THE PHARMA COMPANY SAYING THEY DON'T WANT TO INCLUDE PREGNANT WOMEN IN THEIR RESEARCH STUDIES. SO IT WILL BE INTERESTING TO SEE IF WE CAN ACTUALLY DO SOMETHING WITH THIS REPORT. THERE'S BEEN A TREMENDOUS AMOUNT OF WORK ASSOCIATE WIDE IT AND THE TASK FORCE HAS BEEN TERRIFIC. NEXT SLIDE. AND AGAIN, YOU KNOW WE HAVE MADE A COMMITMENT TO BE TRANSPARENT AND WE WILL REGULARLY REPORT ON PROGRESS TO ALL OF OUR ADVISORY BOARDS AND SX HEAT ADVISORY COUNCIL. NEXT SLIDE. I'M ALMOST DONE. SO IN THE MIDDLE OF ALL THIS, WE HAD A MAJOR SET OF TRANSITIONS THAT OCCURRED IN JANUARY-FEBRUARY SO ALL THE WONDERFUL PEOPLE THAT I WILL DESCRIBE TO YOU AGREE TO SERVE IN THEIR ACTING POSITIONS BEFORE WE EVER IMAGINE HOW COVID-19 WOULD TURN LIFE AS WE KNOW IT UPSIDE DOWN. SO WE'RE TREMENDOUSLY GRATEFUL TO ALL OF THEM FOR DOING WHAT THEY'RE DOING BY DOING IT BUT DOING IT UNDER EXCEPTIONAL CIRCUMSTANCES SO LET ME START WITH ROHAN HAZRA, ACTING ASSOCIATE DIRECTOR FF EXTRA MURAL RESEARCH, [INDISCERNIBLE] ACTUALLY HAD TO POSITIONS SO WE DECIDED TO SPLIT HER JOB AT LEAST TEMPORARILY INTO 2 POSITIONS. SO ROHAN AGREED TO SERVE IN EARLY FEBRUARY. IF YOU DON'T KNOW HIM HE'S A GRADUATE OF JOHNS HOPKINS SCHOOL OF MEDICINE, DID HIS POODIATRIC RESIDENCE SKPE --AND POODIATRIC FELLOWSHIP IN BOSTON AND HOW LUCKY WERE WE THAT BY CHANCE AT THIS TIME IN THE WORLD THAT OUR DIRECTOR OF EXTRA MURAL RESEARCH IS AN EXPERT IN INFECTIOUS DISEASE. SO ROHAN HAS NOT ONLY DONE THIS POSITION FOR EXTRA MURAL RESEARCH BUT HE HAS BEEN AN INCREDIBLE LOAMACYY VALUABLE RESEARCH AND CONSULTANT AND LEADER IN TERMS OF HOW ARE WE AS AN INSTITUTE GOING TO DEAL WITH COVID-19. HE'S BOARD CERT JUSTIFIED IN BOTH PEDIATRICS AND PEDIATRIC ID AND HE CAME TO NICHD IN 2007. AND BEFORE THAT HE WAS IN NCI WHEREEE CONDUCTED CLINICAL STUDIES IN PEDIATRIC HIV, BUT IN 2007 HE CAME TO NICHD, OVERSEEN THE PEDIATRIC HIV/AIDS COHORT STUDY KNOWN AS PHACS, AND HE HAS HIS OWN INTEREST RESEARCH STUDY IN STUDYING THE LONG-TERM IMPACT OF HIV AND ITS TREATMENT ON CHILDREN, ADOLESCENTS AND YOUNG ADULTS WHO WERE INFECTED WITH HIV AS INFANTS. NEXT SLIDE, PLEASE. SO THE OTHER HALF OF THE POSITION WAS THE--SO ROHAN IS THE MORE SCIENTIFIC SIDE BUT THERE'S A TREMENDOUS AMOUNT OF ADMINISTRATIVE EFFORT THAT ALLOWS ALL OF THE GRANTS TO GET PROCESSED AND FUNDED AND ALL OF THE ASSOCIATED ACTIVITIES WITH THAT AS WELL AS OUR COUNCIL, SO GENE HAYUNGA ISAUR ACTING DIRECTOR, DIVISION OF EXTRA MURAL RESEARCH. HE WAS NAMED ACTING DIRECTOR IN FEBRUARY 2020. HE'S CONDUCTED RESEARCH IN TROPICAL MEDICINE AT THE USDA, UNIFORMED SERVICES UNIVERSITY OF HEALTH AND SCIENCES AND NAVAL MEDICAL RESEARCH INSTITUTE, ALSO HAD A STINT IN THE U.S. SENATE WHERE HE WORKED ON MEDICARE REFORM, ALSO A DECORATED COMBAT VETERAN, SERVED IN ACTIVE DUTY SKPE BAKUGAN RESERVE ASSIGNMETS IN THE ARMY WHICH WAS ALL GOOD TRAINING FOR WORKING AT NICHD. HE HAS ALSO BEEN AT OTHER INSTITUTES AT NIH, HE WAS CHIEF OF THE EXTRA MURAL PROJECT REVIEW BRANCH AT THE OFFICE OF SCIENTIFIC AFFAIRS AT NIAAAA,S AND RESEARCH POLICY OFFICER AT THE NIH OFFICE OF WOMEN'S HEALTH. SO HE'S HAD A WELL EXPERIENCED CAREER AND WE'RE DELIGHTED HE IS SERVING IN THIS ROLE RIGHT NOW. IN ADDITION, DR. CONSTANTINE [INDISCERNIBLE] STEPPED DOWN IN FEBRUARY, SO WE HAD 2 OF OUR ESSENTIALLY THE TOP 5 LEADERS AT NICHD STEP DOWN AT THE SAME TIME AND SO WE NEEDED TO NAME AN ACTING DIRECTOR OF THE INTRAMURAL RESEARCH PROGRAM WHICH IS A SIGNIFICANT PART OF OUR PROGRAM BOTH FINANCIALLY AND STAFF WISE ABOUT 900 PEOPLE WORKED IN OUR INTRAMURAL PROGRAM. SO MARY DASSO AGREED AGAIN, PRIOR TO COVID WHO DIDN'T REALLY KNOW WHAT SHE WAS GETTING INTO BUT ALL THESE PEOPLE HAVE BEEN DOING A FANTASTIC JOB, MARY GOT HER Ph.D. AT THE UNIVERSITY OF CAMBRIDGE AS A MARSHAL SCHOLAR IN BIOCHEMISTRY. SHE THEN BECAME A DAMON RUNYON, FELLOW AT UNIVERSITY OF CALIFORNIA SAN DIEGO WHERE SHE BEGAN TO STUDY CELL CYCLE REGULATION. SHE CAME TO NICHD IN 1992 AND RECEIVED TENURE IN 2000. AND SHE'S THE HEAD OF THE SECTION ON CELL CYCLE REGULATION. SHE'S--HER LAB STUDIES MECHANISMS OF CHROMOSOME SEGREGATION. SHE ALSO BECAME THE ASSOCIATE SCIENTIFIC DIRECTOR FOR BUDGET AND ADMINISTRATION WHEN THE INTRAMURAL PROGRAM REORGANIZED IN 2015. NEXT SLIDE. AND LAST BUT NOT LEAST, WE HELD ON NAMING A PERMANENT DIRECTOR OF OUR DIVISION OF INTRAMURAL POPULATION HEALTH RESEARCH BECAUSE WE WERE CONSIDERING WHERE THIS DIVISION WOULD FIT WITHIN THE INTRAMURAL PROGRAM. HISTORIC --HISTORICALLY HAD HAD BEEN OUTSIDE OF THE INTRAMURAL PROGRAM HAVING ITS OWN RELATIONSHIP AND WE WANTED TO MAKE A DECISION AND ASSOCIATE IT WITH STRATEGIC PLANNING AND REORGANIZATION OF THE INSTITUTE. SO WE HAD TEMPORARILY ASKED DR. [INDISCERNIBLE] TO BE THE ACTING DIRECTOR AND WHEN HE STEPPED DOWN WE NEEDED TO NAME A NEW ACTING DIRECTOR. SO DR. UNA, GREWALL HAS BEEN FEBRUARY AGAIN DIDN'T KNOW WHAT SHE WAS GETTING INTO, SHE EARNED HER MPH AND Ph.D. DEGREE IN EPIDEMIOLOGY FROM THE UNIVERSITY SCHOOL OF MICHIGAN PUBLIC HEALTH, SHE CAME TO NICHD IN 2007 AS A STAFF SCIENTIST AND IN THE EPIDEMIOLOGY BRANCH AND HER RESEARCH FOCUSES ON FETAL GROWTH AND PREGNANCY OUTCOMES TO ESPECIALLY IN RELATION TO MATERNAL NUTRITION AND SHE WAS NAMED THE DEPUTY DIRECTOR IN 2013 AND SHE ALSO HAS BEEN SERVING EXCEPTIONAL--I REALLY FEEL INCREDIBLY FORTUNATE TO HAVE SUCH A STRONG TEAM WHO CAME TOGETHER UNDER THESE CIRCUMSTANCES AND THEY'RE DOING AN AMAZING JOB. NEXT SLIDE, PLEASE. SO WE DO HAVE MAJOR SEARCHES UNDERWAY, SO THE LAST 2 POSITIONS THAT I MENTIONED, SO WE ARE MAKING EXCELLENT PROGRESS WITH SELECTION OF OUR NEW SCIENTIFIC DIRECTOR. WE HAD A ROBUST RESPONSE TO THE APPLICATION ANNOUNCEMENT AND WE ALREADY HAVE A SHORT LIST AND THE SHORT LIST WAS DETERMINED BY INTERVIEWING THE HIGHLY QUALIFIED APPLICANTS AND NOW, THE SHORT LIST IS IN OUR OFFICE AND WE--CALENDAR YEAR AND THE PERINENT DIRECTOR FOR DIPHR, IS A MONTH BEHIND BUT UNDERGOING THE SAME SELECTION PROCESS, THEY ARE JUST NOW MOVING TO THE FIRST ROUND OF INTERVIEW. SO I JUST WANT TO COMMUNICATE THAT PROGRESS IS BEING MADE WITH REGARD TO EXTRA MURAL RESEARCH, WE ARE HOLDING ON THE DEFINITION OF THOSE POSITIONS UNTIL WE MAKE A LITTLE BIT MORE HEAD WAY IN TERMS OF IMPLEMENTATION OF OUR STRATEGIC PLAN. THE DIVISION OF EXTRA MURAL RESEARCH WILL LIKELY UNDERGO SOME REORGANIZATION, SO WE ARE HOLDING THOSE 2 POSITIONS UNTIL WE KNOW EXACTLY WHAT THE POSITIONS WILL ENTAIL IN THE FUTURE. NEXT SLIDE. SO, AGAIN WE'RE TRYING TO HIRE PEOPLE. THIS IS AN EXCELLENT TIME TO COME TO WORK FOR THE GOVERNMENT FOR PEOPLE WHO ARE CONCERNED ABOUT THE FUTURE OF ACADEMIA. SO IF ANY OF YOU HAVE FRIENDS WHO ARE INTERESTED IN BEING A SENIOR POLICY ADVISOR FOR CLINICAL RESEARCH AND IMPORTANTLY, WE REALLY, REALLY, REALLY NEED A BRANCH CHIEF TO PREPARE THESE PEOPLE FOR THE BRANCH, IDEALLY WE'RE LOOKING IF ARE A SENIOR PERSON WITH A BACKGROUND IN FETAL MEDICINE OR NEONATAL PERINATOLOGY, THERE WILL AND THEY ARE OFFERING A 12 WEEK MATERNITY LEAVE SO THAT A HUGE BENEFIT. WE ARE WORKING WITH PROGRAM OFFICERS, I'M SCHEDULED TO SPEAK WITH CANDIDATES THIS WEEK BUT AGAIN WE WANT GOOD PEOPLE TO COME TO WORK FOR US, IT DOESN'T MEAN THAT WE CAN'T GO BACK TO ACADEMIA. SO THERE'S MORE INFORMATION AT THE WEBSITE HERE, SO NEXT SLIDE. SO THAT'S KIND OF WHAT I WANTED3 TO COMMUNICATE. I THINK I HAVE AN HOUR, HOW AM I DOING FOR TIME? >> YOU'RE DOING REALLY WELL. WE HAVE LIKE 4 MINUTES LEFT AND HOPEFULLY PEOPLE HAVE QUESTIONS THAT CAN FIT INTO 4 MINUTES. >> AND YOU CAN SPEAK OR YOU CAN USE THE CHAT BOX IF YOU'RE COMFORTABLE WITH THAT. >> DIANNA THIS IS CRAIG MCDONALD. I HAD A QUESTION. >> SURE. >> I WAS STRUCK BY YOUR COMMENTS ABOUT--IT WAS GREAT OVERVIEW, REALLY APPRECIATE IT, I WAS STRUCK BY YOUR COMMENTTHE USE OF TELEHEALTH FOR THE FAMILIES AND PATIENTS WITH DOWN SYNDROME AND THEY'RE INCREASED WILLINGNESS TO PARTICIPATE IN CLINICAL RESEARCH AND DURING THIS PANDEMIC, I THINK THOSE OF US WHO HAVE BEEN INVOLVED IN CLINICAL TRIALS HAVE BEEN STRUCK BY HOW THE USE OF TELEHEALTH AND DIGITAL TECHNOLOGIES AS REALLY ENHANCED OUR ABILITY TO CONDUCT CLINICAL RESEARCH AND CLINICAL TRIALS. OBVIOUSLY REMOTE VISITS, DIGITAL BIOMARKERS AND SO FORTH CAN ENHANCE POLITICAL CARE BUT ALSO ENHANCE OUR CLINICAL TRIALS AND CLINICAL RESEARCH AND CAN ADDRESS ISSUES SUCH AS GEOGRAPHIC BURDENS AND TERMS IN IMPROVING OUR GEOGRAPHIC REACH, DECREASES TIME REQUIRED FOR VISITS AND THE BURDEN OF PARTICIPANTS, YOU KNOW IMPROVES REAL WORLD COMMUNITY BASED ASSESSMENTS AND CAN PERHAPS DECREASE THE COST OF TRIALS BUT IS NICHD, NIH AND PERHAPS NCMRR LOOKING AT RFAs TO PROMOTE THE USE OF TELEHEALTH, DIGITAL BIOMARKERS AND SO FORTH RELATED TO DISABILITIES POPULATIONS AND OTHER POPULATIONS THAT MAY HAVE HEALTH DISPARITIES? >> SO, YOU KNOW I'LL LET THERESA ANSWER THAT AS WELL BUT I MEAN, REMEMBER WE'RE WHAT? FIVE-6 MONTHS INTO THE PANDEMIC RIGHT NOW AND I THINK WHAT HAS SHOWN US IS IT'S BEEN A FAST LEAP INTO THE FUTURE WHEREAS I THINK WE WERE TIP TOEING AROUND SOME OF THE ISSUES OF DOING CLINICAL TRIALS REMOTELY. THIS HAS SHOWN US A LOT ABOUT WHAT WE CAN DO. SO, RIGHT NOW, THE FOCUS FOR OUR STAFF, WE'RE WORKING VERY HARD IS ON GETTING THE RFAs OUT FOR SOME OF THE STUDIES THAT I MENTIONED BUT WE ARE ENCOURAGING PEOPLE TO THINK IN THE NEXT PHASE ABOUT, YOU KNOW ASSUMING THAT COVID GETS UNDER CONTROL, HOW CAN WE REENVISION ALL SORTS OF CLINICAL STUDIES? THE ABILITY TO DO CLINICAL RESEARCH AND PARTICULARLY FOR REMOTE POPULATIONS OR UNDERSERVED POPULATIONS AS LONG AS THEY HAVE INTERNET ACCESS AND THAT'S NOT A GUARANTEE BUT YOU KNOW SO MANY PEOPLE DO HAVE ACCESS TO A MOBILE PHONE WHO CAN PARTICIPATE VIA THE PHONE FOR EXAMPLE. SO I THINK--I TOTALLY AGREE WITH YOU, I THINK THIS IS THE FUTURE BUT WE'RE NOT QUITE THERE YET. BUT EVERYBODY HAS, YOU KNOW THEIR ANTENNAS OUT AND WE'RE OBSERVING AND LEARNING AND PROCESSING THE INFORMATION AND IT WILL CERTAINLY BE INCORPORATED AS WE GO FORWARD. THE I DON'T KNOW, THERESA DO YOU WANT TO ADD SOMETHING? >> SURE. YOU KNOW NCMRR HAS BEEN TOUTING TELEREHAB FOR AS LONG AS I'VE BEEN HERE AND THAT'S OVER 10 YEARS, IF YOU LOOK AT OUR RESEARCH PLAN FROM 2016, SPECIFICALLY CALLS OUT TELEHEALTH, WE'VE BEEN INVOLVED IN MANY DIFFERENT INITIATIVES OVER THE YEARS TO ADD IN-HEALTH TECHNOLOGY TO EXISTING CLINICAL TRIALS, CAN WE START VALIDATING THESE MEASURES, RIGHT? IT'S HARD TO PIVOT IN THE MIDDLE OF THE TRIAL AND SAY NOW ALL OF A SUDDEN, ALSO, ALL THE OUTCOMES ARE GOING TO BE VIRTUAL OR DONE IN A DIFFERENT MANNER. SO, I WOULD SAY THAT THIS IS SOMETHING THAT WE'VE BEEN DOING FOR A LONG TIME, THIS JUST SHINES A NEW LIGHT ON THE IMPORTANCE OF IT. IS THERE A SPECIFIC RFA WITH X-MILLIONS OF DOLLARS SET ASIDE? NO, BUT WE'VE ALWAYS BEEN ACCEPTING THESE APPLICATIONS AND WE CONTINUE TO WOMAN THEM AND I WOULD ALSO POINT OUT THAT 1 OF OUR PRIORITIES, 1 OF OUR RESEARCH PRIORITIES IS AROUND REAL WORLD OUTCOME. SO WE'VE BEEN FOCUSING ON FUNCTION IN THE COMMUNITY, SO I THINK MAYBE PEOPLE ARE CATCHING UP TO US. >> OKAY, WELL, THANK YOU SO MUCH, DIANNA, THAT WAS A GREAT OVERVIEW OF THE PROGRESS AND THANKS IF YOU ALL YOUR HARD WORK DURING THESE REALLY UNUSUAL TIMES, SO MUCH APPRECIATED. >> THANK YOU. AND I'LL BE LISTENING IN. I WILL TURN OFF MY VIDEO FOR BAND WIDTH PURPOSES. SO THANK YOU. PLEASE FEEL FREE TO USE THE CHAT BOX IF YOU HAVE ADDITIONAL QUESTIONS. >> GREAT IDEA, MAINK YOU IF ARE THAT. SO NEXT IT'S A GREAT PLEASURE TO TURN THE FLOOR OVER TO THERESA CRUZ AND I'M SURE I SPEAK FOR THE ENTIRE BOARD WHEN I SAY HARDY CONGRATULATIONS, WE ARE SO EXCITED TO HAVE YOU AT THE HELM AND WE WISH YOU THE BEST OF SUCCESS AND WE YOU KNOW WE ARE BEHIND YOU AND WILLING TO HELP OUT WITH ANYTHING YOU WOULD LIKE TO,A SIGN TO US. CONGRATULATIONS. >> AND ESPECIALLY FROM THE STAFF WITHIN NCI AS WELL, I WILL ADD THAT. [LAUGHTER] >> WELL, THANK YOU, EVERYONE, YOU KNOW I REALLY APPRECIATE ALL THE KIND WORDS AND SUPPORT. LAST YEAR ALL OF IT HAS NOT BEEN THE EASIEST TIME TO DO TRANSITIONS AND BE AN ACTING AND I CERTAINLY DID NOT THINK THIS WOULD BE HOW WE WOULD BE HAVING MY FIRST MEETING AS A DIRECTOR WITH YOU ALL BUT YOU KNOW WE ARE MAKING IT WORK AND I APPRECIATE THE SUPPORT AND I THINK WE'RE GOING TO COME OUT AS A STRONGER GROUP ON THE OTHER END WITH ANY LUCK. NEXT SLIDE. I THOUGHT IT WOULD BE FITTING TO TALK ABOUT ANNIVERSARIES AS A--YOU KNOW AM ON DAY 2 OF THE JOB. YOU KNOW 30 YEARS AGO IN JULY, THE AMERICANS WITH DISABILITIES ACT WAS SIGNED AND THIS IS A WATERSHED LEGISLATION THAT REALLY OPENED DOORS FOR PEOPLE WITH DISABILITIES IN TERMS OF EMPLOYMENT AND PARTICIPATION AND IT REALLY LAID THE GROUND WORK FOR THE CREATION OF THE CENTER. OUR LEGISLATION WAS SIGNED IN NOVEMBER OF 1990 SO WE'RE COMING UP ON OUR 30th ANNIVERSARY AS WELL. DR. BIANCHI, HAS BEEN INVITED NCMRR TO SPEAK ABOUT THAT IN OUR COUNCIL MEETING IN SEPTEMBER, SO WE WILL BE GIVING AN UPDATE AND A REVIEW OF THE 30 YEARS OF NCMRR THEN AND I WOULD ENCOURAGE YOU TO PARTICIPATE IN THAT MEETING AND WE MIGHT TALK ABOUT THAT SOME MORE IN DECEMBER. NEXT SLIDE. THE BRIEF AGENDA FOR TODAY. NEXT SLIDE; AGAIN. AND THERE IS GOING TO BE A QUIZ LATER BETWEEN DR. BIANCHI, STAFF UPDATES AND NCMRR STAFF UPDATES, I HOPE YOU ALL HAVE YOUR BINGO CARDS OUT. I WOULD HOPE THAT IT'S CLEAR THAT WE ARE BEING AS FLEXIBLE AND ADAPTABLE AS WE CAN IN GETTING THE WORK DONE. I WANTED TO ACKNOWLEDGE ELIZA POLK, SHE'S OUR NEW ADMINISTRATIVE ASSISTANT AND IF WE EVER GET TO FLY YOU INTO BETHESDA AGAIN, SHE WILL HELP YOU WITH YOUR TRAVEL NEEDS. WE HIRED A NEW HEALTH SPECIALIST, ALICIA ROSS, SHE STARTED YESTERDAY SO I HAVEN'T ASKED HER TO JUMP INTO THIS MEETING YESTERDAY BUT SHE JOINS US FROM THE NATIONAL LIBRARY OF MEDICINE AND WE ARE IN THE PROCESS OF ONBOARDING A NEW PROGRAM OFFICER THAT WE HOPE TO BE AT FULL STAFF BY THE TIME WE MEET IN DECEMBER. AND SOME OF THESE HIRES WERE BECAUSE OF SOME TRANSITIONS THAT WE'VE HAD SO YOU ALL KNOW HOW WONDERFUL JENNIFER JACKSON IS, OUR ANALYST, HER REPUTATION PROCEEDS HER AND WHEN RADX STARTED AND DR. BIANCHI GAVE A GREAT OVERVIEW OF THAT BEHEMEOUTH OF A PROGRAM, WE SAID WE NEED HELP WITH DATA. I KNOW LET'S ASK JENNIFER, SO SHE WAS ASKED TO DETAIL NIBIB, AND WE ARE SO PLEASED AND PROUD OF THE WORK SHE'S DOING OVER THERE TO HELP THEM MANAGE ALL THEIR THOUSANDS OF APPLICATIONS AND SHE REALLY ROSE TO THE OCCASION SO WE'RE-MARKED FOR IDENTIFICATION NCMRR IS HELPING WITH THE COVID RESPONSE IN AT LEAST THAT TANGIBLE MANNER AND THEN WE ALSO HAD ADAM POLITIS, WHO IS THE DIRECTOR OF THE REHAB PROGRAM AT THE NIH CLINICAL CENTER AND SHE'S BEEN INTERESTED IN MEN AND WOMEN EXTRA MURAL DOES SO HE'S COME ON AS A SPECIAL ASSISTANT TO OUR DIRECTOR SCOTT [INDISCERNIBLE] AND DEPUTY DIRECTOR AND OF COURSE INTEREST IN REHAB OF COURSE HE'S BEEN JOINING SCMRR IN OUR ENDEAVORS AND I WILL SPEAK A LITTLE BIT ABOUT THE WORK HE'S DOING SO THESE ARE OUR NEW HIRES. NEXT SLIDE, PLEASE. OKAY, I WANTED TO HAVE--NEXT SLIDE, THIS HAS A LITTLE BIT ABOUT NIH THAT APPLY TO THE REHAB COMMUNITY. SPECIFICALLY, SO, AGAIN, WE'RE OPEN, BUT PATIENT CARE AND RESEARCHER SAFETY IS REALLY OUR FIRST PRIORITY, AND I TALK TO PEOPLE ALL OVER THE COUNTRY AND SOME ARE DOING CLINICAL WORK AGAIN AND SOME ARE NOT. YOU'RE ALL AT DIFFERENT PLACES AND WE ARE TRYING TO BE AS FLEXIBLE AND ACCOMMODATING AS POSSIBLE. THERE WERE MANY ADMINISTRATIVE FLEXIBILITIES ISSUED IN MARCH. MANY OF THOSE EXPIRED, OKAY? SO THINGS LIKE GETTING YOUR PROGRESS REPORTS IN ON TIME, WE'RE BACK TO THOSE DAYS BUT IMPORTANTLY 1 FLEXIBILITY HAS BEEN EXTENDED AND THAT IS SALARY SUPPORT DURING PANDEMIC RELATED SHUT DOWNS, SO YOU ARE ABLE TO STILL CONTINUE TO KEEP YOUR LAB PAID AND YOUR STAFF. WE REALLY DON'T WANT TO LOSE PROMISING RESEARCHERS BECAUSE OF THIS, SO PLEASE KEEP IN MIND THAT THAT FLEXIBILITY IS STILL IN PLACE, I KNOW A LOT OF YOU ARE PREPARING APPLICATIONS FOR THE FALL DEADLINE AND PLEASE KNOW THAT THERE IS A NOTICE OUT FOR APPLICANTS. THE NUMBER IS LISTED HERE, THE GIST OF IT IS DO NOT INCLUDE CONTINGENCY PLANS FOR COVID, ASSUME EVERYTHING'S GOING TO WORK OUT FINE AND YOU WILL BE ABLE TO DO THE WORK YOU PLANNED, FOCUS ON THE SCIENCE. OKAY? AND THEN ON THE FLIP SIDE, THE REVIEWERS HAVE BEEN GIVEN GUIDANCE TO ASSUME THAT THE PANDEMIC RELATED ISSUES WILL BE RESOLVED SO WE WANT EVERYONE FOCUSING ON THE SCIENCE, AND NOT BEING JUDGED ON HOW MANY, YOU KNOW PPE SUPPLIES YOU'VE GOT IN YOUR LAB, THINGS LIKE THAT, OKAY? AND YOU KNOW AS USUAL, IF YOU HAVE SPECIFIC QUESTIONS, REACH OUT TO YOUR PROGRAM STAFF, GRANTS MEMBERMENT STAFF, THESE ARE GUIDELINES BUT EACH 1 SPECIFIC CASE WILL BE A BIT DIFFERENT. SO WE'RE HERE FOR THAT. NEXT SLIDE. SO THE--SO ABOUT A YEAR AND A HALF AGO, NONI FOR SCIENTIFIC REVIEW CAME TO NICHD COUNCIL AND YOU HAVE A PRESENTATION ABOUT THE END CHOIR PROGRAM, NOT SURE HOW THE ACRONYM WORKS OUT BUT IT'S ABOUT EVALUATING PANEL QUALITY AND REVIEW. AND THIS IS SO IMPORTANT, SO I REALLY WANT TO EMPHASIZE THAT THIS IS A GOOD THING, OKAY? NIH WORKS BECAUSE OF PEER REVIEW. SO WE NEED TO EVALUATE EVERY SO OFTEN AND IN THIS CASE, ALIGN WITH THE CURRENT STATE OF THE SCIENCE. OKAY? SO THE OUTCOME OF THE MOST RECENT ROUND HAS BEEN PUBLISHED JULY 31st THEY MADE THE ANNOUNCEMENTS TO THE PUBLIC AND THERE WERE SEVERAL CHANGES TO STUDY SECTIONS THAT ARE RELEVANT TO REHABILITATION RESEARCHERS. AND THESE GO INTO EFFECT FOR THE OCTOBER DUE DATE. SO IF YOU WERE PLANNING TO SUBMIT AN APPLICATION, FOR EXAMPLE, BEHAVIORIAL MEDICINE, INTERVENTION AND OUTCOMES, BMIO, THAT STUDY SECTION NO LONGER EXISTS, OKAY? NEXT SLIDE. THERE WERE MAJOR CHANGES MADE IN THE HEALTHCARE DELIVERY IRG THINGS LIKE HEALTH SERVICES, DISSEMINATION ASK IMPLEMENTATION RESEARCH AND IN MANY CASES 8 OR 9 OR 10 STUDY SECTIONS WERE ELIMINATED AND NEW 1S WERE CREATED IN THEIR PLACE. THE OTHER 1 I WANT TO BRING NONAPOPTOTIC YOUR ATTENTION AND THE SENSORY MOTOR INTEGRATION 1 UNDER THE INTEGRATIVE FUNCTIONAL AND COGNITIVE NEUROSCIENCE IRG, SO IF YOU ARE WORKING MORE AT THE BASIC END OF THE SPECTRUM, YOU MIGHT BE APPLYING TO SMI. THESE ARE JUST SOME OF THE 1S THAT I PULLED OUT. THERE ARE OTHERS IN CARDIAC IN [INDISCERNIBLE], IF YOU ARE PLEASE, PUTTING IN APPLICATIONS IN THE FALL REALLY TAKE A LOOK AT THE STUDY SECTIONS THAT WILL BE AVAILABLE, LOOK AT THE NEW DESCRIPTIONS, THE 2 STUDY SECTIONS MMRS, SCALABLE RESEARCH SCIENCE AND MOTOR FUNCTION AND SPEECH AND REHAB HAVE NOT BEEN EVALUATED YET. SO THOSE ARE STILL THERE, BUT THERE ARE TIMES COMING, I DON'T KNOW WHEN BUT I HOPE IF YOU WERE ASKED TO PARTICIPATE, I KNOW MANY OF YOU HAVE SURGED ON THE PANELS AND HAVE YOU A LOT OF OPINIONS. IF YOU'RE--IF YOU GET PATCHED TO HELP WITH THIS EFFORT, I DO HOPE YOU TAKE AD ADVANTAGE OF IT BECAUSE I THINK THIS IS REALLY IMPORTANT FOR THE FIELD. OKAY. NEXT SLIDE. SO I DID WANT TO SPEAK A LITTLE BIT ABOUT REHABILITATION AND COVID-19 AND FIRST WE NEED TO STOP AND THANK ALL THE PEEP, FRONT LINE WORKER ANDS HEALTHCARE FIELD AND OF COURSE THE FORMAL AND INFORMAL CARE TAKERS THAT WERE DOING MORE THAN A WERE 6 MONTHS AGO AND WE TALKED A BIT ABOUT THIS AND DR. BIANCHI, TALKED ABOUT THIS BUT I WANTED TO SPENDIE FEW MINUTES TALKING ABOUT COVID AND REHAB. NEXT SLIDE. AND THERE'S A FEW ANIMATIONS HERE SO CAN YOU GO THROUGH THEM BUT IF YOU GO TO PUBMED AND PUT IN REHAB AND COVID-19 YOU WILL SEE LOTS OF ARTICLES LIKE THIS. SO ANALYSIS AND PERSPECTIVE. NEXT. YEAH, JUST RUN THROUGH THE NEXT FEW CLIPS. VIEW POINTS, LETTERS TO THE EDITOR. GREAT, THANKS. HOLD THERE AND THESE HAVE BEEN SO IMPORTANT TO DRAW THE ATTENTION OF THE REHABILITATION NEEDS OF SURVIVORS OF COVID-19 AND DISSEMINATING BEST PRACTICES BUT I WOULD SAY THERE'S VERY LITTLE DATA ON THE CURRENT PANDEMIC ATTACHED TO THEM. SO IF YOU LOOK FOR CLINICAL TRIALS, FOR EXAMPLE, I COULD ONLY FIND 1. AND REHAB IS BEING SUGGESTED FOR EVERYTHING POSSIBLE WHICH IS WONDERFUL, THINGS LIKE CARDIO PULL MONITORARY, POST ICU SYNDROME, CONDITIONING, DISPHASIA, HEADACHE, STROKE, COGNITIVE EFFECTS AND SOAK LOGICAL EFFECTS AS WELL, SO I APLIEWD --APPLAUD PEOPLE FOR BRINGING ATTENTION TO THE PEOPLE OF COVID-19 SURVIVORS WITH REGARD TO RESEARCH AND EXPECTATION BUT WE REALLY NEED TO BACK UP THE DATA. NEXT SLIDE. ON TOP OF ALL OF THAT, WE'VE ALSO TALKED ABOUT HOW SERVICES ARE BEING DISRUPTED SO PEOPLE WHO DON'T HAVE COVID-19 ARE STILL BEING AFFECTED BY THE MITIGATION STRATEGIES SO HERE'S A PAPER FROM JANET BECKER AND JILL STEIN ALONG WITH THEIR INTERNATIONAL COLLEAGUES TO TALK ABOUT WHAT KIND OF SERVICE DISRUPTION THERE HAVE BEEN. SO WE KNOW REPORTS HAVE STOPPED BUT WE DON'T KNOW WHAT THE QUANTITATIVE EFFECT OF THAT IS, WE NEED TO PUT DATA TO THAT AND I WOULD ENCOURAGE PEOPLE TO SUPPORT THOSE TYPES OF STUDIES AND THEN NEXT SLIDE. SO THIS GOES TO CRAIG'S QUESTION A BIT EARLIER, YOU KNOW WHAT ARE THE LONG-TERM EFFECTS OF THIS PANDEMIC FOR PEOPLE WITH DISABILITIES AND WHAT'S THE FUTURE OF REHAB? DO WE REALLY NEED TO THINK DIFFERENTLY ABOUT HOW WE DO--HOW WE DO TRIALS GOING FORWARD AND WE'VE TALKED ABOUT TELEREHAB, I STAY CONNECTED CLOSELY TO THAT AS OUTCOME AND THEN OF COURSE THERE'S OTHER THINGS THAT GO BEYOND THE PHYSICAL REHAB, THE PSYCHOSOCIAL, THE BEHAVIORIAL ECONOMIC PEOPLE WITH DISABILITIES, THERE ARE MORE ECONOMIC EFFECTS OF ECONOMIC DOWN TURNS, OF COURSE WE'RE IN A MAJOR 1 NOW. IT TOOK MORE TIME FOR THEM TO RECOVER FROM THE RECESSIONS AND THERE'S LOTS OF EFFECTS THERE. SO I WOULD PUT THOSE OUT THERE CAN AS THINGS WE NEED TO DISCUSS IN THE FIELD. I'M SURE MANY OF HAVE YOU SEEN THESE RESOURCES BUT I WANT TO PUT THEM OUT THERE. ON THE RIGHT WE HAVE A DOCUMENT FROM P A HO, YOU MAY REMEMBER ANTHONY [INDISCERNIBLE] WHO CAME A FEW YEARS AGO TO SPEAK TO YOU ALL, THEY PUBLISHED THIS IN MAY, VERMEN INFECTED VIEWING CONSIDERATIONS DURING COVID-19 AND IT HAS RECOMMENDATIONS FOR GOVERNMENTS AND PROVIDERS AND PEOPLE WITH DISABILITIES, ET CETERA AND THE 1 OFTEN--DECISION LEFT ARE IS FROM THE WORLD HEALTH ORGANIZATION AND IT WAS PUBLISHED AT THE END OF JUNE AND IT'S REALLY A PAMPHLET. SO YOU SEND PEOPLE HOME WHO HAVE HAD COVID-19 AND IT HAS RECOMMENDATIONS FOR SELF-CARE AND SELF-MANAGEMENT. NEXT. I WANT TO UPDATE YOU A LITTLE BIT ON NCMRR INIAATIVES. BIG THING WE'VE DONE THIS SUMMER, NEXT SLIDE AND I WANT TO ACKNOWLEDGE RALPH NIPKIN AND I JOE BARNS FOR THE INFORMATION ON GETTING THE INTERNATIONAL CLASSIFICATION FRANCIS COLLINS STRUCTURE INFORMATION OUT. I WANT TO ACKNOWLEDGE OUR CONFOUNDERS, NCMRR CANNOT SUPPORT THIS ALONE SO I WANT TO THANK NINDS, NICCH, NIBIB, NINDR, AND NIDCD FOR TRIBUTING TO THIS PROGRAM. WE'VE HAD GOOD TURNOVER, WE'VE HAD THIS PROGRAM SINCE THE YEAR 2000. FIRST I WILL START WITH THE INDUM WENT SITES SO TO SPEAK. SO ART, WHICH IS LED BY [INDISCERNIBLE] AT UNIVERSITY OF PITTSBURGH AMONG OTHER INSTITUTIONS. LOOKING AT REGENRATIVE REHABILITATION, WE ALSO HAVE THE NEUROMODDULATION CENTER AT NUSC LED BY COUT. THANK YOU. AND THEY ARE ALSO SERVING AS OUR COORDINATING COMMITTEE, COORDINATING CENTER. WE HAVE A NEW SITE FROM STANFORD THAT SCOTT [INDISCERNIBLE] HIS RESTORE CENTER WHICH IS A PIVOT FOR THIS GROUP, REALLY LOOKING AT OUTCOMES FROM KIND OF SPECIALLY AVAILABLE OFF THE SHELF TYPE DEVICES AND HOW THAT,A PLIES TO PEOPLE WITH DISABILITIES. WE HAVE A NEW CENTER FROM AN EXPERIENCED GROUP AT THE SHIRLEY RYAN ABILITY LAB, THE C-STAR GROUPS AND THEY ARE LOOKING AT A COMPLIMENTARY TOPIC TO THE RESTORE CENTER ON HOW DO WE MAKE CUSTOM DEVICES FOR UNDERSTANDING MOVEMENT AND FUNCTION AND PEOPLE WITH DISABILITIES, WE ALSO HAVE 2 BRAND NEW CENTERS. WE'RE VERY EXCITED TO HAVE THE LEARN GROUP WITH LINDA REZONING NICK AND BROWN, REALLY GETTING INTO DISSEMINATION, IMPLEMENTATION, LEARNING HEALTH SYSTEMS WHICH IS SOMETHING WE HAVEN'T HAD BEFORE AND WE'RE PRETTY EXCITED TO ADD THAT TO THE GROUP AND THEN WE HAVE A PEDIATRIC FOCUS CENTER WHICH WE HAVE ALSO NOT HAD BEFORE AND THAT'S LED BY SHARON [INDISCERNIBLE] AND OTHERS AT VIRGINIA TECH. --ET CETERA AND RALPH AND JILL ARE AVAILABLE OFFLINE IF YOU HAVE MORE QUESTIONS ABOUT THEM. NEXT SLIDE. SO WE'VE HAD A FEW OTHER FUNDING OPPORTUNITY ANNOUNCEMENTS THAT I JUST WANTED TO UPDATE YOU ON. THE PEDIATRIC REHAB RFA, WHY WERE ABLE TO MAKE 3 AWARD THIS IS SUMMER. THEY WERE HOPING TO GET MORE OUT BUT THE MONEY WAS A BIT TIGHTER THAN WE HAD EXPECTED. BUT WE'RE STILL VERY EXCITED ABOUT THOSE 3 PROJECTS, OUR EARLY CAREER RESEARCHER AWARD, KIND OF LARGE RO-3, THE DUE DATE WAS AT THE END OF MARCH. WE WERE ABLE TO EXTEND THAT TO MAKE FIEVER, GIVE PEOPLE MORE OPPORTUNITY TO GET THOSE IN, WE HAD A REALLY ROBUST RESPONSE, VERY IMPRESSED WITH THE NUMBER OF APPLICATIONS WE RECEIVED. THEY'VE BEEN REVIEWED AND ARE GOING TO COUNCIL IN THE FALL SO WE'RE EXCITED TO CONTINUE THAT PROGRAM AND GHEAN, THE NEXT DUE DATE WILL BE MARCH OF 21 AND THEN THERE'S ANOTHER PROJECT THAT WE'VE BEEN WORKING ON AND THIS IS SOMETHING THAT ADAM [INDISCERNIBLE] IS HELPFUL WITH AS WELL AS JENNIFER JACKSON ON CREATING A RESOURCE FOR THE COMMUNITY TO SEARCH FOR FEDERALLY FUNDED DISABILITY RESEARCH SO WOO HAD THE NIH REPORTER AND THE FEDERAL REPORTER AND THOSE ARE GREAT BUT THERE ISN'T A DISABILITY CATEGORY AND THEY DON'T INCORPORATE RESEARCH FROM NSF FOR EXAMPLE. SO THERE ARE STIMULAR TYPES OF TOPIC SPECIFIC REGISTERS AND [INDISCERNIBLE] FOR EXAMPLE, AND AUTISM--EPILEPSY AND AUTISM. SO WE'VE BEEN WORKING WITH NIDILRR AND THE IN, IH LIBRARY TO PUT TOGETHER THIS RESOURCE AND WE'RE HOPING TO HAVE IT UP AROUND THE TIME OF THE CONFERENCE. NEXT SLIDE. STAFF IS CONTINUING TO DO ALL THE OUTREACH THAT WE CAN AND BE AS VIRTUALLY PRESENT AS POSSIBLE. I WANT TO THANK JOE BONNER FOR WORKING WITH THE AMPUTEE COALITION AND DOING A NICE WEBINAR FOR THAT GROUP AND IT'S HEAVILY CONSUMER BASED SO IT'S NICE WE HAVE THOSE CONVERSATIONS, RALPH WAS PART OF THE PLANNING COMMITTEE FOR A NATIONAL ACADEMY OF MEETINGS. UPON THE LAST TIME WE MET THERE WAS A LOT OF DISCUSSION AROUND BIOMARKERS AND THE IMPORTANCE OF THAT, SO RALPH WAS PART OF THAT MEETING THIS WAS INITIATED BY THE SOCIAL SECURITY ADMINISTRATION THAT ENCOURAGED YOU TO LOOK AT THE REPORT OUT FROM THAT. I'VE BEEN IN TOUCH WITH THE ENGINEERS, SO I WAS PART OF THE PANEL AT THE IEEE MEETING THAT WAS SUPPOSED TO BE IN MONTREAL AND WE DID A VIRTUAL PANEL INSTEAD AND THEN, JENNIFER JACKSON PUT TOGETHER WITH THE OTHER NIH COLLEAGUES, THE FIRST FEDERAL FUNDING PANEL AT THE AMERICAN SOCIETY OF BIOMECHANICS. SO WE'RE GETTING OUT AS WE CAN VIRTUALLY. AND JUST WE'RE AVAILABLE, IF YOU ARE PUTTING TOGETHER A MEETING AND YOU THINK IT WOULD BE USEFUL FOR STAFF TO BE THERE, BOTH FOR US TO LEARN AND FOR YOUR CONSTITUENTS TO TALK TO US, YOU KNOW PLEASE LET ME KNOW, WE ENJOY THIS, PARTICULARLY RALPH. HE HAS A FULL FALL SCHEDULE. OKAY, NEXT SLIDE. WE'VE ALSO BEEN BUSY PLANNING NIH WORKSHOPS SO MANY OF YOU WILL REMEMBER A COUPLE MEETINGS AGO, CHOLINE LONGAVIN WHO IS THE DIRECTOR OF NICCH, CAME TO AN ADVISORY BOARD, I THINK THAT WAS 1 OF HER FIRST WEEKS ON THE JOB TO TALK ABOUT HER INTEREST IN MY O FACIAL PAIN AND AS PART OF THE HEAL INITIATIVE, YOU HAD DISCUSSIONS FROM REBECCA BAKER ON THAT, HELPING END ADDICTION LONG-TERM. THEIR PLANNING, WE ARE PLANNING, A WORKSHOP IN SEPTEMBER MAINLY SPONSORED BY NCCIH AND NIBIB ON IMAGING AND QUANTIFICATION OF MY O FACIAL PAIN SO HOW CAN WE ADVANCE THE SCIENCE OF PAIN TREATMENT? WELL FIRST WE NEED TO KNOW WHAT WE'RE LOOKING AT. SO THEY HAVE A REALLY NICE AGENDA FEATURING A COUPLE OF PSYCHIATRIST AND PHYSICAL THERAPIST, WITH SEVERAL OF OUR COLLEAGUES AT A WORKSHOP LOOKING AT ADDRESSING NEUROIMAGING CHALLENGES ACROSS POPULATIONS AND SETTINGS. SO I THINK THERE ARE CERTAINLY APPLICATIONS TO PEOPLE WITH DISABILITIES FOR WHOM IT'S NOT EASY TO GET PULLED INTO AN MRI FOR AN HOUR OR 2, SO WE ARE ENCOURAGING PEOPLE TO SIGN UP, THEY'RE ALL FREE, ALL VIRTUAL, WE'RE HOPING YOU CAN JOIN US. NEXT SLIDE. WE'VE HEARD JOE SPEAK ABOUT OUR COLLABORATION WITH THE OFFICE OF NINDS AND THE OFFICE OF PREVENTION, WE WERE SUPPOSED TO HAVE THIS BIG MEETING IN MARCH AND RIGHT AROUND EVERYTHING SHUTTING DOWN AND IT WAS DIFFICULT TO PIVOT TO THAT 1. SO THEY WENT BACK TO THE DRAWING BOARD AND CAME UP WITH A NEW TIMING FOR THE AGENDA SO WE WILL DO 3 HALF DAYS IN DECEMBER. WE'VE BEEN WORKING WITH OUR PARTNERS TO MAKE SURE THAT OUR SYSTEMATIC REVIEW IS UP TO DATE AND THAT WE'RE NOT TALKING ABOUT OLD INFORMATION. THIS IS REALLY KEEPING US UP TO DATE AS POSSIBLE AND AGAIN TO REMIND YOU ALL THAT THE GOAL HERE IS TO INFORM PHYSICAL ACTIVITY GUIDELINES AND REALLY HEALTH AND WELLNESS FOR PEOPLE WHO USE WHEELCHAIRS OR LIKELY TO BE USING THEM. NEXT SLIDE. AND WE'RE HAVING A CONFERENCE TOO. [LAUGHTER]% I'M GOING TO SAY MORE ABOUT THIS LATER. SO THIS SLIDE IS FOR FOLKS WHO WILL TUNE OFF AFTER LUNCH AND NOT COME BACK, BUT I WANT TO REMIND PEOPLE WE'RE HAVING A TRANSNIH 1 FERENCE ON OCTOBER 15-16 AND IT WILL BE VIRTUAL. WE'VE ALREADY HAD OVER 700 PEOPLE REGISTER SO THE WORD'S GETTING OUT THERE BUT I WOULD REALLY LIKE TO HIT A THOUSAND SO PLEASE REGISTER TODAY. AND IF YOU WANT TO HEAR MORE ABOUT THE CONFERENCE, YOU HAVE TO STICK AROUND FOR THE TALK AFTER THE BREAK. OKAY, NEXT SLIDE. OKAY, 1 MORE. SO I WANTED TO WRAP UP THIS PRESENTATION BY TALKING A LITTLE BIT ABOUT THE LENS AND THE PHILOSOPHY WITH WHICH I'M COMING TO THIS NEW POSITION. AND I REALLY THINK OF KIND OF 3 AREAS THAT THE CENTER CAN FOCUS ON AND GROW ON AND ME, TOO, FRANKLY. THE FIRST AREA IS PARTNERSHIPS, SO ALLISON DID A WONDERFUL JOB IN GOING OUT THERE AND MEETING WITH ANYBODY THAT WOULD SAY HELLO TO HER AND REALLY STARTING A LOT OF GREAT RELATIONSHIPS AND CONTINUING AND STRENGTHENING 1S THAT WE HAVE HAD SINCE THE BEGINNING OF THE CENTER. I HOPE THAT IT WAS CLEAR FROM THIS PRESENTATION THAT NCMRR AND NOT AN ISLAND, THAT WE ARE ENGAGED WITH OUR COLLEAGUES BOTH AT NIH AS WELL AS ACROSS THE FEDERAL GOVERNMENT SO I'M REALLY SEEKING TO CONTINUE THOSE RELATIONSHIPS, TO GROW THOSE PARTNERSHIPS, THERE ARE SOME FEDERAL AGENCIES THAT WE HAVEN'T DONE AS MUCH WTH LATELY AND I THINK THERE ARE OPPORTUNITIES THERE. THERE MAY BE OPPORTUNITIES FOR PUBLIC PRIVATE PARTNERSHIP AND THAT'S SOMETHING THAT WE HAVEN'T HAD THE RIGHT OPPORTUNITY YET BUT I WONDER IF THERE MIGHT BE SOME MORE OPPORTUNITIES THERE SO THAT IS 1 AREA THAT I'M LOOKING TOWARDS. THE SECOND AREA IS COMMUNICATION SO STAFF KNOWS HOW GREAT YOU GUYS ARE AND STAFF KNOWS THE WONDERFUL RESEARCH YOU'RE DOING BUT I DON'T KNOW THAT WE DO THE BEST JOB OF PROMOTING YOU ALL. SO I THINK THAT'S SOMETHING THEY WOULD LIKE US TO WORK ON AND THINGS LIKE MAYBE SET UP AN NCMRR LECTURE SERIES, MAYBE WE EXPAND IT FROM HEHEALTH BENEFITS AND ACTUARIAL TO DISABILITY, I THINK THERE'S LOTS OF THINGS WE COULD DO THERE WHERE WE REALLY FEATURE YOU ALL. AND NICHD HAS A GREAT COMMUNICATIONS DEPARTMENT AND THEY ARE RESPONSE AND I --RESPONSIVE AND THEY LOVE YOU GUYS. I NEED TO MAKE SURE WE ARE AS A CENTER WORKING WITH THEM AS MUCH AS WE CAN, SO THAT AS MUCH AS TWITTER CAN DO AND I'M EXCITED ABOUT THOSE OPPORTUNITIES AS WELL. AND THEN THE LAST 1, I LABELED IT RESOURCES, BUT IT'S A BIT MORE THAN THAT, I WOULD SAY, SO THE MAIN THING THAT WE DO IS FUND GRANTS AND YOUR SCIENCE. I WONDER IF THERE ARE PROJECTS OR SCIENCE THAT DOESN'T FIT IN THE BOXES. OF THE TYPICAL RO1. ARE THERE THINGS YOU WANT TO DO THAT RIGHT NOW WE DON'T REALLY HAVE A GOOD WAY FOR YOU TO DO THEM? I THINK ABOUT ARE THERE RISKS WE COULD BE TAKING AND MORE INNOVATIVE SCIENCE IF WE HAD OTHER MECHANSMS TO EMPLOYEE. NOT EVERYTHING CAN BE DONE WITH AN RO1. AND THAT'S OUR BREAD AND BUTTER. I WOULD LIKE TO THINK CREATIVELY ABOUT CERTAIN TYPES OF SCIENCE WE WANT TO DO, AND BY WE, I MEAN THE REHAB FIELD, NOT WHAT I'M SITTING HERE TALKING ABOUT, I WANT TO HEAR FROM YOU ALL THAT YOU WANT TO DO AND YOU'RE TRYING TO DO AND YOU DON'T HAVE A GOOD WAY TO GET IN THE DOOR. I CAN'T GUARANTEE MORE MONEY OR A SPECIFIC PROJECT BUT I WANT TO HEAR ABOUT WAYS THAT WE CAN PROVIDE YOU WITH THOSE AVENUES TO COME IN. DO YOU HAVE THE RIGHT REVIEW PANEL, DO YOU HAVE WHAT YOU NEED TO GETD YOUR WORK DONE? I THINK THAT WRAPS IT UP FOR ME. I WENT A LITTLE OVER TIME. I APOLOGIZE BUT I THINK WE HAVE OPPORTUNITY TO GET ON TRACK, SO IF YOU WANT TO GO TO THE LAST SLIDE. I'LL TAKE QUESTIONS. THANK YOU THEORIES AWE ARE SO EXCITED ABOUT YOUR VISION AND IDEAS AND FOR THOSE THINGS THAT DON'T FIT INTO THE RO1 BOXES. I WOULD LIKE TO OPEN IT UP FOR QUESTIONS NOW, ARE THERE ANY MEMBERS WHO HAVE QUESTIONS IF ARE THERESA AND YOU'RE WELCOME TO USE THE CHAT BOX AS WELL. SHE JUST WRAPPED IT UP SO NEATLY. >> YEAH, CAN I ADD SOMETHING, SINCE IT'S A BIT QUIET, I WILL ADD THE FACT THAT I THINK THE WHAT WE'RE GOING THROUGH NOW IS A GREAT OPPORTUNITY FOR OUR CENTER, SO AS MUCH AS RESEARCHERS OR OPPORTUNISTS ON THE 1 HAND IT HELPS US UNDERSTAND THE DEFICITS FOR PEOPLE WITH DISABILITIES IN THEIR HEALTHCARE NEEDS AND STUDIES AND SO ON, SO WE CAN DO STUDIES TO REVEAL OUR BLIND SPOTS BUT AT THE SAME TIME AS THERESA ARTICULATED, SUPPORTING THE REAL WORLD OUTCOMES, THAT'S IN OUR DNA ALREADY, WE'RE AHEAD OF THAT CURVE AND I THINK THE COVID CASE IS A GREAT TIME FOR UNDERSTANDING AND USING THAT IN OUR BROADER OPERATING OPERATING GLOBALLY--POPULATIONS BECAUSE IT WILL HELP PEOPLE OUT IN THEIR COMMUNITIES AND SERVE MORE REMOTELY. SO I WANT TO ENCOURAGE YOU AND YOUR COLLEAGUES TO COME UP WITH RESEARCH PROPOSALS BUT NOT TAKE ADVANTAGE BUT TO REFLECT OUR TIMES AND OUR NEW UNDERSTANDING. SO, OVER. >> THANKS FOR THAT POINT RALPH. GREAT POINT. >> YEAH AND IN IS DIANNA BIANCHI, I'VE BEEN TRYING TO PROMOTE THE IDEA THAT IS A GIANT NATURAL EXPERIMENT, 1 OF WHICH I HOPE WE NEVER EXPERIENCE AGAIN IN OUR LIFETIME BUT THERE'S SO MANY OPPORTUNITIES BECAUSE THIS HAS AFFECTED EVERYONE AROUND THE WORLD, THERE'S SO MANY OPPORTUNITIES TO DEVELOP HYPOTHESIS BASED QUESTIONS AS TO YOU KNOW WHEN THINGS SHUT DOWN HOW DOES IT AFFECT, YOU NAME IT, YOU KNOW ASPECTS OF REHABILITATION OR EDUCATION. I DIDN'T HAVE A CHANCE IN MY TALK TO TALK ABOUT SCHOOLS BUT, YOU KNOW WE ARE REALLY NEED TO UNDERSTAND THE EFFECTS OF ONLINE LEARNING AND WHAT LONG-TERM--WE ARE ENCOURAGING YOU TO BE MORE ENTREPRENEURIAL. >> OKAY, IF THERE ARE NO MOW QUESTIONS WE WILL MOVE ON TO CONCEPT CLEARANCE AND YOU SHOULD ARE RECEIVED 2 DOCUMENTS FOR THE CONCEPT CLEARANCE FROM RAEVERL. ONE OF THEM IS 820 CRAMS AND THE OTHER IS 920 DEBUT. >> SO I HAVE DO A LITTLE BIT OF HOUSEKEEPING THAT I NEGLECTED IN THE MORNING OR EARLIER, SO, YOU ALL KNOW THAT WE HAD RESCHEDULE OUR MAY MEETING AND PART OF THAT WAS ABOUT MAKING SURE WE WERE ALL UP TO DATE ON PAPERWORK AND THAT ALL OF YOU WERE APPROPRIATELY ASSIGNED AS SPECIAL GOVERNMENT EMPLOYEES. SO THANK YOU SO MUCH FOR RESPONDING TO THOSE E-MAILS AND REQUESTS AND PUTTING IN ALL THOSE PIECES OF INFORMATION WHICH HAVING TO DO THESE KINDS OF REPORTS I UNDERSTAND IS AWFUL. THAT SAID, NOT EVERYONE AS BEEN PROCESSED AT THIS POINT O ONLY A HANDFUL OF YOU ARE OFFICIAL SPECIAL GOVERNMENT EMPLOYEES, OKAY? SO WHEN YOU GUYS VOTED ON THE MINUTES, ONLY A HANDFUL OF YOU COUNTED. BUT THIS IS A PUBLIC MEETING SO WE CAN HAVE THESE DISCUSSIONS AND WE STILL WANT YOUR INPUT BUT FOR OFFICIAL RECORD KEEPING PURPOSES, JUST BE--I WANT YOU ALL TO BE AWARE OF THATLET CONCEPT WE'RE PRESENTING NOW DO NOT TECHNICALLY NEED TO BE VOTED ON BUT I THINK AS FAR AS TRANSPARENCY AND MY DESIRE TO ENGAGE WITH YOU AND TALK TO YOU ABOUT THINGS, I DO WANT TO GET YOUR OPINIONS AND YOUR BUY-INS SO I WILL ASK FOR EITHER YOUR SUPPORT FOR THE CONCEPT OR NOT BUT I WANTED TO BE CLEAR ABOUT THAT IN THAT SOME OF YOUR VOTES ARE TECH UNTILICALLY NOT VOTES, YOU ARE PUBLIC INTERESTED PARTICIPANTS. AND THIS WILL ALL BE RESOLVED BY THE TIME WE MEET IN DECEMBER. IT'S JUST BEENA DIFFICULT JOB IN MANAGEMENT AND THEY'VE DONE A GREAT JOB TO GETTING US TO THE POINT WHERE WE COULD HAVE THIS MEETING AND I AM GRATEFUL FOR THEIR ASSISTANCE BUT DOES ANYONE HAVE QUESTIONS ABOUT THAT? >> WE'VE PRESENTED THEM IN A BROAD MANNER SO THAT YOU AND YOUR COLLEAGUES WILL NOT BE IN CONFLICT OF INTEREST FOR ACTUALLY, IF YOU WANT TO DEVELOP A SUBCOMMISSION, SO THEY DISCUSS VERY BROADLY BUT WE WANT YOU TO TELL US IF WE'RE ON THE RIGHT TRACK OR SOME OTHER ANGLE TO PLAY TO OR PART OF THE FORMAL APPROVAL PROCESS TO HELP US MOVE ON THESE INITIATIVES. >> OKAY. >> GO AHEAD. >> DO YOU WANT TO US TO PRESENT THE CONCEPTS OR DO YOU WANT US TO COMMENT ON THEM FOR WHAT WE'VE SEEN ALREADY. >> I WILL PRESENT THEM AND THEN WE CAN TALK ABOUT THEM. SO ANY OTHER QUESTIONS BEFORE I JUMP IN? SO THE FIRST 1 I WANT TO DISCUSS WITH YOU AND THE UNDERGRADUATE SIZE FOR ASSISTIVE TECHNOLOGY, THIS CAME OUT OF A DISCUSSION YOU ALL HAD LAST MAY WHERE YOU TALKED ABOUT THE IMPORTANCE OF PIPELINE DEVELOPMENT AND THE NEED TO ENGAGE STUDENTS EARLIER IN THE PROCESS OF THEIR CAREERS TO THINK ABOUT RESEARCH AND REHABILITATION. SO NIAID HAS A CHALLENGE THAT THEY HAVE ISSUES FOR 8 OR 9 YEARS AND IT IS CALLED DEBUT WHICH IS DESIGNED BY BIOMEDICAL UNDERGRADUATE TEAM AND WE HAVE ASKED THEM IF WE COULD COLLABORATE. THE PURPLES OF THIS CONCEPT WOULD BE TO CREATE A PRIZE WITHIN THE DEBUT. CURRENTLY THERE ARE PRIZES FOR AIDS OR HIV RERESEARCH FOR TECHNOLOGIES FOR LOW RESOURCE SET EXPTION THOSE ARE SUPPORTED BY THE OFFICE OF AIDS RESEARCH AND MINORITY HEALTH AND HEALTH DISPARITIES SO WE WOULD CREATE A SIMILAR NCMRR SPONSORS CATEGORY. RIGHT NOW TECHNOLOGY LIEWGZS FOR UNMET AREA OF HEALTHCARE ARE ACCEPTED FOR INTERVIEW AND NIAID PICKS UP THE FUNDS FOR THE OTHER TOPIC AREA. SO ERIC DID HAVE YOU QUESTIONS ABOUT THIS 1? >> I'M QUITE FAMILIAR WITH IT AND IT'S WONDERFUL BECAUSE IT REALLY ALLOWS STUDENTS TO TACKLE PROBLEMS AND I THOUGHT 1 OF THE THINGS WE MIGHT BE ABLE TO DO OR TO ADD TO THIS IS TO HELP PUT DEPARTMENTS AND TEAMS IN CONTACT WITH SOME OF OUR PIs THAT ARE FUNDED BY NCMR BECAUSE 1 OF THE BIGGEST CHALLENGES FOR STUDENT SYSTEM TO COME UP WITH OPTIONS AND SO WHO KNOWS BETTER HOW TO HELP DEVELOP STUDENTS DEVELOP PROJECTS THAN OTHER PEOPLE [INDISCERNIBLE]. EITHER THEMSELVES OR MAYBE SOME OF THE CENTERS THAT HAVE PARTICIPATE THE. I THINK THAT'S CERTAINLY SOMETHING WE CAN DO ON OUR WEBSITE, WE CAN HIGHLIGHT THE WAY TEAMS LOOK UP INTUITIONS AND MAYBE THEY DON'T HAVE THOSE CONNECTIONS AND WE CAN CERTAINLY POINT THEM IN THE DIRECTION OF HOW TO FIND PEOPLE IN THEIR INSTITUTION OR--% >> OR MAYBE BEYOND IF THE GOAL IS TO BAWDEN OUR BASE, THOSE INSTITUTIONS THAT HAVE STRONG PROGRAMS WE WOULD HAVE A RELATIVELY EASY TIME TO FIND THOSE PROGECS, IT'S THOSE STUDENTS WITH UNIVERSITIES THAT DON'T HAVE STRONG GROUP PROGRAMS THAT WE WOULD LIKE TO HELP. >> SO SOMETHING SPECIFIC? SHRKS SO 1 WAY WOULD TO BE TO ENCOURAGE OR COME UP WITH A LIST OF PROJECTS THAT WOULD BE IN OUR FIELD THAT WOULD HAVE DESIGN CHALLENGES THAT NEEDS TO [INDISCERNIBLE]. THE. >> I HOPE THEY'RE ALL LISTENING. I THINK THAT'S GREAT. I'M ALWAYS IMPRESSED SO RALPH AND I HAVE SERVED AS REVIEWERS FOR THIS PROGRAM FOR NIBIB, DANA [INDISCERNIBLE] ACTUALLY RUNS IT, A COLLEAGUE OF OURS AND I'M ALWAYS IMPRESS WIDE WHAT THEY CAME UP WITH AND IF WE COULD DIRECT THEM TO MAYBE THINK ABOUT ANOTHER TOPIC. I HAVE HIGH HOPES FOR WHAT WOULD COME IN. AND DO IT THROUGH THE ADVISORY COUNCIL OR COME UP WITH THE NEW BRAND CHALLENGES AND IMPLEMENTATION, AGAIN, JUST TO POINT STUDENTS IN RIGHT DIRECTION. >> I THINK YOU'RE ABSOLUTELY RIGHT. IT WOULD BE GREAT TO HAVE A LIST OF--WISH LIST BUT ALSO PART OF THE MAGIC OF THE PROGRAM IS IN THE BOTTOM UP. THEY TAKE THESE ENGINEERING STUDENTS AND HAVE THEM GET INVOLVED IN THE CLINICS AND ACTUALLY WORK DIRECTLY WITH PEOPLE WITH DISABILITIES UNDERSTAND A LITTLE LOCAL UNMET NEEDS SO ALSO THE LIGHT BULB GOES OFF IN THE STUDENT THEMSELVES WHEN THEY REALIZE A SO I THINK YOU'RE RIGHT, BOTH STRATEGIES COMING DOWN WITH THE TOP WITH SUGGESTIONS, THE STUDENTS REALLY SEE THE LIFE OF PEOPLE WITH DISABILITIES AND AN ENGINEER FOR THAT. SO APPRECIATE YOUR INPUT. I AGREE THAT'S VERY VALUABLE. >> GO AHEAD. >> I WAS JUST GOING TO SAY THAT I HOPE THE WORD ASSISTIVE IS REALLY BROADLY DEFINED AND I WONDER ABOUT CHANGING IT TO REHABILITATIVE TECHNOLOGIES JUST BECAUSE PEOPLE MISUNDERSTAND THE WORD ASSISTIVE TECHNOLOGY AND THEY MIGHT SEE THAT AS VERY LIMITED AND WE REALLY WANT IT TO BE BROAD AND ANY TECHNOLOGY THAT CAN HELP AN INDIVIDUAL WITH A DISABILITY. >> I AGREE. I'VE THOUGHT OF IT A COUPLE DIFFERENT WAYS SO I DO AGREE THAT A. T. IS THE MORE LIMITED AND WE COULD CERTAINLY INCLUDE IT. >> THERE IS SUCH AN EMPHASIS HERE WITH DESIGN TEAMS ON SCIENCE AND WHETHER REALLY BE THE ASPIRATIONS AND GOALS OF DIVERSITY AND INCLUSION COULD REALLY BE INCORPORATED INTO THE FORMATION OF THESE DESIGN TEAMS. I THINK THAT BOTH IN THE COMPOSITION OF THE TEAMS PERHAPS BRINGING IN PERSONS WITH DISABILITIES INTO THE TEAM TO PROVIDE INPUT, YOU KNOW ADVOCACY GROUPS AND SO FORTH AS WELL AS JUST THE COMPETITION OF THE TEAM AS WELL IN TERMS OF REALLY AN EMPHASIS ON DIVERSITY AND INCLUSION WITH REGARD TO THE FORMULATION OF THESE TEAMS. THAT'S A REALLY GOOD POINT SO THERE ARE KIND OF THE GENERAL SUBMISSION AND I CAN TALK TO NIBIB ABOUT HOW THEY WANT TO ADD DIVERSITY LANGUAGE THERE AND THEN WHEN WE TALK ABOUT OUR SPECIFIC AWARDS, WE CAN EMPHASIZE THE IMPORTANCE OF USER CENTRIC DESIGN AND INCLUSION OF CONSUMERS AND THINGS LIKE THAT. SO I THINK WE COULD HIT IT FROM 2 DIFFERENT WAYS. , YEAH, THAT WILL BE GREAT. >> HEY, THERESA I HAD A COMMENT, I TRIED TO PUT IT IN THE COMMENT BACK BUT 1 OF UNDERGRADS ARE FAIRLY EARLY IN THEIR TRAINING AND WE'VE BEEN TRYING TO DO A STRONG TRAINING PROGRAM, WE HAVE NOT IDENTIFIED USHED GRADS BECAUSE IT'S SO EARLY, SO 1 IS A QUESTION IS, IS THERE A WAY TO MEASURE SUCCESS FOR THE PIPELINE, MEANING, YOU KNOW IF THIS IS SUCCESSFUL, ABOUT THIS AND SECONDLY IS WHAT ERIC SAID, CONTINUITY. COULD PART OF THE AWARD BE FUNDING OR VISIT A LAB TO MAKE SURE A STUDENT GET CONNECT WIDE A GRAD SCHOOL OR SOMETHING LIKE THAT TO INSURE SOME SORT OF SUPPORT AND CONTINUITY IN HAD THEIR TRAINING AND DEVELOPMENT? >> CAN I JUMP IN ON THAT THERESA? >> YEAH, I THINK YOU'RE THINKING OF THE R25S WHERE IT'S A GRANT FOR A COURSE. THIS IS JUST A SINGLE AWARD AND WHAT YOU'RE SAYING IS VERY IMPORTANT BUT IT'S KIND OF BEYOND THE SCOPE OF JUST GIVING THEM A FEW THOUSAND DOLLARS REWARD TO TAKE BACK TO THE STUDENTS. SO I THINK THAT'S IMPORTANT. >> I CAN UNDERSTAND THAT BUT IF WE'RE GOING TO SUPPORT OF SUPPORT AN AWARD, SHOULDN'T WE UNDERSTANDS WHAT IT ACTUALLY DOES FOR PIPELINE? >> YEAH, WE SHOULD GET BACK TO PREVIOUS AWARDEES OVER THE YEARS AND ASK THEM FOR UPDATES AND YES, THAT WOULD BE A GREAT--THAT WOULD BE A NICE--IS THAT WHAT YOU'RE THINKING ABOUT. >> YEAH, YEAH, THAT'S 1 ISSUE. YOU KNOW WE NEED TO JUST FOLLOW UP BECAUSE, YOU KNOW, WE NEVER KNOW WHEN THESE UNDERGRADS END UP GOING BUT SOMETIMES YOU NEED MORE OF AN EXPECTATION OR A PUSH THAT THEY'RE GOING TO CONNECT WITH SOMEONE, I THINK BECAUSE OTHERWISE WE JUST LOSE THEM. I MEAN CERTAINLY, I THINK IT'S A GREAT PROGRAM. I WANT TO FULLY SAY YES, I'M JUST HOPING WE CAN MEASURE WHAT SUCCESSFUL, SO IF WE KNOW IT'S SUCCESSFUL, MAYBE IN A BIGGER PROGRAM. >> YEAH, SO SOME OF THESE WINNERS HAVE COMPANIES ESSENTIALLY. THEY'RE FINISHING THEIR SENIOR YEAR OF COLLEGE AND YOU HAVE THIS IDEA AND NOW THEY'RE A COMPANY SO I THINK CONNECTING THEM WITH SBIR RESOURCES IN PARTICULAR IS SOMETHING THAT WE CAN DO AND THIS IS KIND OF OUR TOES IN THE WATER, WE'VE NEVER RUN A CHALLENGE SO WE'RE USING NIBIB'S EXPERIENCE, BUT IF WE HAVE A REALLY NICE RESPONSE, THERE'S NO REASON WHY WE WOULDN'T DO THIS OURSELVES AS PART OF NICHD, AND THEN WE CAN--WE CAN DO GRANT CHALLENGES AND THINGS LIKE THIS, THIS IS BABY STEP TOE IN THE WATER AND A LEARNING EXPERIENCE FOR US, BUT I'M TAKING ALL OF IT IN. I'M COGNIZANT OF TIME, ARE THERE ANY MORE COMMENTS ON THIS 1? >> JUST 1 MORE QUICK 1, FOLLOWING UP ON AL'S POINT. I THINK THIS FITS INTO YOUR PHILOSOPHY THAT YOU LAID OUT. WE CAN DO A LOT TO PROVIDE RESEARCH--SO IF WE CAN TAKE THESE YOUNG WINNERS, MAYBE IN SECOND OR THIRD PLACE, BUT THEN PLUG THEM INTO THE COMMUNITY, EITHER BY HELPING THEM GET TO GRAD SCHOOL OR, YOU KNOW JUST SIMPLY CONNECTING THEM WITH SOME OF OUR LEADERS THAT WILL MAKE A BIG IMPACT ON THE RESEARCH GROUP [INDISCERNIBLE]. >> GREAT. THANK YOU. >> ALL RIGHT, THANK YOU. >> OKAY. >> I DON'T THINK YOU DO. OKAY. IF I COULD GET YOUR VOTE IN THE CHAT, SO WE CAN SEE IT, I WOULD APPRECIATE THAT. >> SO JUST VOTE YES OR NO? >> YES, IN FAVOR, OPPOSED OR ABSTAIN. >> THANK YOU YOU. AND THE SECOND CONCEPT IS NOT AN OPEN COMPETITION, IT'S AN INTERAGENCY AGREEMENT. SO YOU DON'T ACTUALLY HAVE TO VOTE ON THIS BUT I WOULD LIKE YOUR OPINION. IN 2019 NCMRR ENTERED INTO A AGREEMENT FOR THE CDC CRAM SURVEY WHICH IS A PREGNANCY RISK ASSESSMENT AND MONITORING SURVEILLANCE SYSTEM AND THE PURPOSE OF THIS IS TO GENERATE DATA ON THE PREGNANCY OF EXPERIENCES OF WOMEN WITH DISABILITIES BASED ON SURVEY RESPONSES FROM THE NATIONALLY REPRESENTED SAMPLE OF U.S. WOMEN WHO HAVE RECENTLY GIVEN BIRTH. SO THIS A REALLY NICE WAY FOR NCMRR TO CONNECT WITH THE OTHER BRANCHES OF NICHD FOR US TO CONNECT WITH THE MATERNAL CONVERSATION WHICH IS GOING ON IN THIS COUNTRY AND TO MAKE SURE THAT WE HAVE THE DATA FOR PEOPLE WITH DISABILITIES TO SUPPORT OUR EFFORTS. THIS IS VERY COMPLIMENTARY TO THE REALLY GREAT WORK THAT PEOPLE HAVE DONE IN THIS AREA INCLUDING FORMER BOARD MEMBERS DOING THEM. STRUCTURED INTERVIEWS WITH WOMEN AND GETTING TO KNOW THEIR EXPERIENCES BUT WE'RE LOOKING FOR MORE GENERALIZED DATA THAT COULD BE USED TO CREATE HYPOTHESIS. THE CURRENT LEVEL OF DATA OF FUNDING FOR THIS,A LOWS US TO GET THE 6 APPROVED QUESTIONS IN SURVEYS IN 24 STATES SO WE'RE ASKING TO CONTINUE THAT LEVEL OF SUPPORT, WE WILL BE LOOKING FOR OTHER COLLABORATORS ON THIS TO GET A HIGHER NUMBER OF CONTRIBUTING SITES AND EVENTUALLY WE WOULD LIKE TO MOVE THIS INTO THEIR BASE SO THAT WE DON'T FLEED TO SUPPLEMENT EACH YEAR I WILL TOTALLY ADMIT THAT OUR CONVERSATIONS WITH CDC HAVE STOPPED IN THE LAST FEW MONTHS. QUITE UNDERSTANDABLY THE STAFF HAS BEEN DIVERTED ON TO COVID RELATED MEASURES BUT WE'VE ALREADY MADE IN INVESTMENT AND I WOULD NOT--I THINK IT WOULD BE A SHAME IF THE PANDEMIC LED US TO STOP THIS ENDEAVOR. SO THOUGHTS ON THIS. >> SO THERESA, I HAVE A QUESTION ABOUT HOW DOES THIS THE--WHEN THE SURVEY IS AVAILABLE HOW DOES BOTH THE NIH AND CDC GO ABOUT MAKING SURE THEY ARE ABLE TO CAPTURE THE POPULATION THAT WOULD BE RELEVANT FOR PARTICULARLY AS IT RELATES TO WOMEN WITH DISABILITIES TO ARE PREGNANT. >> SURE, SO, PRAM WORKS BY A LOTTERY SYSTEM THAT THEY SEND OUT POST CARDS SAYING THAT WE NOTICED YOU JUST HAD A BABY AND THEN IT ASKS RETROSPECTIVELY HAVE YOU HAD DIFFICULTY WITH MOBILITY, DID YOU HAVE DIFFICULTY--YOU KNOW AND RATING. THERE ARE 6 QUESTIONS RELATED TO MOBILITY, VISION, HEARING, CONCENTRATION, SELF-CARE AND COMMUNICATION, SO IT'S NOT THAT THEY'RE TARGETING WOMEN WITH DISABILITIES, THEY ARE TARGETING PREGNANT WOMEN WHO JUST HAD A BABY AND HAD THEIR RECORDS THAT THEY KNOW THESE WOMEN HAVE HAD BABIES AND THEN THEY ASK THEM ABOUT THEIR EXPERIENCES ON THAT DISABILITY SCALE. ASK WE JUST STARTED 19 SO WE'RE JUST STARTING TO GET DATA FROM THOSE PREGNANCIES. YEAH. >> WE ARE RUNNING A LITTLE BIT OVERTIME BUT I DON'T WANT TO CUT THE COMMENTS OFF. THERESA WE MADE IT TO THIS PARTICULAR-- >> IF YOU'RE SUPPORTIVE, I WOULD LOVE TO SEE IT IN THE CHAT BOX OR RAISE YOUR HAND. I THINK THEY'VE ENABLED THAT, MAYBE. >> OKAY, I'M NOT SURE I CAN SEE ALL THE CHATS BUT I'LL LET YOU MONITOR THAT, THERESA AND LET US KNOW IF THERE'S ANYTHING ELSE WE NEED TO DISCUSS. >> I THINK WE'RE GOOD. >> ALL RIGHT, THAIRNG YOU. SO WE HAVE ON THE AGENDA TO HAVE A BREAK NOW, SO WE'RE A BIT BEHIND. WE ARE 10 MINUTES SHORTER THAN WE HOPE TO BE FOR THE BREAK BUT LET'S SEE IF WE CAN ALL RECONVENE AT 12:15 AND PICK UP HERE WHERE WE LEFT OFF. WE HAVE A LOT OF STUDENTS TO HEAR FROM KEN, YEAH, AND WE'LL BE HEARING ABOUT THE REHABILITATION RESEARCH CONFERENCE AND PLANS. SO SEE YOU IN A FEW MINUTES. ALL RIGHT, SO, I'M GOING TO GO AHEAD AND TURN IT OVER TO THERESA TO GIVE THE UPDATE ON THE REHABILITATION RESEARCH CONFERENCE IN OCTOBER. >> THANK YOU AND KEN, SORRY ABOUT THAT. BUT WE DO HEAR YOU GREAT AND WE CAN SEE THE SLIDES WHEN WE GET THERE, SO, 2 OUT OF 3 AIN'T BAD. >> OKAY. >> ALL RIGHT, SO I HOPE EVERYONE'S BACK AND IF YOU WANTED TO TURN OFF YOUR CAMERAS WHILE YOU CHEW THAT, IS OKAY WITH ME. WHAT I'D LIKE TO DO HERE IS GIVE A LITTLE UPDATE. IT'S BEEN A LONG TIME SINCE WE MET IN PERSON TO WORK ON BOTH THE REHAB CONFERENCE AND THE RESEARCH PLAN AND WE'VE HAD A FEW HICCUPS, THERE. ON NEXT SLIDE, PLEASE. WE WILL START WITH THE CONFERENCE. NEXT SLIDE. SOPHISTICATED JUST TO REVIEW THE BASICS THAT WE'RE ALLOT SAME PAGE, OCTOBER 15-16 AND IN A VIRTUAL ENVIRONMENT. THIS HAS REALLY BEEN A TRANSNIH EFFORT, 15 INSTITUTES AND CENTERS HAVE CONTRIBUTED TO THAT TRANSITIONING TO A VIRTUAL CONFERENCE THROUGH THE REHABILITATION COORDINATING COMMITTEE. FUNDING HAS BEEN PROVIDED BY NCHID, NIAID, NICHD AND YOUR STUDENTS AND ET CETERA. WE'VE BEEN WORKING ON ADJUSTMENTS TO THE TIMING OF THE AGENDA TO MAKE SURE THAT WE CAN ACCOMMODATE DIFFERENT TIME ZONES AS MUCH AS POSSIBLE AND WE'VE REALLY BEEN EMPHASIZING ACCESSIBILITY OF THE PLATFORM. THE CONTENT WILL BE ON DEMAND FOR A YEAR AFTER THE MEETING SO KEEP THAT IN MIND AND REALLY ENCOURAGE YOU TO REGISTER AND JOIN US. I PARTICULARLY WANT TO THANK THE MEMBERS OF THE ADVISORY BOARD WHO HELPED WITH THE AGENDA CREATION. THIS IS LIKE A YEAR AGO, I I'M NOT SURE IF YOU WILL ALL REMEMBER BUT I WANTED TO ACKNOWLEDGE [INDISCERNIBLE] RICH ELLISON WHO COULD NOT WITH US TODAY, ROBINS WATSON, [LISTING NAMES ] IF I MISSED ANYONE, I APOLOGIZE, PLEASE LET ME KNOW ANGRILY THROUGH THE CHAT, BUT I GOT EVERYONE WHO HELPED WITH THE VISION AND FORMATION OF THIS MEETING. NEXT SLIDE. OKAY, SO THE CONFERENCE WILL NOT BE LIKE THIS WEBEX, WE ARE GOING TO BE USING THIS VIRTUAL ENVIRONMENT AND I HAVE PICTURES OF ALL THESE THINGS THEY WANT TO WALK YOU THROUGH WHAT'S AVAILABLE. SO THERE WILL BE A MAIN LOBBY, WELCOME ADDRESS FROM DR. BIANCHI, AS PEOPLE COME IN, THERE ARE THINGS LIKE A HELP DESK THERE, DIRECTIONS TO WHERE YOU GO NEXT, THERE WILL BE A SPEAKER HALL, WE'RE GOING TO KEEP IT WITH A SINGLE SPEAKER AT A TIME. WE WILL NONAPOPTOTIC THE HAVE CONCURRENT SESSIONS SO EVERYONE WILL [AUDIO CUTS OUT ]--OUR SPEAKER PREP CALLS NOW AND WE'RE DOING THAT SO WE CAN MAKE SURE THAT LIKE THINGS LIKE CLOSED CAPTIONING WORK. THERE WILL THEN BE LIVE Q&A AND SEVERAL OF YOU HAVE VOLUNTEERED TO HELP WITH THAT, MODERATING QUESTIONS AND I REALLY APPRECIATE YOUR HELP WITH THAT, SO THANK YOU, AGAIN. THERE WILL BE A POSTER HALL SO OUR ABSTRACT SUBMISSIONS CLOSED ON FRIDAY, WE HAD ALMOST A HUNDRED SUBMISSIONS, SO IT WAS VERY EXCITING TO SEE THAT. WE CAN ACCOMMODATE MOST OF THEM AND THEN THE TOP 10 AS DETERMINED BY NIH STAFF WILL ALSO GET TO RECORD AN AUDYE TRACK THAT PLAYS A LONG WITH THEIR POSTER EVERYBODY WILL GET A POSTER AND THEN SOME OF THEM WILL HAVE AUDIO TRACKS WHERE THE PIs ARE WALKING PEOPLE THROUGH THEM. THERE WILL BE AN EXHIBIT HALL WITH A HANDFUL OF BOOTHS AND THEY WILL FEATURE NIH STAFF, JUST LIKE YOU WOULD AT A CONFERENCE, YOU WALK BY THE NIH SECTION OF SFN AND THEN YOU STOP BY AND SAY, HEY, CAN I TALK TO YOU AND QUITE A NUMBER OF THEM HAVE OFFERED TO BE AVAILABLE AND IF YOU WANT TO HOPE OVER AND DO A VIDEO CONFERENCE IN ZOOM, THEY'RE READY TO WILLING TO DO THAT. WE'VE ALSO TALKED TO THE INFRASTRUCTURE NETWORK AND THEY WILL HAVE A BOOTH WHERE THEY CAN FEATURE ALL THE OPPORTUNITIES THEY ARE OFFERING NOW. WE'RE ALSO HAVING 1 ON DATA BROADLY, SO THERE ARE COMMON DATA ELEMENTS WE WOULD LIKE TO HIGHLIGHT AND THEN WE ASKED OUR OTHER FEDERAL FUNDERS IF THEY WOULD LIKE TO CONTRIBUTE AS WELL. THERE WILL BE A NETWORKING LOUNGE AND WE'VE SCHEDULED MODERATED DISCUSSIONS AROUND OUR THEME, AROUND OUR RESEARCH PLANNED THEMES SO THERE WILL BE A COUPLE NIH STAFF, WITH CUED QUESTIONS TO DISCUSS, SAY, REHABILITATION SCROOSES THE LIFE SPAN AT NOON AND PEOPLE WHO WOULD LIKE TO GO INTO THAT CHAT ROOM AND TALK ABOUT IT ARE WOMAN TO AND WE ARE HOPING TO GET SOME GOOD DISCUSSIONS THERE. AND THERE ARE LOTS OF OPPORTUNITIES TO ENGAGE WITH OTHER PARTICIPANTS IN A MEETING THROUGH CHAT WINDOWS. OF KIND OF THE LAY OUT, NEXT SLIDE. SO I'M GOING TO SHOW YOU SLIDES FOR THE SAME MEETING FOR THE INITIATIVE MEETING, YOU CAN GO TO THIS WEBSITE. IT WAS HELD IN JUNE, IF YOU ARE INTERESTED IN PLAYING AROUND AND SEEING WHAT YOU LIKE OR DON'T LIKE. THEY ARE BUILDING OUR CONFERENCE CENTER RIGHT NOW. SO YOU WALK IN AND IT'S A BIG LOBBY, THERE'S A HELP DESK, SIGNS FOR WHERE YOU CAN GO TO SEE THINGS, THERE'S A VIDEO IN THE CENTER WHICH WILL BE THE WELCOME. NEXT SLIDE. HERE'S AN EXAMPLE OF A SPEAKER HALL. IT DOES--IT DOESN'T STAY THIS SMALL, IT DOES GO FULL SCREEN BUT YOU FEEL LIKE YOU'RE SITTING IN A LECTURE HALL AND IT STARTS AND IT GOES TO A DIFFERENT FULL SCREEN SO CAN YOU SEE THE PERSON SPEAKING AS WELL AS THE SLIDES. OKAY, NEXT SLIDE. SO HERE'S AN EXAMPLE OF THE POSTER SECTION. SO THE BRAIN INITIATIVE HAS DIFFERENT TYPES OF NEUROSCIENCE SO WE WOULD HAVE OUR THEME, AGING ACROSS THE LIFE SPAN AND INFRASTRUCTURE AND THOSE TYPES OF TOPICS AND THEN YOU COULD GO AND CLICK ON THAT AND GET ALL THE POSTERS THAT WERE SUBMITTED UNDER THAT THEME AND THEN YOU COULD READ THOSE PDFs AND THEN LIKE. OKAY, NEXT SLIDE. THIS IS WHAT THE EXHIBIT HALL WOULD LOOK LIKE, WE WOULD HAVE FEWER BOOTHS, NOT SURE ABOUT THE COST ISSUES BUT THAL IS WHERE YOU COULD COME DURING YOUR LUNCH BREAK BEFORE THE MEETING, AFTER THE MEETING AND TALK TO PEOPLE. NEXT SLIDE. THIS IS WHAT EYE BOOTH LOOKS LIKE IN CASE YOU'VE NEVER BEEN TO A BOOTH. THERE ARE VIDEOS PLAYING IN THE BACKGROUND, SLIDES, PEOPLE HAVE 1 PAGER FIST THEY WANT TO GIVE OUT OUR INFRASTRUCTURE MIGHT HAVE QUESTIONS THEY WANT TO ASK PEOPLE, WHAT KIND OF RESOURCES DO YOU NEED, YOU KNOW WHAT STAGE OF YOUR CAREER ARE YOU AT. AND YOU TALK TO YOUR COLLEAGUES, SO THERE'S A COUPLE EXAMPLES OF MODERATED CHAT WITH THE BRAIN INITIATIVE DID SO THEY DID 1 ON NEUROETHICS, THEY DID 1 ON DISSEMINATION, GENE SCIENCE, ET CETERA. SO IT WOULD BE POSTED WHAT TIME PEOPLE WERE GOING TO GATHER IN THIS ROOM TO TALK ABOUT THESE THINGS. OKAY ACCIDENT NEXT SLIDE. I WILL PAUSE THERE AND ASK PEOPLE IF THEY HAVE QUESTIONS ABOUT THE CONFERENCE AND WHAT WE'RE TRYING TO DO HERE. >> I AM REALLY IMPRESSED. IT'S MUCH MORE--AT LEAST IT LOOKS VISUALLY MUCH MORE LIKE A REAL CONFERENCE AND THAN I THOUGHT IT MIGHT SO THAT'S REALLY EXCITING. >> WE'RE TRYING. >> THERESA ARE YOU GOING TO USE SOME OF THE SAME SET UP LIKE PICTURES? BECAUSE I WAS LOOKING AT THE PEOPLE, LIKE DIFFERENT PEOPLE AROUND THE DIFFERENT--AND THE DIVERSITY AND ALL THAT, I THOUGHT IT WAS REALLY A NICE MIX, IF NICE COMBINATION, ARE YOU GOING TO KEEP THAT OR CREATE YOUR OWN? >> YEAH, SO, FULL DISCLOSURE, I WAS ON THE PLANNING COMMITTEE FOR THE BRAIN INITIATIVE MEETING AND I SAID, THESE PEOPLE ARE GREAT BUT WE NEED MORE PEOPLE WITH DISABILITIES SO WE NEED TO FIND MORE ADVERTISING SO THOSE ARE MY POSITIONS AND YES, I'VE EXPRESSED DIVERSITY ON MANY DIFFERENT LEVELS AND HOW I WANT THE PEOPLE DRESSED, TO GET SOME OF THESE IN EVERYONE'S IN A BUSINESS SUIT, I'M LIKE THAT'S NOT QUITE THE VIBE WE'RE GOING FOR BUT WHAT I AM TRYING TO MAKE IT LOOK INCLUSIVE SO I'M GLAD YOU PICKED UP ON THAT AND YES, WE ARE CONTINUING THAT. AND I'M SURE MANY OF YOU HAVE BEEN GOING TO CONFERENCES LIKE THIS OVER THE LAST 4 OR 5 MONTHS. SO IF THERE WERE ANYTHING THAT REALLY WORKED THAT YOU WOULD LIKE TO LET ME KNOW ABOUT OR THINGS THAT REALLY DID NOT WORK, I WOULD ALSO LIKE TO KNOW ABOUT THAT. YOU KNOW WE'RE IN THE BUILDING PHASE RIGHT NOW SO WOO HAVE A LITTLE BIT OF TIME TO CHANGE SOME STUFF BUT YOU KNOW I APPRECIATE FEEDBACK IF ANY OF YOU HAVE THEM. >> I HAVE 1--GO AHEAD. I HAVE 1 MORE QUESTION, IS THERE A LIMIT TO HOW MANY PEOPLE CAN REGISTER IF IT'S VIRTUAL. >> NO. SO THE COST FOR THIS COME WITH HOW MUCH CONTENT WE PUT IN IT, NONAPOPTOTIC THE HOW MANY PEOPLE SHOW UP. IT'S MUCH MORE EASIER TO LET PEOPLE IN, THAN CONTENT BECAUSE THAT'S WHEN THE COST CHANGES. SO WE'RE GOOD WITH MORE PEOPLE. >> FIRST OF ALL CONGRATULATION ON THE APPOINTMENT. WELL DESERVED. OF COURSE WE'VE ALL BEEN TO A LOT OF CONFERENCES, TO EDE'S POINT IT ACTUALLY LOOKS LIKE YOU'RE GOING INTO AN ACTUAL CONFERENCE VENUE. I HAVE A QUESTION ABOUT THE POSTER SESSIONS. THAT'S SOMETHING I'VE SEEN IN THE PREVIOUS CONFERENCES THAT JUST DOESN'T SEEM TO QUITE GET IT AND PART OF IT IS BECAUSE WITH POSTERS YOU USUALLY STEP UP, THE PERSON FINISHES THEIR CONVERSATION AND STARTS. DOESN'T NECESSARILY WORK THAT WAY, YOU TEXT AND MAKE CONVERSATION. SO IS THERE SOMETHING THAT YOU KNOW YOU'RE THINKING THAT WE--THIS APPROXIMATE CONFERENCE MIGHT DO WHERE IT'S KIND OF LIKE EVERY 15 MINUTES THE PERSON STARTS THEIR POSTER KIND OF TALK OR HOW WILL THAT KIND OF--HOW MIGHT YOU MITIGATE THAT? >> YEAH, SO, WE HAD A LOT OF DISCUSSION ABOUT SHOULD WE EVEN BOTHER WITH THE POSTER SESSION, IS IT NOT QUITE THE SAME? YOU KNOW IS IT WORTH IT? THINGS LIKE THAT. WE DECIDED IT WAS A GOOD OPPORTUNITY AND WE WANTED TO TRY TO DO IT. SO WHAT HAPPENS IS WHEN SOMEONE GOES TO A POSTER, AS I MENTIONED SOME OF THEM WILL HAVE AN OWD YE TRACK, SO YOU PLAY IT AND THE PERSON WALKS THEM THROUGH IT. AS YOU WOULD A CONFERENCE, THE OTHERS YOU'RE JUST GOING TO GET THE POSTER, YOU WILL GET THE PDF. BUT THEN YOU READ IT AND YOU CAN SEE, THE LIST OF ALL THE PEOPLE THAT ARE AT THE MEETING AND CLICK ON IT AND SAY, HEY, I HAD A QUESTION ABOUT YOUR METHOD, I'M LOOKING AT YOUR POSTER AND THAT PERSON GETS A NOTIFICATION THAT SOMEONE'S LOOKING AT THEIR POSTER AND THEN THEY CAN COME OVER AND YOU CAN--AND YOU KNOW WE MIGHT BE DOING THESE THINGS FOR A WHILE. SO I THINK IT'S GOING TO BE A LEARNING EXPERIENCE, EITHER WAY BUT I WELCOME MORE SUGGESTIONS IF PEOPLE HAVE--I SHOULD SAY THE PLATFORM DOESN'T SUPPORT THE VIDEO CONFERENCE. SO--ABOUT THERE'S NOTHING STOPPING SOMEONE SAYING, I'M GOING THROUGH YOUR POSTER, WOULD YOU MIND IF WE HOP OVER TO ZOOM AND TALK FOR 10 MACHINEUTES? THERE'S NO REASON WHY PEOPLE CAN'T DO THAT, I DON'T KNOW IF THEY WILL, BUT WE WILL HAVE THE OPPORTUNITY. >> [INDISCERNIBLE]--HAD A VERY SIMILAR LAY OUT, LOOKS LIKE [INDISCERNIBLE] THE OPPORTUNITY TO HAVE A LOT OF CONVERSATIONS AND SO WHAT A LOT OF THE POSTER SESSION AND PRESENTERS DID WAS SAY HERE'S MY POSTER, CAN YOU FIND ME ON ZOOM, THEY JUST HAVE ZOOM. SO IT'S SOMETHING [INDISCERNIBLE] AND LOOK AT OTHER [INDISCERNIBLE]. >> YEAH THEY HAVEN'T MADE THE POSTERS YET, WE'VE JUST GOTTEN THE ABSTRACT SO WHEN WE ACCEPT THEM THAT WILL BE GOOD TIME TO SAY, YOU MIGHT WANT TO THINK ABOUT THESE WAYS TO ENGAGE PEOPLE. THAT WOULD BE GOOD. I DON'T WANT TO FORCE PEOPLE TO DO THAT BUT I THINK WE'VE GOT A GREEN CELLS GREEN CELLS GARIOUS BUNCH. OTHER QUESTIONS ABOUT THE CONFERENCE? >> OKAY, FEEL FREE TO E-MAIL, CHAT, I'M NOT GOING ANYWHERE. ALL RIGHT, NEXT SLIDE, WE'RE SWITCH OVER TO DISCUSSING THE RESEARCH PLAN. WE HAVE A COVER, THAT'S THE HARDEST PART, I THINK. THAT TOOK US THE MOST DELIBERATIONS. SO LET ME GET MY NOTES UP. OKAY. SO THIS IS THE ART WORK THAT WE'RE LOOKING FOR, LOOKING TO USE, EXCUSE ME, AND THEN WE ARE REPEATING THIS ART WORK IN THE CONFERENCE BACKGROUND AND LABELS AND THINGS LIKE THAT. SO THERE SHOULD BE VISUAL CONNECTIVITY BETWEEN THE RESEARCH PLAN AND THE CONFERENCE ENVIRONMENT. NEXT SLIDE. SO HERE I WANTED TO ACKNOWLEDGE THE PEOPLE THAT HAVE BEEN REALLY HELPFUL IN WORKING THROUGH THE RESEARCH PLAN WITH US PARTICULARLY [LISTING NAMES OF TEAM ] AS WELL AS EDE, SHE WAS ON BOTH COMMITTEES. SO IF I FORGOT YOUR NAME, PLEASE SEND ME THE ANGRY CHAT. I WOULD SAY TAKEN--THEY WE WERE SUPPOSED TO DO A LOT OF WORK THIS SUMMER AND WE HAD TO HOLD THAT FOR A COUPLE REASONS, 1 BEING RELATED TO THE PANDEMIC AND THE SECOND BEING RELATED TO PEOPLE'S STATUS ON THE BOARD AND MAKING SURE WE HAD ALL THE PAPERWORK SETTLED. I'LL BE HONEST. SO THAT SAID, BECAUSE WE STARTED SO EARLY IS BECAUSE WE'VE BEEN SO PRODUCTIVE EARLIER, WE'RE REALLY IN A GOOD POSITION MPLET I'M NOT WORRIED WE'RE NOT GOING TO GET THIS TO CONGRESS IN 2021 WHICH IS OUR GOAL. SO RIGHT NOW NIH STAFF WORKED THIS SUMMER ON GETTING OUR 2019 DATA, JENNIFER HAS BEEN WORKING ON THIS EVEN THOUGH SHE'S DOING THIS DETAIL OVER AT NIBIB AND WE'RE HOPING IN SEPTEMBER THAT WE WILL HAVE THE DATA SECTIONS WHERE WE--YOU KNOW ADVANCED FROM THE 2015 PLAN AND OUR CURRENT NUMBERS ARE GOING TO BE FY19 TO SHOW THE PROGRESS WE'VE MADE IN THOSE CATEGORIES. OUR ACCOMPLISHMENT SECTIONS WHERE WE PULLED OUT SPECIFIC THINGS WE DID IN RELATION TO DOLLARS, INIAATIVES, WORKSHOPS THOSE THINGS AND WHEN I SAY STAFF WORKED VERY HARD, I'M TALKING NIH STAFF, NOT JUST THE CENTER WHO CERTAINLY CONTRIBUTED BUT THIS IS TRANSNIH HERE. AND OUR COLLABORATIONS SECTION WHERE WE TALK ABOUT THE TRANSFEDERAL WORK THAT WE DO, WE REALLY NEED TO PICK AN END DATE, SO A LOT OF THESE ARE ONGOING PROCESSES AND COLLABORATIONS AND THINGS AND WE JUST HAVE TO PICK AN END AND THAT'S WHEN WE WILL WRAP UP EACH OF THOSE SECTIONS. WE AGREED WE WOULD KEEP THE RESEARCH THEME CONSTANT BUT WE WILL UPDATE THE RESEARCH OBJECTIVES ISSUES THOSE HAVE BEEN VETTED BOTH BY THE SUBCOMMITTEE. WE WILL SHOW YOU IN A MINUTE. THE NEXT STEP IS REALLY MAKING SURE WE GET BUY-IN FROM THE FIELD. SO, THE PLAN HAD BEEN TO YOU KNOW GO OUT AND SHAKE HANDS AND YOU KNOW KIND OF PUT THIS OUT THERE AT VARIOUS MEETINGS, THAT HASN'T QUITE HAPPENED WITH THOSE PLANS SO WHAT WE'RE LOOKING TO DO INSTEAD IS TO SET UP AN IDEA SCALE SITE AT OTHER NIH INSTITUTES HAVE USED THIS TO GET FEEDBACK ON THEIR STRATEGIC PLANS OR RESEARCH PLANS SO WE'RE--THAT IS MY PLAN A. I THINK THAT'S PLAN C AT THIS POINT. THAT IS PLAN C TO MAKE SURE WE GET FEEDBACK FROM THE COMMUNITY AND THE PLAN IS TO HAVE THAT OPEN OVERLAPPING THE CONFERENCE. SO IF YOU'RE IN A--YOU SEE A TOSS BY SOMEONE WHO'S DISCUSSING 1 OF RESEARCH THEMES AND YOU GET AN IDEA AND YOU WANT TO POP OVER AND CONTRIBUTE TO THE CONVERSATION THERE, YOU ARE ABLE TO DO THAT. IF THAT DOESN'T WORK WE STILL HAVE PLAN B WHICH IS A REGULAR REQUEST FOR INFORMATION, THAT'S KIND OF OUR STANDARD OPERATING HOW WE GET INPUT FROM THE FIELD SO I'M TRYING TO MAKE SURE THIS IS NOT NIH IMPOSING THIS RESEARCH PLAN ON YOU ALL. THIS IS A PARTNERSHIP THAT WE'RE INTERESTED IN YOUR FEEDBACK AND INCORPORATING IT. THESE RESEARCH PLANS ARE ONLY AS GOOD AS THE BUY-IN FROM THE COMMUNITY. SO I WANT YOU ALL TO KNOW THAT AND HAVE IDEAS FOR HOW WE CAN DO THAT BETTER, PLEASE LET ME KNOW. THE OTHER THING WE'RE WORKING THROUGH ON A PHILOSOPHICAL LEVEL MAYBE IS HOW DO WE ACKNOWLEDGE THE PANDEMIC IN THIS DOCUMENT WITHOUT MAKING IT ABOUT THE PANDEMIC, RIGHT? SO IT WOULD BE VERY TONE DEAF OF US NOT TO TALK ABOUT IT IN SUPER WAY BUT WE DON'T WANT THIS TO TURN INTO A PANDEMIC DRIVEN RESEARCH PLAN. SO THAT'S SOMETHING THAT WE'RE WORKING ON NOW. NEXT SLIDE. SO I JUST WANTED TO POINT OUT A COUPLE PLACES WHERE WE MADE CHANGES FROM THE RESEARCH PLAN SO WHERE WE'VE GROWN OR SHIFTED A LITTLE BIT. IN OUR FIRST RESEARCH THEME WHICH IS REHABILITATION ACROSS THE LIFE SPAN, WE'VE ADDED MORE OF A FOCUS ON AGING WITH A DISABILITY AND AGING INTO A DISANLT. WE HAD TALKED ABOUT WELLNESS AND NUTRITION ASK ACTIVITY AND SLEEP, AND WE'RE CALLING IT OUT. WE HAD PREVIOUSLY TALKED ABOUT IMPLEMENTATION AND DISSEMINATION RESEARCH FOR REHAB INTERVENTIONS. HERE WE EXPANDED IT TO INCLUDE THINGS LIKE PREVENTIVE SERVICES AND COMMON MEDICAL INTERVENTIONS THAT WE'RE MAKING SURE THAT PEOPLE WITH DISABILITIES ARE GOING TO HAVE ACCESS TO THOSE. AND THEN, WHEN WE TALK ABOUT TRANSITION, WE ADDED LANGUAGE TO DISCUSS THINGS TO HIGHLIGHT FUNCTION. SO WE HAD PREVIOUSLY TALKED ABOUT MAXIMIZING INTERVENTIONS BUT HERE WE'RE TALKING ABOUT GETTING THE HIGHEST LEVEL OF FUNCTION AND THEN THE LAST BULLET THERE HAVE BEEN GENERAL TALK ABOUT THE IMPORTANCE OF LONGITUDINAL DATA SETS. SO HERE WE'RE CONNECTING TO EXISTING 1 THAT ARE OUT THERE THAT WE SHOULD BE ABLE TO TAP INTO FOR REHAB PURPOSES. I'M GOING TO LEAVE THAT 1 FOR MAYBE 10 MORE SECONDS. OKAY, NEXT SLIDE. SO HERE WE KEPT MOST OF THE SAME LANGUAGE BUT THE LAST ISSUE OF THE PLAN REALLY FOCUSED ON INDEPENDENCE AND HERE WE WANTED TO MAKE SURE THAT THERE WAS A GREATER SENSE OF PARTICIPATION AND CHOICE. SO WE ADDED LANGUAGE ABOUT PARTICIPATING IN ADDITION TO INDEPENDENT. THERE WAS MAYBE A LITTLE BIT OF NEGATIVE WORDS THAT ARE ASSOCIATE WIDE CARE GIVING SO WE MADE SURE THAT WE TALKED ABOUT, YOU KNOW BENEFITS OF CARE GIVING% IN ADDITION TO THINGS LIKE STRESSORS. A BULLET ABOUT USING--INCLUDING CONSUMERS OF REHAB SERVICES OF PARTNERS BUT IT WAS KIND OF FILL WIDE A BUNCH OF QUALIFIERS SO WE'RE MUCH MORE DIRECT HERE IN THE IMPORTANCE OF INCLUDING THE END USER OF THESE TECHNOLOGIES OR SERVICES. AND THEN IN THE LAST BULLET WE ADDED LANGUAGE ON REDUCING BARRIERS, A KIND OF, YOU KNOW NOT JUST ENVIRONMENTAL BUT PERSONAL, ET CETERA. SO I WILL LEAVE THAT FOR ANOTHER 10-SECONDS. OKAY, NEXT SLIDE. SO HERE THERE WAS A DESIRE TO EMPHASIZE USER-CENTRIC TECHNOLOGY AS WELL AS PROMOTION OF OPEN SOURCE. BEING THE PRESCIENT INTELIENT PEOPLE WE ARE, WE TALKED ABOUT TELEHEALTH BUT MAYBE WE WANT TO TURN THAT 1 UP A NOTCH, AS WELL AS WE HAD PREVIOUS TALKED ABOUT OUTCOME MEASURES BUT HERE THERE'S THE NUANCE OF FUNCTIONAL OUTCOMES BEING LINKED TO THE PHYSIOLOGICAL AFFECTS OF THE SOABL PROCESS. WE DIDN'T QUITE HAVE THAT CONNECTION IN THE PREVIOUS ITERATION AND THEN THE LAST BULLET, WE HAD NOT IN THE PREVIOUS ROUND OR IN THE PREVIOUS RESEARCH PLAN TALKED A LOT ABOUT SUPPORT SYSTEMS FOR CLINICAL DECISION MAKING SO HERE WE HAVE THE IDEA OF USING AUGMENTED INTELLIGENCE SYSTEMS FOR PERHAPS CLINICAL CARE AS AN EXAMPLE AS WELL AS BRINGING IN MULTIMODAL DATA SETS AND PROCESSING THAT. AGAIN, I WILL LEAVE THAT FOR 10-SECONDS. AS A REMINDER, THESE WILL ALL BE POSTED PUBLICLY TO MAKE COMMENTS EITHER AS A REQUEST SITE OR AS PART OF A REGULAR REQUEST FOR NEXT SLIDE. SO HERE SOME OF THE NEW LANGUAGE IN THE SECOND BULLET TALKING ABOUT HAVING THIS INTEGRATED TRANSLATIONAL MODEL, SO THAT WE AREN'T JUST DOING THIS SERIES OF EXPERIMENTS THAT WE'RE THINKING ABOUT HOW WOULD IMPLEMENT AN INTERVENTION AT THE SAME TIME THAT YOU'RE TESTING FOR EFFICACY FOR EXAMPLE.%-œTHEREWAS A GREATER EMPHASISON HEALTH SERVICES RESEARCH AND USING EPIDEMIOLOGICAL METHODS THERE WAS A DESIRE TO EMPHASIZE ECONOMICS. SO ARE WE MOVING US DOWN THE TRANSLATIONAL PIPELINE A BIT HERE. AND THEN THE LAST BULLET, EMPHASIZING DATA SHARING WHEN APPROPRIATE AND PROMOTING COMMON DATA ELEMENTS. FIVE, MORE SECONDS. >> THERESA? >> YES. >> THIS IS JAVIER, MY QUESTION IS WE DID ALL THIS DRAFTS BEFORE THE PANDEMIC SET IN, WITH THE PANDEMIC SITUATION SOME OF THE THINGS HAVE CHANGED OR NEED TO BE MODIFIED AND I JUST WANTED TO FIND OUT ESPECIALLY WITH THE REALITY OF TELEHEALTH VIRTUAL OPPORTUNITIES AND TO REMOTE WAYS OF EITHER MEDICAL INTERVENTION SO REHABILITATION AND INTERVENTIONS LIKE WE SAW SOME IN THE PRESENTATION BY DR. BIANCHI, NOW MY QUESTION SPECIFICALLY, SHOULD THIS STRUCTURE REMAIN AS IT IS RIGHT NOW OR DO WE NEED TO TAKE A BROADER LOOK GOING INTO THE FUTURE? >> RIGHT. SO YOU'RE ADDRESSING A COUPLE ISSUES, I THINK. SO 1 THIS IS STILL A DRAFT SO WE CAN MAKE CHANGES AT ANY POINT. SO IF THERE ARE THINGS THAT YOU THINK NEED TO BE CHANGED FOR PUBLIC COMMENT ABSOLUTELY WE CAN DO THAT. EVEN AT THAT POINT WHEN IT'S OUT THERE, IT'S STILL GOING TO GET REVISED AGAIN SO I'M NOT EXPECTING THE FINAL UNTIL DECEMBER REALLY. SO YEAH, THERE'S ABSOLUTELY TIME, THERE'S ABSOLUTELY OPPORTUNITY AND THEN YOUR OTHER COMMENT, YOU'RE RIGHT, THE WORLD IS DIFFERENT AND WE NEED TO ACKNOWLEDGE THAT. BUT WE DON'T WANT EVERYTHING TO BE ABOUT WELL, NOW THAT WE'RE IN THE PANDEMIC WORLD, BLAH, BLAH, BLAH, BLAH. I THINK WE NEED TO TWEAK SOME OF THE LANGUAGE TO BE MINDFUL OF OUR CURRENT WORLD BUT I DON'T WANT IT TO BE A DOCUMENT THAT'S ALL ABOUT THE PANDEMIC. >> YES, YOU'RE CORRECT. I THINK YOUR LAST 2 STATEMENTS ARE RIGHT. IT SHOULD NOT OF COURSE ALL BE ABOUT THE PANDEMIC WHAT I THINK I'M ASKING IS PERHAPS WE SHOULD ALL JUST LOOK AT THE DRAFT AGAIN AND SEE WHERE SOME CHANGES MIGHT BE NECESSARY TO REFLECT SOME OF THE RECENT SITUATIONS THAT WERE AIMED WHICH IS LIKELY TO BE WITH US FOR A LONG TIME. >> ABSOLUTELY. YOU KNOW, SO HOW ABOUT I GET THROUGH THE REST OF THE SLIDES AND THEN WE CAN TALK ABOUT WHAT WE WANT THE NEXT STEPS TO BE. IS THAT FAIR? >> OKAY, YES. >> OKAY. LET'S DO NEXT 1. OKAY, SO HERE THERE WAS AN EMPHASIS ON RAPID SOLUTIONS. SO ARE WE RESPONDING QUICKLY ENOUGH. THERE WAS A DESIRE TO GO FROM BENCH TO BEDSIDE TO BENCH WHICH WAS A BIT OF A CHANGE FROM THE PREVIOUS VERSION, I DON'T KNOW THAT WE EMPHASIZED HAVING ISHT VENTION BASED MECHANISMS SO WE MADE THAT CLEAR AND THEN THERE WAS A GREATER ROLE DEAL OF DISCUSSION ABOUT BIOMARKERS AND A COUPLE DIFFERENT CONTEXT SO COULD THEY BE MARKERS OF DISEASE OR PROGNOSIS LOOKING AT BIOTYPES OF RESPONDERS VERSUS NONRESPONDERS AND THEN COULD WE ALSO USE BIOMARKERS MORE TO ASSESS TARGET ENGAGEMENT. SO THERE'S A MORE NUANCED DISCUSSION AROUND BIOMARKERS AND THEN IN THE LAST BULLET THERE WAS A CHANGE IN LANGUAGE ABOUT TARGETING MULTISINNER GESTIC INTERVENTIONS BEFORE WE TALKED ABOUT MULTIMODAL BUT WE HADN'T GOT INTO THE MECHANISM SO I WOULD SAY UNDERSTANDING œMECHANISM IS WHAT CAME OUT OF OUR TRANSLATIONAL ACTION. AND OUR LAST SLIDE, BUILDING RESEARCH CAPACITY AND INFRASTRUCTURE THERE WAS MORE OF AN EMPHASIS ON TRAINING AT ALL CAREER STAGES SO NOT JUST FOCUSING ON THE GRADUATE STUDENTS OR POSTY DOCS BUT MAKING SURE THERE'S OPPORTUNITIES FOR CONTINUED LEARNING. THE IDEA WE'RE CREATING AN ECOSYSTEM THAT HAS A SELF-SUSTAINING ASPECT TO IT. AND THEN WE HAD TALKED PREVIOUSLY ABOUT THE IMPORTANCE OF TEAM SCIENCE AND INTERDISCIPLINARY WORK BUT NOW THERE IS MORE OF A CALL FOR INCENTIVIZING THAT, HOW DO WE MAKE THAT WORTH OF INVESTMENT SO, I THINK WE CAN GO TO THE NEXT 2. YOU KNOW I MENTIONED SEVERAL PEOPLE WHO WERE ON THE ORIGINAL COMMITTEE BUT THERE WERE OTHERS OF YOU THAT MAY HAVE MORE COMMENTS FOR THIS THAT WASN'T BEEN AS INVOLVED AS MUCH AND I'LL STOP TALKING AND YOU GUYS TELL ME THAT. >> IT SEEMS LIKE WE WANT TO [INDISCERNIBLE] NCMRR HAS ALL THE TECHNOLOGIES AND [INDISCERNIBLE] AND 1 WAY TO ADDRESS THE PANDEMIC WOULD BE TO PUT A PARAGRAPH STATING THAT SPECIFICALLY, MAKING CHANGES TO THE [INDISCERNIBLE] IF YOU AGREE WIDE THAT, [INDISCERNIBLE] THAT WOULD BE--SO ERIC I DON'T KNOW IF EVERYONE'S HAVING THIS PROBLEM, BUT YOU'RE FADING IN AND OUT FOR ME, IF YOU COULD INCAP SURVEYSALATE THE POINT YOU WANT TO MAKE SO THAT IT'S CLEAR TO EVERYONE. >> SORRY DID YOU MISS MOST OF THAT. >> I DID, BUT THAT'S MUCH BETTER, MUCH BETTER. >> MAYBE I WAS A BIT TOO FAR AWAY. BUT QUICKLY, MAYBE MANY OF ISSUES RELATED TO THE PANDEMIC CAN BE INCORPORATED INTO THE PREAMBLE BEFORE YOU LIST SPECIFIC OBJECTIVES BECAUSE MUCH OF WHAT HAS DONE FOR A LONG TIME AND RELEVANT [INDISCERNIBLE]. THE SECOND POINT WAS I THINK WE TRUST YOUR PROACH IN HOW TO ADDRESS THE PANDEMIC SO IF YOU WANT TO TAKE A CRACK AT THAT [INDISCERNIBLE], MAYBE DISSEMINATE IT THAT WAY. >> YEAH, THIS IS ROD, YOU KNOW THIS ISN'T--THIS IS A PUBLIC HEALTH EMERGENCY SO MAYBE WE IDENTIFY IT AS PANDEMIC COVID SPECIFIC, IT'S HOW DOES REHABILITATION RESEARCH FIT INTO THE PUBLIC HEALTH EMERGENCIES, CREATE MORE OF A DYNAMIC WIDE SPREAD. FURTHER THOUGHT ON THAT BECAUSE THERE'S THERE'S HURRICANES, THERE'S OTHER TYPES OF PANDEMICS, YOU KNOW ALL SORTS OF PUBLIC HEALTH DISASTERS. >> THE COMMENTS AND TAKE A LOOK AT TI THINK THE DANGER IN THAT IS PROBABLY THE OVERINDEXOT COVID PANDEMIC, I THINK LIKE ERIC IF WE WOULD JUST SAY, THAT THIS IS PRIOR AND ALL RELEVANT BUT MEANT TO GO BEYOND COVID AS WELL. I THINK IF WE TAKE TOO MUCH MORE TIME, IT WOULD TAKE FOR THIS TO GET OUT FOR OTHER PEOPLE TO TAKE A LOOK AT AND COMMENT. >> SO I HAVE NOT WRITTEN THE INTRODUCTION YET. SO I WAS WAITING UNTIL THE END, AT LIKE ERIC'S APPROACH THAT YOU CAN TALK ABOUT A LOT OF THAT THERE AND AL'S COMMENT ABOUT THE TIMING OF THIS, THIS IS A DOCUMENT CREATED BEFORE AND HOPEFULLY AFTER, WITH THE HEALTH EMERGENCY, I THINK ROB'S POINT IS SPOT ON AND PEOPLE WITH DISABILITIES NEED TO BE PART OF THE DISASTER PLAN FOR EVERYTHING, NOT JUST PANDEMICS AND WE SEEM TO HAVE TO LEARN THAT OVER AND OVER AGAIN UNFORTUNATELY. I'M HEARING FROM PEOPLE WOULD LIKE TO TAKE A LOOK AND OTHERS WHO THINK IT MAYBE CAN STAND AS IT IS BUT WE SHOULD DEFINITELY ACKNOWLEDGE THE PANDEMIC AND THEN INTRODUCTION. THE SITE IS NOT UP YET SO WE COULD WORK ON THIS FOR A COUPLE MORE WEEKS BUT I AGREE THAT WE CAN'T STRETCH THIS OUT FOREVER. BY THE END OF THE MONTH, IF YOU DON'T WANT TO COMMENT, THAT'S FINE TOO, THEN I WILL GET TO WORK CRAFTING THE INTRODUCTION WHICH I CAN SHARE WITH YOU. IN MY COPIOUS FREE TIME. DOES THAT SOUND LIKE A PLAN? >> SOUNDS LIKE A PLAN TO ME. SO I THINK THAT'S ALL I WANTED TO SAY ON THESE TOPICS AGAIN I'VE LOOKED AT COMMUNICATIONS WE'RE WORKING ON HERE AND I JUST YOU WILL BE AMDASES DORS THAT YOU USUALLY--AMBASSADORS THAT YOU USUALLY ARE AND WITH THAT I WILL STOP TALKING AND TURN IT BACK TO EDE? THANK YOU FOR THE OVERVIEW OF THE PLAN AND THE CONFERENCE AND GETTING THOSE SO WE CAN MAKE COMMENTS AND I THINK PROBABLY PEOPLE HAVE REALLY GREAT IDEAS TO ADD FOR THE INTRA DOO FOR THOSE THAT HAVE BEEN MENTIONED I WOULD LIKE NOW TO TURN IT OVER, THANK YOU FOR STAYING ON TIME. I WOULD LOAMACYIC TO--LIKE TO TURN IT OVER TO KEN OTTE NBACHER, THIS IS HIS LAST MEETING AS A BOARD MEMBER, AND WE ARE SAD TO SEE HIM GO AND WE APPRECIATE ALL THE EXPERT HE SHARED OVER THE YEARS ON THE BOARD AND WE ARE FORTUNATE THAT HE'S ALSO GIVING US THE SCIENTIFIC PRESENTATION TODAY SO KEN, TAKE IT AWAY. >> THANK YOU. THANK YOU CAN YOU HEAR ME. FIRST OF ALL I WOULD LIKE TO SAY THANK YOU TO NCMRR, AND DR. CRUZ AND DR. NIPTKIN, AND STAFF AND PROFESSIONALS FOR OPPORTUNITY TO SPEAK THIS AFTERNOON AND I HAD A LITTLE BIT OF A TECHNICAL GLITCH GETTING STARTED THIS MORNING ISSUES THE COMPUTER, I NORMALLY USE FOR THESE THINGS FOR SOME REASON DIDN'T WANT TO COOPERATE WITH THE WEBEX SO I'M HAVING TO USE A DESKTOP THAT IS A LITTLE BIT OLDER AND WE'RE NOT ABLE TO GET COORDINATE BOTH THE VIDEO AND THE SOUND SO THERE'S NO PICTURE AND I'M SORT OF DISAPPOINTED IN THAT BECAUSE I ACTUALLY WORE A TIE TODAY, FIRST TIME I'VE WORN A TIRE IN 6 MONTHS. SO LET'S GET STARTED, FIRST I WANT TO TELL YOU I DON'T HAVE AN OUTLINE SLIDE WHICH I SHOULD HAVE INCLUDED BUT I WANT TO TALK A BIT ABOUT THE BACKGROUND ASSOCIATED WITH DATA SCIENCE AND TERMINOLOGY WE'RE USING THESE DAYS WHICH ALL RELATIVELY NEW TERMINOLOGY BUT GIVE YOU A BIT OF A CONTEXT OF THAT AND BACKGROUND IN DEFINITIONS AND DATA SCIENCE GENERALLY THEN TALK RELATIONSHIP BETWEEN DATA SCIENCE AND REHABILITATION HOW DOES IT FIT IN WITH REHABILITATION AND HISTORY AND CONBE NEKSES THAT ARE RELATED TO DATA SCIENCE WITHIN OUR FIELD OF REHABILITATION SCIENCE AND REHABILITATION MEDICINE AND THEN THIRD, JUST TALK A LITTLE BIT ABOUT THE POTENTIALLY USEFUL RESOURCES THAT ARE CURRENTLY AVAILABLE IN THESE OPPORTUNITIES THAT ARE EMERGING THAT ARE NOT RELATED TO ARTIFICIAL INTELLIGENCE AND SCIENCE AND OTHER AREAS THAT ARE HAVING A MAJOR IMPACT ON OUR SOCIETY IN GENERAL BUT SPECIFICALLY NOW RELATED TO HEALTH. NEXT SLIDE. SO DATA SCIENCE, THIS IS A QUOTE FROM SCIENCE AND ARTICLE WAS PUBLISH INDEED 2011 AND I WILL READ IT THE MARCH OF QUANTIFICATION MADE POSSIBLE BY ENORMOUS NEW SOURCES OF DATA WILL SWEEP THROUGH ACADEMIA, BUSINESS, HEALTHCARE AND GOVERNMENT THERE'S NO AREA THAT WILL BE UNTOUCHED. SO THAT'S HAPPENED. IT'S HAPPENING NOW AND IT'S CONTINUING TO HAPPEN AND IT WILL NOT GO AWAY SO IT'S SOMETHING THAT WE WANT TO HAVE HAPPEN, TO IMPROVE HEALTHCARE, IMPROVE OUTCOMES FOR PEOPLE WITH DISABILITIES SO NEXT SLIDE, THIS IS ANOTHER QUOTE THAT'S SPECIFICALLY RELATED COMES FROM AN ARTICLE IN HEALTH AFFAIRS AND AGAIN I'LL READ THIS. BIOMEDICAL SCIENTIFIC COMMUNITY IS CURRENTLY EXPERIENCING A DRAMATIC EXPANSION OF HOW DATA ARE BEING USED TO GENERATE NEW KNOWLEDGE AND ACCOMPLISH THE GOALS OF REDUCING DISEASE AND DISABILITY AND IMPROVED HEALTHCARE DELIVERY. SO IF DATA SCIENCE, LARGE DATA, BIG DATA WHATEVER YOU CALL IT CAN HELP DO THAT THEN IT'S SOMETHING THAT WE SHOULD ALL BE PAYING ATTENTION TO AND KNOW SOMETHING ABOUT EVEN IF WE DON'T USE THESE PROCEDURES IN OUR OWN RESEARCH. SO NEXT SLIDE. AND THIS CAN BE CHALLENGING, THE TERMINOLOGY AND IN THE LAST 10 YEARS CHANGED FAIRLY DRAMATICALLY AND SOME OF THE TERMINOLOGY THAT'S COMMONLY USED AND SOME NOT SO COMMONLY USED INFORMATION OVERLOAD, INFO TOCKSICATION, INFORMATION ANXIETY, INFORMATION EXPLOSION, AND MY PERSONAL FAVOR, INFO OBESITY. AND SOME OF THESE TERMS HAVE BEEN AROUND FOR A WHILE BUT THEY ALL KIND OF GIVE YOU THE SAME SENSE THEY CAN ALSO BE CONFUSING WHARKS DO THEY MEAN IN IS THERE A CENTRAL FOCUS THAT'S RELEVANT TO REHABILITATION AND DISABILITY AND RECOVERY. NEXT SLIDE. AND PART OF THIS AND SOME OF THIS RELATED TO THE TERMINOLOGY WE'RE CURRENTLY USING, BIG DATA WAS A POPULAR TERM BUT IT'S GETTING REPLACED SLOWLY, AND I'LL TALK ABOUT THAT IN A MINUTE AND DATA SCIENCE AND DATA DISCOVERY BUT THEY ALL HAVE COMPONENTS THAT ARE ASSOCIATED WITH THOSE TERMS AND SOME OF THOSE COMPONENTS ARE OVERLAPPING AND SOME OF THEM ARE NOT, SO IF YOU'RE A PERSON WHO USES DAILY BASIS THEA SCIENCE AND SOMEONE ELSE USES DATA DISCOVERY, WELL MOST OF TIME YOU'RE TALKING ABOUT THE SAME THING OR A LOT OF THE SAME THINGS BUT OCCASIONALLY YOU'RE TALKING ABOUT DIFFERENT THINGS AND IT'S USEFUL TO KNOW AND BE AWARE THAT THAT'S AN ISSUE IN AN CERTAINLY--CERTAINLY MERGING FIELD LIKE THIS. NEXT SLIDE. SO I WANTED TO AGAIN TALK ABOUT NOT JUST THE NIH BUT THE FEDERAL AGENCIES BACKGROUND. SO THE FIRST PART OF THAT STARTS WITH COMPUTERS AND THE INTERNET AND CLOUD WHICH EVERYONE'S VERY FAMILIAR WITH AS I THINK MANY OF YOU KNOW I'VE BEEN INVOLVED WITH THE NUMBER OF COLLEAGUES, FOR THE PAST 10 YEARS AND DOING RESEARCH RELATED TO WHAT WE HAVE ALWAYS REFERRED TO AS LARGE DATA AND THEY WERE USING THAT TERM BACK IN 2000 WHEN THEY WERE DOING THIS WORK BECAUSE WE WEREN'T SURE WHAT THE TERM WAS AND LARGE SEEMED PRETTY HARMLESS AND IN 2012 NIH BECAME INVOLVED IN IN AREA AND THE BIG DATA TO KNOWLEDGE MORE COMMONLY REFERRED TO AS BD2K, BD2K PROGRAM WAS STARTED AND AIER OR SO AFTER THAT THIS DATA SHARING AND I'LL TELL YOU MORE ABOUT THAT IN A MINUTE BUT MORE STRATEGICALLY THE DATA PLAN FOR SCIENCE WAS RELEASED BY NIH IN JUNE OF 2018 AND THE STRATEGIC PLAN IS REAL LYE AN EXCELLENT DOCUMENT. IF YOU HAVEN'T HAD A CHANCE TO LOOK AT IT, IT'S NOT VERY LONG, IT'S VERY WELL ORGANIZED AND IT HAS A LOT OF INFORMATION THAT I THINK IS RELEVANT TO THE FIELD AND IT WOULD BE A GREAT RESOURCE PARTICULARLY FOR THOSE WHO ARE IN ACADEMIC ENVIRONMENTS AND TEACHING OUR EDUCATING AND WORKING WITH OUR FACULTY AND POST DOC AND GRADUATE STIEWBT STUDENTS. SO NEXT SLIDE, JUST REAL QUICKLY SO THE PD2 K WAS INITIATED IN THE OFFICE OF THE DIRECTOR AND AGAIN, THERE'S A SLIGHT TYPO IN THERE THAT ESTABLISHED IN 2012 AND THE LAST PART OF THE NUMBERS MISSING, BUT OUT OF THAT, THE NEXT SLIDE, PLEASE, THE 4 AREAS THERE, THE 1 THAT REALLY ENDED UP GETTING A LOT OF ATTENTION WAS THE ANALYTICAL METHODS IN SOFTWARE, BUT A LOST PEOPLE DURING MADE AVAILABLE WENT TO DEVELOP CENTERS OF EXCELLENCE AND THERE WERE GOOD CENTERS OF EXCELLENCE AND SOME OF THEM ARE STILL AROUND BUT NIH HAS MOVED MOVED AWAY FROM THE BD2K, AND BIG DATA OR THAT WAY OF CONCEPTUALIZING THINK IT'S A LITTLE TOO NARROW, SO NEXT SLIDE, PLEASE THE OTHER DEVELOPMENT THAT I REFERRED TO IN THE LIST WAS THIS NOTION OF DATA SHARING AND THIS IS SOMETHING THAT'S STILL SOMETHING THAT'S IN THE WORKS AND THIS WASN'T INITIATED BY A NIH, IT WAS INITIATE BIDE A WHITE HOUSE OFFICE OF POLICY IN 2013 AND THE POLICY REQUIRED THAT ANY FELLOWSHIP FEDERAL AGENCY THAT ALLOCATED MORE THAN A HUNDRED THOUSAND DOLLARS AIER IN RESEARCH OR DEVELOPMENT ACTIVITIES HAD TO HAVE A POLICY RELATED TO NOT JUST PUBLISHING AND SHARING THE DATA, NOT JUST PUBLISHING THE DATA BUT ACTUALLY SHARING THE DATA AND THAT HAS EVOLVED INTO MAKING THE ACTUAL DATA AVAILABLE, RAW DATA AVAILABLE AND A LOT HAS BEEN WRITTEN OVER THAT OVER THE LAST FEW YEARS AND NOW YOU SEE JOARNALS THAT ARE REQUIRED WHEN YOU SUBMIT AN ARTICLE AND YOU HAVE WRITE A STATEMENT ON HOW THE DATA WILL BE AVAILABLE AND THIS DATA SHARING IS BECOMING A VERY IMPORTANT PART OF DATA SCIENCE AND LARGE DATA MOVEMENT BECAUSE AND BASICALLY CREATES A LOT OF NEW DATA BY REQUIRING PEOPLE WHO HAVE FUNDED PROJECTS SUPPORTED BY THE FEDERAL GOVERNMENT TO SHARE THAT DATA AND HAD A FAIRLY BASIC LEVEL. SO NEXT SLIDE PLEASE THAT BRINGS US TO THE STRATEGIC PLAN FOR DATA SCIENCE THAT WAS PASSED IN 2018--OR RELEASED IN 2018 AND IT HAS THESE 5 MAJOR COMPONENTS, DATA INFRASTRUCTURE, DATA MODERNIZATION, DATA MANAGEMENT, WORKFORCE DEVELOPMENT AND ARE PRODUCIBILITY AND SUSTAINABILITY, THIS WORKFORCE DEVELOPMENT AND RELEVANT TO ORIENTATION AND OUR FIELDS. SO NEXT SLIDE, PLEASE. THIS IS AN EXAMPLE OF SOME OF THAT DATA THAT'S BECOME AVAILABLE MORE RECENTLY IN THESE DATA WAREHOUSES AND DATA REPOSITORIES AND IF YOU THINK CERTAINLY 10 YEARS AGO AND 5 YEARS AGO WHAT A DATA REPOSITORY WAS OR WHAT A DATA WAREHOUSE WAS AND THERE ARE LITERALLY HUNDREDS OR THOUSANDS OF THEM THAT ARE AVAILABLE AND SOME OF THEM ARE VERY GOOD, SOME OF THEM ARE NOT SO GOOD. IT'S A CHALLENGE. IF YOU DON'T UNDERSTAND THE LARGER PICTURE AND THE COMPONENTS OF IT, OF WHETHER THESE DATA WAREHOUSING BUT IF YOU TRYING TO INVELV SECONDARY DATA ANALYSIS, HO YOU DO YOU FIND OUT WHERE THE GOOD DATA IS AND ONCE YOU FIND IT HOW DO YOU DO WITH IT, HOW DO YOU MANAGE IT, ANALYZE IT, HOW DO YOU MAIC IT BECOME USEFUL TO THE FIELD? NEXT SLIDE, SO HERE'S WHERE I WANT TO MAKE THE TRANSITION TO REHABILITATION, SO THAT'S AN INTRODUCTION AND BACKGROUND OF ISSUES RELATED TO DATA SCIENCE. AND AGAIN WITHIN REHABILITATION, I WILL NOT READ THROUGH THIS SLIDE, YOU CAN LOOK AT IT YOURSELF, EVERYBODY KNOWS THIS BUT THERE'S A LOT MORE DATA AVAILABLE BECAUSE OF THE VARIETY OF CHANGES IN DATA SCIENCE ITSELF AND COMPUTER SCIENCE AND INFORMATION TECHNOLOGY AND THE INTERNET AND THE CLOUD AND ALL OF THE THINGS THAT ARE RELATED TO THIS LARGER MOVEMENT SO NEXT SLIDE. AND FOR US AND INFORMATION, THIS IS NOT AS TRUE 10 YEARS AGO AS IT IS TODAY, BUT WHEN I WENT THROUGH MY RESEARCH TRAINING BUT REHABILITATION WAS TRAINED THROUGH PATIENT ORIENTED RESEARCH AND THAT'S THE WAY IT SHOULD BE, THAT'S WHAT WE SHOULD BE DOING, WE SHOULD BE DOING PATIENT ORIENTED PROSPECTIVE CLINICAL RESEARCH TO HELP HIM PROVE FOR THE AREA OF ATHAT WILL SIS FOR LARGER BIGGER DATA. NEXT SLIDE. SO THAT THAT'S A CHALLENGE FOR US IF WE'RE GOING TO PARTICIPATE IN DATA SCIENCE AND THE ONLY ACTIVITIES THAT ARE ASSOCIATED WITH THE PROGRESSION THAT IS GOING ALONG WITH THE MASSIVE INCREASE IN DATA WE SEE IN DATA REPOSITORIES AND DATA WAREHOUSES. SO REHABILITATION AND 1 OF THE FIRST THIS IS THE HISTORY AND PERSONAL BACKGROUND, REHABILITATION IS 1 OF THE FIRST HEALTH PROFESSIONS TO REALLY RECOGNIZE AND EXPLORE FUNCTIONAL INDEPENDENCE FOR WITH GOALS FOR PERSONS WITH DISABILITY AND CHRONIC CONDITIONS. NOW THAT SEEMS KIND OF ODD IN 2020 BUT IT'S TRUE AND SOME OF US KIND OF LIVE THROUGH THAT, SO NEXT SLIDE. ONE OF THOSE PEOPLE WHO HELP TO MAKE THAT HAPPEN IS DR. GRAININGER AND HE WROTE A BOOK IN 1984 CALLED FUNCTIONAL ASSESSMENT AND REHABILITATION AND MEDICINE AND IT--I'LL READ THROUGH, BUT I WILL READ THROUGH THIS QUOTE FROM THE BOOK. FUNCTIONAL INDEPENDENT REFERS TO THE PERSON'S ABILITY TO PERFORM THE TASKS NECESSARY FOR DAILY LIVING. VOCATIONAL PURSUITS, SOCIAL INTERACTIONS, LEISURE ACTIVITIES AND RELATED BEHAVIORS SO TODAY WHEN WE READ AS REHABILITATION FOR PROFESSIONALS WE THINK, YES, THATTA'S WHAT WE DO. --THAT'S WHAT WE DO. WELL BACK IN THE 1980S THAT'S NOT REALLY WHAT REHABILITATION WAS DOING. THIS WAS FAIR,LY AT --FAIRLY, AT THE TIME UNUSUAL APPROACH THAT DR. GRANGER AND HIS COLLEAGUES TOOK. NEXT SLIDE. DR. GRANGER NOT ONLY DEVELOPED A FRAMEWORK IN TERMS OF FUNCTION AND THE IMPORTANCE OF FUNCTION AND BROAD IMPLICATIONS OF FUNCTION AND HEALTHCARE, HE ACTUALLY DEVELOPED A MEASURE AND CREATED A DATA SET AND CREATED THE FUNCTION THEY CRATED NOT JUST DR. GRANGER BUT BYRON HAMILTON AND OTHER COLLEAGUES, DWAYNE GRESHAM, AND FUNCTIONAL INDEPENDENT IN THE FIELD, IT WAS DEVELOPED A COUPLE YEARS LATER AFTER THE BOOK AND THE UDSMR, AND THE UNIFORM DATA SYSTEM FOR MEDICAL REHABILITATION IN 1989 WAS A WAY TO USE THAT DATA AND GO BEYOND THE APPLICATION TO INDIVIDUAL PATIENTS BUT CREATE A DATA SET ON THEM AND SO THAT'S WHAT THE UNIFORM DATA SET FOR MEDICAL REHABILITATION DOES, IT PROVIDED A MEASURE FOR LOOKING FOR FUNCTIONAL OUTCOMES WHICH COLLECT THAD IMAGE BUT IT WASN'T THAT--CLICKED THAT IMAGE, IT WAS IMPORTANT BUT A LOTS OF NEW PEOPLE WERE CREATING MEASURES BUT WHAT THEY DID WAS TO COLLECT THE DATA SO THEY STARTED UDSMR, THE UNIFORM DATA SYSTEM FOR MEDICAL REHABILITATION. SO THE UDSMR WAS A DATA FOR REHAB DATA AND IT WAS THE FIRST 1 AND IT REALLY BROUGHT US AT THE TIME, I HAD THE OPPORTUNITY 921990 TO START CO-WORKERSING WITH DR. GRANGER AND HO'S HOW I GOT INTERESTED IN THE DATA AND THE ACTIVITIES ASSOCIATED WITH IT, AND WORKING THROUGH THE UDSMR, AND WAYOU YOU COULD DO WITH THE LARGE SET OF DATA RATHER THAN THE DATA YOU COLLECTED IN A TRIAL OR A SINGLE STUDY. SO NEXT SLIDE, THIS DATA SCIENCE APPLICATION, 1 OF THE THINGS I LEARNED GRADUALLY AND HAS APPLICATIONS FOR THE FIELD WE'RE EXPLORING IS THIS LEVEL OF THE METRICS AND THE PATIENT LEVEL, FACILITY LEVEL AND POPULATION HEALTH LEVEL. WE IN THE FIELD HAVE BEEN FOCUSED ON PATIENT LEVEL OUTCOMES, THAT'S WAWE WANT TO DO, WE WANT INDIVIDUAL PATIENTS WHO RECEIVE OUR SERVICES TO IMPROVE BUT THERE ARE ALSO OPPORTUNITIES TO IMPROVE AT THE FACILITY LEVEL OR POPULATION LEVEL AND IMPROVE. THERE'S EXAMPLES WE COULD GO THROUGH BUT IN THE INSDENSE OF TIME, I WILL NOT DO THAT NOW. LET'S GO AHEAD AND GO TO THE NEXT SLIDE. SO 1 OF THE THINGS WE GOT INVOLVE WIDE EARLY ON WAS THE FACILITY LEVEL IMPLICATIONS FOR LARGE DATA THIS IS ABOUT THE SAME TIME THAT THE AFFORDABLE CARE ACT CAME OUT IN 2010. THERE WERE AREAS THAT BECAME VERY IMPORTANT, HOSPITAL READMISSIONS WAS PART OF IT, IT WAS PART OF THE ACT THAT READMISSION, REDUCTION PROGRAM AND THAT REDUCTION PROGRAM WAS DESIGNED TO LOOK AT READMISSIONS FROM THE FACILITY LEVEL,A THE HOSPITAL LEVEL AND IT BECAME--IT WAS WIDELY TAKEN AS SOMETHING THAT THE FIELD NEEDED TO PAY ATTENTION, I SAY THE FIELD, NOT JUST REHABILITATION, I MEAN MEDICINE, SO THERE WERE A LOT OF STUDIES AND WORK DONE RELATED TO LOOKING AT READMISSION BUT IT WASN'T READMISSION RELATED TO SPECIFIC PATIENTS. IT WAS READMISSION AS 1 OF THOSE HOSPITAL LEVEL, FACILITY LEVEL VARIABLES BECAUSE IT WAS TIED TO PAYMENT AND WE BECAME INTERESTED IN THAT AS MOST OF THE WORK THAT WAS GOING ON, WAS GOING ON IN ACUTE CARE NOT IN REHABILITATION. SO NEXT SLIDE. ONE OF THE FIRST STUDIES AGAIN THIS IS BACK IN 2010, A LITTLE AFTER 2010, ALL THE ATTENTION WAS BEING PAID TO ACUTE CARE. WE THOUGHT THERE'S GROUPS OF PEOPLE, PARTICULARLY INDIVIDUALS WITH STROKE, JOINT REPLACEMENTS VARIOUS NEUROLOGICAL CONDITIONS, TBI, POTENTIALLY AT-RISK FOR HIGH RISK FOR READMISSIONS BUT THEY WERE EXCLUDED FROM THE STUDIES THAT WERE DONE AT THE TIME AND SO WE WROTE GRANTS AND FOLK YOUUS OFFICE OF DIVERSITY THE ACUTE CARE POPULATION. THE PEOPLE THAT ARE RECEIVING REHAB SERVICES. NEXT SLIDE. WE WENT THROUGH AND DID A NUMBER OF STUDIES WHERE A PERIOD, 4 OR 5 YEARS, MAYBE LONGER THAN THAT AND WE WERE LIKING AT NOT PERSON LEVEL OUTCOMES, ALTHOUGH THOSE ARE VERY IMPORTANT WE WANTED TO SHOW THE IMPORTANCE OF THE SYSTEM AND FACILITY LEVEL OUTCOMES AND EVEN THE PUBLIC HEALTH RELATED OUTCOMES SOPHISTICATEDY THIS IS AN EXAMPLE OF THE RANGE OF PEOPLE WHO AND AGAIN IN A PREVIOUS SLIDE THEY WERE SHOWING THE READMISSION RATE FOR DIFFERENT THE GEOGRAPHIC VARIATION OF THOSE READMISSION RATES AND THOSE READMISSION RATES ARE ASSOCIATE WIDE LARGE AMOUNTS OF MONEY THAT ARE ASSOCIATED, AGAIN, THIS IS ALL MEDICARE DATA, LARGE AMOUNTS OF MONEY THAT ARE ASSOCIATED WITH PAYMENT FOR HEALTHCARE SERVICES AND AS THOSE WHO ARE FAMILIAR WITH MR. YOUNG HEARD HIM TALK, HE'S AN EXCELLENT SPEAKER AND HE FREQUENTLY SAYS PAYMENT DRIVES PRACTICE AND HE'S RIGHT ABOUT THAT, PAYMENT DOES DRIVE PRACTICE. SO WHEN YOU CAN UNDERSTAND PAYMENT THEN YOU HAVE A BETTER CHANCE OF BEING ABLE TO INFLUENCE PRACTICE AND SO LOOKINGA THE SOME OF THESE THINGS AT THE BROADER LEVEL HAS IMPLICATIONS FOR PRACTICE, HAS IMPLICATIONS FOR DRIVING PRACTICE AND THIS A GRAPH THAT SHOWS THE RANGE OF READMISSIONS AND POST ACUTE CARE SETTINGS FOR INDIVIDUALS WITH STROKE AND OTHER DISABILITIES ACROSS THE U.S. AND IT RANGES FROM 8.3% TO 13.37% AND THIS HAS BEEN BACK IN, WELL THIS IS A PAPER THAT WAS PUBLISHED IN 2014 AND THERE'S SIGNIFICANT DIFFERENCES ACROSS THE COUNTRY IN TERMS OF READMISSION RATES AND SO WHY IS THAT? AND WHAT DOES THAT MEAN? AND HOW DOES THAT AFFECT WHAT WE DO IN TERMS OF THE SERVICES WE PROVIDE? NEXT SLIDE. SO THESE ARE A FEW OF THE PAPERS THAT WERE--DR. GRANGER AND HIS COLLEAGUES DEVELOPED AND THAT TRANSITIONED INTO MEDICARE DATA AND WE'RE STILL USING THAT AND I HIGHLIGHTED ANN [INDISCERNIBLE], SHE'S THE REHAB NURSE AND I HIGHLIGHTED HER BECAUSE SHE'S AN EXAMPLE OF THE PEOPLE WHO WERE TRAINED IN THIS--THIS PROCESS. IN FACT, THE PAPER THERE IS ANN [INDISCERNIBLE]'S DISSERTATION. THAT ARTICLE IS BASED ON HER DISSERTATION THAT SHE COMPLETED AND THE PEOPLE THAT WERE THE MEMBERS OF HUR COMMITTEE WERE PARTS OF OUR DISSERTATION COMMITTEE AND ANN WENT ON TO BE VERY SUCCESSFUL IN THIS FIELD AND SHE WORKS AT RTI AND SHE'S 1 OF THE PEOPLE HELPING MAKE THE POLICY FOR HEALTHCARE RELATED TO REHABILITATION, AT RTI. SO SHE'S HAVING A MAJOR IMPACT AND SHE STARTEDUTE IN THIS AREA IN THE EARLY DAYS WITH THE UDS FOLKS AND DR. GRANGER AND THIS COLLEGE. NEXT SLIDE. SO THAT'S A BIT OF HISTORY AND PERSONAL INFORMATION RELATED TO THE RESEARCH WE'VE BEEN DOING. I WANT TO SPEND THE LAST 5 MINUTES GOING OVER THE RESOURCES THAT ARE STILL AVAILABLE. AGAIN, DR. CRUZ MENTIONED THE NEW RESEARCH INFRASTRUCTURE OR RESOURCES PROGRAMS, THE P2 C GRANTS AND PROGRAMSA THAT ARE AVAILABLE AND THOSE ARE REALLY, REALLY USEFUL, HELPFUL PROGRAMS TO THE FIELD. WE WERE FORTUNATE TO HAVE FUNDING FOR 10 YEARS ON THE GRANT THAT WE HAD AND THE LAST CYCLE WE DIDN'T SUBMIT 1 BECAUSE IT WAS NONAPOPTOTICY LONGER SOMETHING THAT NEEDED AS MUCH AS IT HAD GOTTEN AND IT WASN'T SOMETHING THAT PEOPLE DON'T KNOW ABOUT ANYMORE, ABOUT YOU IN THE LAST YEAR WE'RE STILL IN A NO COST EXTENSION AND HAVE TRIED TO FIGURE OUT HOW TO INSTITUTIONALIZE THAT SO NEXT SLIDE AND OUR CENTERS MANY OF YOU KNOW, INCLUDED EDUCATION AND THESE ARE EDUCATION CENTERS AND INCLUDED DATA AND PROJECTS VISITING SCHOLARS AND SO WE DID OUR DATA DIRECTORY RESEARCH DEPARTMENT. NEXT SLIDE, DATA DIRECTORY IS SOMETHING WE HAVE DONE WITH CORNELL UNIVERSITY THEY HAVE BEEN OUR PARTNER FOR 10 YEARS, THEY WERE THE PARTNER IN THE VERY BEGINNING AND PARTNER IN THE END AND WE'VE ACTUALLY BEEN WORKING WITH THEM AND THEY'RE GOING TO MAINTAIN THE DATA DIRECTORY AND THE DATA DIRECTORY WILL BE MAINTAINED BY THE FOLKS AT CORNELL AND IT WILL BE--IT WON'T--NEW DATA SETS WON'T BE ADDED TO IT BECAUSE WE WON'T HAVE THE FUNDING TO CONTINUE TO DO THAT BUT THOSE DATA SETS THAT ARE IN THE DIRECT LEERY AND THE SERVICES THAT ARE PART OF THAT DIRECTORY WILL--WILL CONTINUE AFTEREUR FUNDING FOR THE CLDRNs. THE NEXT SLIDE, PLEASE. AND THE SAME THING FOR THE DATA ARCHIVING, UNIVERSITY OF MICHIGAN AND A GROUP THERE CALLED ICPSR, AND THEY CREATED A DATA DIRECTORY, NOT A DATA DIRECTORY BUT A REPOSITORY THAT'S SPECIFICALLY RELATED TO REHABILITATION, IT'S CALLED THE DEPTH AND ICPSR, WHICH IS IMEAN AN INSTITUTE AT THE UNIVERSITY OF MICHIGAN, THAT I HAVE BEEN DOING DATA ARCHIVING SINCE THE 1960S SO THEY'RE VERY ESTABLISHED, THEY DO DATA ARCHIVING, ACROSS A WIDE RANGE OF PROFESSIONS AND THEY'RE GOING TO MAINTAIN THE DATA--THAT DATA ARCHIVE IS PART OF THEIR--DATA ARCHIVING SERVICE NOW, SO THAT WILL MAINTAIN AND BE AVAILABLE TO PEOPLE WHO ARE DOING RESEARCH RELATED TO REHABILITATION AND DISABILITY IN THE FUTURE. SO NEXT SLIDE. AND THESE ARE JUST AN OVERVIEW OF SOME OF THE PILOT PROJECTS AND VISITING SCHOLARS WE'VE HAD OVER THE YEARS. NEXT SLIDE. THIS IS--MANY OF HAVE YOU PROBABLY SEEN THIS SLIDE BECAUSE I'VE USED IT A NUMBER OF TIMES BUT A FEW YEARS AGO, WE WERE TRYING TO SHOW IMPACT OF THE CLDRRAND OUR ACTIVITIES AND WE DID A GOOGLE SEARCH OF BIG DATA AND NEXT SLIDE PLEASE, OUR ELCRR GRANT OUR PROGRAM CAME UP AS PART OF THAT AND WEE WERE PROUD OF THAT. WE COULDN'T PUT IT IN A PROGRESS REPORT BUT WE THOUGHT IT WAS USEFUL INFORMATION. NEXT SLIDE, PLEASE. SO, IN CLOSING, I'M A BIG FAN OF JOSEPH CAMPBELL AND THIS IS 1 OF--IN REHABILITATION, AS MENTIONED EARLIER, THERE'S MORE PEOPLE DOING HEALTH SERVICES RELATED ACTIVITIES AND I TEND TO NOT USE HEALTH SERVICES TO DESCRIBE WHAT WE DO BECAUSE I THINK WAWE DO INVOLVES REHABILITATION, IT'S A REHABILITATION, IT'S COMBENATION, REHABILITATION, HEALTH SERVICES IF YOU WILL. NEXT SLIDE SLIDE, PLEASE. AND I WANT TO JUST FINISH BY SAYING A BIT ABOUT WHAT'S HAPPENING IN THE LARGER FIELD AND FOR THOSE WHO ARE INTERESTED IN THE BIG PICTURE, THIS IS A GREAT RESOURCE. ARTIFICIAL INTELLIGENCE AND HEALTHCARE, THIS IS JUST RECENTLY RELEASED BY THE NATIONAL ACADEMIES AND IT'S A GREAT OVERVIEW OF ARTIFICIAL INTELLIGENCE AND HEALTHCARE AND WHAT THE IMPLICATIONS ARE. NEXT SLIDE, PLEASE. IF YOU WANT TO GO BEYOND THAT I WOULD RECOMMEND DEEP MEDICINE BY ERIC TOPO, THIS IS A FASCINATING BOOK THAT TALKS ABOUT THE IMPLICATIONS OF ARTIFICIAL INTELLIGENCE AS A MAJOR MOVEMENT WITHIN SOCIETY AND HE EQUATES IT TO SOMETHING ALONG THE LINES OF THE REVOLUTIONS OR THE CHANGES THAT ARE HAPPENING IN THE INDUSTRIAL REVELATION AND NOW THERE'S ARTIFICIAL INTELLIGENCE REVOLUTION THAT BEGAN IN 2000 AND IS REALLY CHANGING THE CULTURE IN MANY, MANY WAYS. NEXT SLIDE. SO FINALLY, I WOULD LIKE TO END BY THE QUOTES FROM THE ROCK, T. S. ELLIOTT AND 1 OF MY FAVORITE POEMS, I LEFT OFF THE FIRST LINE, WHERE IS THE LEFT WE HAVE LOST IN LIVING, WHERE'S THE WISDOM WE HAVE LOST IN KNOWLEDGE AND WHERE'S THE KNOWLEDGE WE HAVE LOST IN INFORMATION, NEXT SLIDE, AND WITH THE APPROPRIATE APOLOGIES TO T. S. ELLIOTT WHERE IS THE INFORMATION WE HAVE LOST IN DATA. IF YOU CAN FIND THAT INFORMATION FOR THE FIELD, I HOPE THAT THAT WOULD BE MORE PEOPLE WHO WILL BE INTERESTED IN THIS AREA CAN CONTINUE TO DO THIS WORK. NEXT SLIDE. AND THANK YOU VERY MUCH FOR YOUR TIME AND ATTENTION AND I KNOW THERE'S NOT TIME FOR QUESTIONS BUT I THINK MOST OF YOU KNOW WHERE YOU CAN FIND ME AND SO, I WOULD BE HAPPY TO TALK WITH YOU ABOUT ANY OF THE COMMENTS THAT WERE COVERED IN MY TALK. SO THANK YOU AGAIN FOR YOUR ATTENTION. >> THANK YOU SO MUCH, KEN, HAVE YOU THE NEXT 15 MINUTES TO MAKE COMMENTS, I HOPE YOU WILL NOT MIND IF I BORROW A COUPLE OF THEM. I'M GOING TO TAKE THE PREROGATIVE JUST TO ASK, IF YOU HAVE 1 SENTENCE OR WORDS OF WISDOM TO SHARE, RELATED TO HOW DO WE MAKE THAT CONNECTION. YOU MADE THE POINT ABOUT PAYMENT DRIVES PRACTICE AND I KNOW IN YOUR WORK YOU'RE VERY MUCH MOTIVATED BY THE GOAL OF IDENTIFYING WHAT IS IT ABOUT PRACTICE THAT'S MOST EFFECTIVE AND 1 FORT BIG CONCERNS THAT CAME OUT OF THE SPINAL CORD 2020 CONFERENCE IS THE RESEARCH DOESN'T SEEM TO BE DRIVING PRACTICE. WHAT DO WE DO ABOUT THAT? THE PEOPLE THAT WE WANT TO RESPOND AND IMPROVE THE PRACTICE? I KNOW IT'S A BIG QUESTION FOR COUPLE MINUTES. [LAUGHTER] >> YEAH, NO THAT'S A GOOD QUESTION. I GUESS THE WAY I WOULD RESPOND TO THAT IS SO WE, OVER THE YEARS, AND I GUESS IT'S PROBABLY ME MORE OVER THE YEARS, I WON'T SPEAK FOR MY COLLEAGUES BUT HAVE MOVED MORE TOWARDS TRYING TO IDENTIFY AND PARTICULARLY IF YOU ARE GOING TO DO BIG PROJECTS, IF YOU ARE GOING TO DO FUND THAGOREAN REQUIRES, YOU WILL RESEARCH THAT REQUIRES SUBSTANTIAL FUNDING. IF YOU COME UP WITH GOOD IDEAS CAN YOU GET FUNDED BUT COMING UP WITH REALLY GOOD IDEAS IS VERY DIFFICULT TO DO. DO. ONE THING THAT WE HAVE DONE IS WE HAVE LOOKED AT AREAS THAT ARE DEFINED AS IMPORTANT BY CONSTITUENTS. A GOOD EXAMPLE, AN EXAMPLE WE'RE USING RIGHT NOW. THE IMPACT ACT, EVERYONE IS FAMILIAR WITH THE IMPACT ACT AND IT'S LOOKING AT THE TRANSITION OF POST ACUTE CARE. SO THE IMPACT ACT HAS A BUNCH OF COMPONENTS TO IT RELATED TO FUNCTION, RELATED TO WHETHER PEOPLE ARE GOING HOME AFTER THEY HAVE REHAB, AND THOSE THOSE ITEMS AND THE IMPACT ACT NEED TO BE RESEARCHED. THEY NEED PEOPLE TO DO THE RESEARCH RELATED TO THAT ACT. BECAUSE THAT--THEN THAT PART OF THAT ACT ALL OF THE CHANGES FOR EXAMPLE, I APOLOGIZE FOR PEOPLE WHO AREN'T----HOME HEALTH AND REPLACING THE MEASURES IN SNPs, AND THEY WILL HAVE A MAJOR IMPACT ON FUNCTION OUTCOMES AND IT'S A PAYMENT RELATED THING AND WE SHOULD BE DOING THE RESEARCH ON THAT, THAT'S REHABILITATION SHOULD BE DOING THE RESEARCH ACT SO TAKING, I KNOW PEOPLE HAVE AGAIN SPINAL CORD INJURIES, IS JUST 1 FOCUS OF THAT, BUT IT'S AN IMPORTANT FOCUS AND FINDING WAYS TO MAKE THE CONNECTION BETWEEN THE AREAS THAT YOU'RE INTERESTED IN, AND THOSE OPPORTUNITIES LIKE THE IMPACT ACT IS--IRB MEAN WE DO THAT PARTLY BECAUSE THAT'S A WAY TO HELP GET FUNDED AND IT'S BEEN RELATIVELY SUCCESSFUL FOR US BECAUSE YOU DON'T HAVE TO MAKE THE ARGUMENT THAT THIS WAS IMPORTANT BECAUSE IT'S ALREADY BEEN MADE. IT'S THE IMPACT ACT. >> THAT'S VERY INSIGHTFUL. I APPRECIATE THAT. SO NOW WE'RE GOING TO MOVE INTO YOUR COMMENTS AS A RETIRING MEMBER. >> CAN I GET IN ON THE SEND-OFF BECAUSE I THINK OFFICIALLY, I WANT TO REALLY THANK KEN FOR THE WORK HE'S DONE FOR THE BOARD AND THE LARGER COMMUNITY AND YOU KNOW HE'S A VERY MODEST, VERY GRACIOUS PERSON. HE HIGHLIGHTED A LITTLE BIT THAT HE HAD ISOTOPE INFRASTRUCTURE NETWORK TO HELP PEOPLE UNDERSTAND CONNECT TO HEALTH SERVICES RESEARCH, THAT'S 1 THING, HE'S ALSO LED 1 OF OUR MAJOR CAREER DEVELOPMENT NETWORKS WHO HELP PEOPLE WHO WANT TO GET INTO RESEARCH AND GET THEIR CAREERS GOING, 1 OF OUR K12 NETWORK WHICH IS CONNECTED TO A LOT OF OTs, AND TTs AND SO ON AND HE'S DONE THAT VERY QUIETLY, HE HAD MULTIPLE NIH GRANTS. HE MENTIONED ABOUT REHAB, GERIATRIC ISSUES, HEALTH SERVICES AND HE'S BEEN AN INCREDIBLE ROLE MODEL FOR THE FIELD. I'VE SENT A NUMBER OF PEOPLE, REFERRED A NUMBER OF PEOPLE TO HIM SO I DON'T KNOW HOW HE ACCOMMODATES THEM OR HAS A GOOD SPAM FILTER ON HIS E-MAIL, BUT HE'S GRACIOUSLY DONE THIS, HE'S BEEN THE LIAISON FROM THE BOARD TO A LARGER NICHD COUNCILEE, HE'S REPORTED BACK ON THOSE MEETINGS AND BY THE WAY WITH KEN RETIRING, OUR INGLISH--ART WILL TAKE ON THAT ROLE BUT KEN'S DONE AN INCREDIBLE AMOUNT OF WORK AND SUPPORTING US AND TEACHING ME ABOUT HOW UNDERSTANDING HEALTH SERVICES REALLY SHOWS YOU, IT'S THE WHOLE OPPOSITE END OF CASE STUDIES, SHOWS LARGER BEHAVIORS AND DOES DRIVE HOW WE SUPPORT PEOPLE WITH DISABILITIES AND YOU KNOW IN LETTING KEN MAKE HIS CLOSING REMARKS, I WANTED TO REALLY LET YOU KNOW, YOU KNOW ALL THESE DONE FOR US AND HE'S DONE IT SO QUIETLY AND SO GRACIOUSLY, HE'S BEEN A REAL SUPPORTER AND WE ALL APPRECIATE THAT. SO, NOW I'VE SUFFICIENTLY EMBARRASSED HIM. I WILL TURN IT OVER. KEN? >> THANK YOU. >> THANK YOU VERY MUCH RALPH, I HAVE TO ADMIT THE FEELING IS MUTUAL BECAUSE YOU'VE BEEN HELPFUL, YOU'VE BEEN THE MOST RESPONSIVE PROJECT OFFICER AND COLLABORATOR PERSON TO GIVE KNOWLEDGE TO AND I CONDITIONED TELL YOU HOW PANE PEOPLE I HAVE SAID, YOU SHOULD GO BACH TO DWR NITKIN. SO THEY DO AND INVARIABLY I'VE NEVER HAD ANYONE COME BACK AND SAY, YOU KNOW YOU SHOULDN'T HAVE SENT ME TO SEE HIM. HE DIDN'T HELP ME AT ALL. I'VE NEVER HEARD THAT. SO, IT RUNS BOTH WAYS, RALPH. THANK YOU. AND I'M NOT SURE THAT I SHOULD SAY ANYTHING NOW, I JUST SAY, WELL ... THANKS, RALPH. I GUESS, YOU KNOW IT'S% INTERESTING, I WAS THINKING ABOUT, I'VE BEEN THINKING ABOUT THERE JUST A BIT, THIS IDEA OF GOODBYES OR FAREWELLS, IT'S INTERESTING HOW IT'S--IT SEEMS TO ME IT'S KIND OF CHANGING AND AGAIN THIS IS RELATED TO THE PANDEMIC AND THE COVID, 1 OF THE WAYS YOU SEE THAT IS IN JUST AMAZING NUMBER OF CHANGES OR CREATIVITY AND YOUR E-MAILS AND THE ENDING THE--INSTEAD OF SAYING, YOU WRITE SOMETHING AND YOU SAY ALL THE BEST OR YOU A REGARDS OR YOU SAY SINCERELY, THEY'RE NOT SAYING THAT ANYMORE. THEY'RE COMING UP WITH THESE ARE WAYS TO END THINGS AND THEY'RE VERY, VERY CREATIVE. IT'S JUST SOMETHING THAT--AND I THINK IT'S AGAIN A REFLECTION OF THE TIMES IN TERMS OF HOW THINGS END. SO I DON'T LIKE TO THINK ABOUT ENDINGS, WHEN BEAM TALK ABOUT ENDINGS AND GOODBYES, I USUALLY, WELL, YOU KNOW 40 YEARS AGO, MY FAVORITE NOVEL WAS FINNEGANS WAKE BY JAMES JOYCE, ANYBODY KNOW FINNEGAN'S LAKE, JAMES, HE WROTE ULYSSES. HE'S VERY, VERY WELL KNOWN WRITEN BUT, FINNEGAN'S WAKE WASN'T--WELL IT WAS A PRETTY POPULAR BOOK BUT THE THING ABOUT FINNEGAN'S WAKE THAT I REALLY, REALLY LIKED THAT MADE AN IMPRESSION ON ME WAS THE LAST PAGE. SO THE LAST PAGE OF FINNEGAN'S WAKE ENDS IN THE MIDDLE OF A SCIENCE, THERE'S AND IT'S LIKE, THERE'S NO END, IT JUST CONTINUES. THE STORY CONTINUES AND YOU AS THE READY GET TO DECIDE HOW THE STORY CONTINUES AND SO THAT'S KIND OF THE WAY THAT I TEND TO SAY GOODBYES AS IF IT'S NOT AN END, IT'S JUST A STOPPING AND A CONTINUATION. AND SO I CURRENTLY FEEL LIKE I'M GOING TO CONTINUE TO STAY INVOLVED IN WAYS THAT I DON'T EVEN KNOW NOW RELATED TO REHABILITATION AND RELATED TO NCMRR, AND RELATED TO THE THINGS WE'RE ALL TRYING TO DO. THANK YOU. THANK YOU VERY MUCH. >> ALSO, CAN I PUT IN--I ALSO WANT TO PUT IN A GOOD WORD FOR ANOTHER 1 OF OUR COLLEAGUES, RICHARD ELINSON, WHICH SHIFTS WITH SUPPORT OF HIS WIFE AND FAMILY WASN'T ABLE TO MAKE OUR LAST COUPLE OF MEETINGS BUT AS YOU KNOW RICHARD, HE WAS SOMEBODY WHO HAD VERY SUCCESSFUL IN ADVERTISEMENT AND THE BUSINESS WORLD AND BECAUSE OF TIS PERSONAL CONNECTION WITH CEREBRAL PALSY HE TOOK ON THE JOB OF THE INTERFACE OF BUILDING SUPPORT FOR REHABILITATION AND FOR KIDS WITH DISABILITIES. HE'S HAD SOME VERY SUCCESSFUL ORGANIZATIONS AND MEETINGS AND SO ON AND HE ACTUALLY JUMPED IN TO HELP NICH D WHEN THE WHOLE INSTITUTE WAS REDOING SOME OF ITS BRANDING AND HE WANTED TO JUST LET THE BOARD KNOW HOW MUCH THIS CONNECTION MEANT TO HIM, HOW MUCH HE LEARNED AND HOW MUCH HE WANTS TO KIND OF GET YOU GUYS, YOU KNOW DOING SUCH NEAT THINGS AND THE WORLD--YOU KNOW PEOPLE OUTSIDE JUST DON'T APPRECIATE IT. SOMETIMES IT'S JUST THE LANGUAGE WE USE WHERE OUR OWN WORST ENEMIES AND HE WANTED TO ENCOURAGE YOU TO BRING YOUR STORIES TO THINK MORE ABOUT HOW DO YOU TELL THE PEOPLE OF THE SCIENTIFIC THINGS, PEOPLE LOVED HEARING ABOUT SCIENCE AND IN PARTICULAR, THINGS YOU ARE DOING TO SUPPORT PEOPLE WITH DISABILITIES AND UNDERSTANDING THEIR NEEDS. AND SO HE WANTED ME TO PUT IN A GOOD WORD FOR THAT BECAUSE HE'S ALSO FORMALLY AT THE END END --END OF HIS TERM AS WELL. >> THANKS IF ARE THAT RALPH. >> AND FROM ALL OF US KEN, WE APPRECIATE SO MUCH THE INSIGHTS THAT YOU'VE SHARED WITH US AND THE GUIDANCE YOU'VE GIVEN US ON VARIOUS TOPICS IT'S BEEN INVALUABLE AND I KNOW YOU WILL CONTINUE TO BE INVOLVED THROUGH LEARN AND I THINK THAT'S SO EXCITING FOR THE REHABILITATION RESEARCH COMMUNITY. SO THANKS FOR ALL YOU DO AND I KNOW WE WILL SEE EACH OTHER SOON. SO THANK YOU. >> THANK YOU. >> ALL RIGHT, SO THE NEXT ITEM IS PLANNING FOR OUR NEXT MEETING. I WILL TURN IT OVER TO THERESA AND RALPH TO LEAD US THROUGH THAT PROCESS. >> SURE. SO WE'RE GOING TO DO THIS VIRTUALLY IN DECEMBER. SO I WOULD LOVE TO HEAR FEEDBACK ON THE FORMAT. WAS THIS OKAY? MIDDLE OF THE DAY? FOUR HOURS? DOES THAT WORK FOR YOU GUYS? NORMALLY OUR MEETINGS ARE A DAY AND HALF SO WE'RE DEFINITELY LOOSING CONTENT BUT I THINK WE MIGHT LOSE OTHER THINGS IF WE TRY TO REPLICATE A DAY AND HALF MEETING SO, YOU KNOW OUR INITIAL THOUGHTS ARE TO KEEP IT TO A HALF DAY IN DECEMBER BUT, YOU KNOW I--PLEASE FEEL FREE TO E-MAIL ME AND RALPH OR LET US KNOW NOW. YOU KNOW OUR FEELINGS ON THESE TYPES OF FORMATS AND WHAT PEOPLE CAN REASONABLY SUSTAIN SO THAT IS THE FIRST THING AND THEN THE SECOND THING, YOU KNOW OTHER TOPICS THAT YOU'RE INTERESTED IN AS MUCH TIME AS WE HAVE THAT WE COULD ACCOMMODATE SPEAKERS. >> --COVID IS TELEREHABILITATION A TOPIC THAT WOULD BE WORTH DIVES INTO A BIT MORE DEEPLY IN TERMS OF SOME OF THE CHALLENGES ASSOCIATED WITH THE UNIQUE NEEDS OF REHABILITATION WHICH ARE DIFFERENT THAN MEDICINE WHERE YOU CAN INSPECT [INDISCERNIBLE] FROM A DISTANCE. >> I LIKE THAT IDEA. I THINK THERE'S BEEN QUITE A NUMBER OF PUBLICATIONS THAT HAVE COME UP RECENTLY RELATED TO COVID RELATED TELEREHABILITATION AND TELEASSESSMENT FOR REHABILITATION PURPOSES SO I THINK THAT'S A GREAT IDEA. WE WILL HAVE TO GIVE SOME THOUGHT TO WHO MIGHT PRESENT ON THAT. I THINK IT'S AN EXCELLENT TOPIC AND I IT'S A GREAT IDEA. SO I WOULD PUSH YOU FURTHER. SAYING SO WHAT DOES THIS GROUP NEED TO HEAR? WHAT KIND OF EXPERTS ONER ANGLES YOU WOULD LIKE US TO BRING IN? WHAT IS MISSING? HOW DO WE SUPPLEMENT OUR OWN KNOWLEDGE? >> YEAH, WHAT ARE THE LATEST ADVANCES IN TECHNOLOGY THAT OVERCOME THE BARRIERS TO ACCESS WHETHER IT'S WiFi, ACTUAL DIGITAL DISPLAYS, HOW YOU ENGAGE IN PARTICIPANTS IN EXERCISE AND BE ABLE TO SEE THEIR MOVEMENTS, SOME OF THE TECHNOLOGY COMPONENTS AND THEN FROM A SAFETY STANDPOINT WHAT ARE THE CONSIDERATIONS WITH RESPECT TO MONITORING, EXERCISE AND REHABILITATION FROM A DISTANCE TO PREVENT, YOU KNOW EXCESSIVE ELEVATION, BLOOD, OR FALLS OR ANY NUMBER OF PROBLEMS ASSOCIATED WITH NOT BEING THERE IN PERSON. SO THOSE WOULD BE THE 2 THINGS LIKE THE TECHNOLOGY AND THE SAFETY HOW FAR CAN WE PUSH THE INFIELD BASICALLY AND THE RESOURCES THAT ARE AVAILABLE TO HELP US DO THAT. YEAH, SO, YOU KNOW YOU SAID THE TECHNOLOGY ON 1 THING AND THE WHOLE PSYCHOLOGY OF APPLIED BEHAVIOR IS A DIFFERENT THING THAT'S A VERY IMPORTANT PIECE OF IT. >> ABSOLUTELY MPLET SOCIAL DENAMSICS AND PSYCHOLOGY ASSOCIATE WIDE GROUP OR INDIVIDUAL BASED EXERCISE TYPES OF COURSES, HOW DOES COVID AFFECT--HOW DOES ASHING INCREASE THE SEDENTARY AND MANY OF OUR DISABLED--IN MANY OF OUR POPULATIONS WITH DISABILITIES HOW DOES COVID EXACERBATES THOSE DEFICITS IN WAYS THAT COULD BE TARGETED WITH TELEHEALTH REHABILITATION UNIQUELY. >> I ALSO THINK IT WOULD BE IMPORTANT TO HEAR FROM PEOPLE THAT HAVE ACTUALLY RECEIVED TELEREHAB AND THE RECEPTION. I DON'T THINK THAT THAT IS--WE DON'T UNDERSTAND HOW IT'S BEING RECEIVED TO THE OTHER END AT THIS POINT. >> YEAH, THERE'S SOME IN THAT AREA SUGGESTING THAT THE [INDISCERNIBLE] PREFER IT MORE THAN THE PROVIDERS WHICH IS AN INTERESTING DYNAMIC. PATIENTS DON'T HAVE TO LEAVE THEIR HOUSE, PROVIDERS FEEL LIKE THEY'RE LOSING THAT HANDS-ON HUMAN TOUCH FULFILLING COMPONENT AND SOMETIMES IT'S ALONG THOSE LINES OF COMPARE AND CONTRAST MIGHT BE INTERESTING. , IT'S ALMOST THE ANALOGY OF TELEEDUCATION. >> YEAH. >> RIGHT. >> AND ON THAT--IT'S INTERESTING YOU MENTIONED EDUCATION BECAUSE I DO THINK THE PERCEPTION MIGHT BE DIFFERENT WITH FAMILIES AND PERSPECTIVE, I DON'T THINK THAT IT'S BEEN AS--AS UNIVERSALLY WELCOMED FROM A PAIRNLT PERSPECTIVE AS MAYBE IT HAS IN AN ADULT REHAB PERSPECTIVE SO PARENTS FEEL LIKE THEY'RE MISS THAGOREAN INTERACTION WITH THE PROVIDERS THAT BOTH THEY AND THEIR CHILDREN NEED, I'VE HEARD FROM MANY PARENTS ON THAT, SO YOU MIGHT WANT TO THINK ABOUT ACROSS THE SPECTRUM. >> SO THIS IS BARB, I WANTED TO DISCUSS PEOPLE WITH DISABILITIES RELATED TO COVID. BECAUSE I KNOW PEOPLE ARE COMING OUT OF THE OTHER SIDE OF THIS WITH SOME LONGER--WELL, NOT SHORT, BUT SOME DISABILITY THAT'S REQUIRING IN-PATIENT REHAB BUT I THINK THERE'S LONGER TERM DISABILITIES AS WELL. SO, YOU KNOW IT'S A NEW POPULATION FOR REHAB TO ADDRESS THEIR NEEDS. >> YEAH. >> YEAH. >> OUR REHAB UNIT AS SEEN A LOT OF THAT FOR THE IN-PATIENT. >> A LOT OF LINGERING SYMPTOMS THAT'S FOR SURE. >> THAT SOUNDS LIKE IT'S A TIMELY TOPIC AND 1 THAT'S CERTAINLY--FOR US TO PURSUE, SO I CAN WORK WITH YOU THERESA AND RALPH ON IDENTIFYING SOMEONE WHO MIGHT BE ABLE TO COME IN AND SPEAK TO THAT ISSUE FROM THE PRACTICES --PROVIDER PERSPECTIVE AND ALSO FROM THE PATIENT PERSPECTIVE. >> YOU KNOW SOMETHING THAT INTERESTS ME IS SOMEBODY, LIVING WITH A SPINAL CORD INJURY, IT DOESN'T SEEM LIKE OUR POPULATION, THIS IS ALL ANECDOTAL BUT THE SEVERITY DOESN'T REALLY IMPACT OR HASN'T--PEOPLE I KNOW WITH SPINAL CORD INJURIES HAVE GOTTEN COVID, THEY SEEM TO EITHER RECOVER NORMALLY OR JUST KIND OF PROCEED WITH THE PROGRESSION WITH THE DISEASE AS ANYONE ELSE WOULD, YOU KNOW NOT BARRING RESPIRATORY OR HIGH LEVEL QUADRAPLEGIC, WHERE THE RESPIRATORY ISSUES COULD BE WORSE AND HARDER TO OVERCOME IT SO I FOUND THAT REALLY INTERESTING. I'M CURIOUS HOW THAT WOULD AFFECT OTHER OR MORE PEOPLE IN OUR COMMUNITY AND OTHER DISABILITIES. >> ROB, I WANT TO MAKE SURE I UNDERSTAND YOU CORRECTLY THAT YOU SAID FROM YOUR EXPERIENCE AND FROM THOSE THAT YOU HAVE SPOKE TO THAT THE IMPACT OF SPINAL CORD INJURY HAS NOT BEEN RELATED TO DISEASE SEVERITY? ANECDOTAL, BUT YEAH, IN THOSE LIMITED SETS, LIMITED KNOWLEDGE THAT I HAVE [INDISCERNIBLE], IT'S YEAH, SEEMS LIKE A LOT OF PEOPLE ARE JUST KIND OF DEALING WITH IT NORMALLY OR JUST LIKE ANYBODY ELSE UPON PHYSICALLY. I FIND THAT ENCOURAGING BUT ALSO INTERESTING. >> AND PROBABLY PART OF THAT RELATES TO THE DISABILITY AND SEVERITY OF THE COVID PRESENTATION, TOO, RIGHT? >> NOT ONLY IN SEVERITY BUT WHICH TISSUES SEEM TO GET INVOLVED BECAUSE THOSE TISSUES RELATE TO YOUR IMPAIRMENT SO YOUR FAGHT O PHYSIOLOGY IS GOING TO HAPPEN. TRICKY. >> YEAH. >> INTERESTING. >> I HAD A QUICK QUESTION FOR YOU RALPH AND THERESA, FOR YOUR ORGANIZATION FOR PEOPLE WITH ONGOING REHAB TRIALS, HAVE YOU PROVIDED ANY KIND OF GUIDANCE ON SOAPABLE COVID MITIGATIONS FOR INTERVENTION, MITIGATION, ASSESSMENTS, STUFF LIKE THAT, THAT WILL BE HELPFUL AS WELL, HOW PEOPLE ARE ADAPTING TO RESEARCH. >> YEAH,. >> YEAH. SO REMEMBER THAT NIH HASN'T SAID, YOU GUYS NEED TO STOP DOING YOUR RESEARCH, RIGHT? SO THESE ARE ARE ALL INDEPENDENT DECISIONS THAT LOCAL HEALTH DEPARTMENTS ARE MAKING AND LOCAL INSTITUTIONS AND IRBs, SO THERE ISN'T KIND OF THIS ONE-SIZE-FITS-ALL FROM NIH ON HOW YOU GUYS ARE SUPPOSED TO BE UP AND RUNNING OR NOT SO IT'S REALLY CASE BY CASE WHERE WE ARE ASKING YOU ALL TO LOOK AT THE SITUATION, WEIGH THE RISKS AND BENEFITS AND I'VE HAD MANY CONVERSATIONS WITH PEOPLE AND THEY'VE COME UP WITH VERY DIFFERENT ASSESSMENTS OF THOSE RISKS AND BENEFITS. SO IT'S CERTAINLY A TOPIC FOR DISCUSSION AND TO LAY OUT SOME ISSUES BUT, YOU KNOW I DON'T HAVE AN NIH POLICY THAT I CAN DIRECT YOU GUYS TO OTHER THAN PATIENT SAFETY. >> THE REASON I ASK IS, YOU KNOW FOR INDUSTRY, YOU KNOW FDA IS SUBMITTED GUIDELINES OF COVID, NONE OF THESE ARE HARD FAST RULES, THEY'RE JUST SAYING, YOU KNOW FOR COVID MITIGATIONS YOU MIGHT WANT TO MAKE SURE SAFETY EVALUATIONS ARE OUT [INDISCERNIBLE] LEAVING IT TO THE SPONSORS BUT THEY WANT INTERACTION OF WHAT YOU'RE DOING BECAUSE THESE MIGHT BE REGISTRATION TRIALS SO THEY SUPPORT AN INTEGRITY OF THE DATA, WE WILL SLEEP APNEA AND OBESITYY WHAT INDUSTRY DOES. >> YEAH, YEAH. LET ME GIVE YOU 32Y QUICK ANSWERS, ON 1 HAND WE HAVE VERY CLEVER PIVOTS AND CREATIVE SOLUTIONS TO STAYING IN TOUCH WITH THEIR PATIENT POPULATIONS REMOTELY, THAT'S 1 ISSUE, SO WE WILL GIVE PEOPLE CREDIT IF ARE THAT, THE SECOND THING IS WE OBVIOUSLY WANT TO GUIDE AGAINST YET THEY STILL HAVE SAFETY AND OVERSIGHT BECAUSE IF DOING REMOTELY, YOU WORRY THAT YOU'RE CAUSING CERTAIN BEHAVIORS THAT YOU'RE NOT RIGHT THERE TO SUPERVISE, YOU MIGHT MISS SOMETHING, SO THAT IS PREEMINENT AND THE THIRD THING IS I'M SURE THIS MIGHT DRIVE STATISTICAL COLLEAGUES CRAZY ABOUT YOU HOW DO YOU COMPARE DATA BEFORE COVID, AFTER COVID WITH THESE CHANGES? >> MAYBE FOR US AS A GROUP, SEEING HOW THESE CHANGES ARE OCCURRING MIGHT BE HELPFUL TO UNDERSTAND GOING FORWARD. >> I JUST WANT TO--IT'S A QUICK COMMENT, ANYTHING BACK TO THE ISSUE OF THE CONSUMER AND COVID, YOU KNOW AS WE KNOW IT'S DISPROPORTIONAL EFFECT OF THE COVID IS ON PEOPLE OF COLOR SO WHEN YOU ARE LOOKING FOR PEOPLE TO COME AND PRESENT, IF YOU COULD LOOK AT THAT ASPECT OF DISPROPORTIONATELY AND MAKE SURE WE CAN GET A GOOD REPRESENTATION THAT WILL BE HELPFUL. >> VERY GOOD POINT, [INDISCERNIBLE]. WELL, WE'VE COME TO ALMOST THE END OF OUR TIME, WE'VE DONE SUCH A GOOD JOB OF KEEPING ON TIME. THANKS TO EVERYONE FOR TAKING THE TIME OUT TO PARTICIPATE IN TODAY'S MEETING. I THINK IT WENT SMOOTHLY AND I APPRECIATE THAT EVERYONE REALLY CONTRIBUTED TO THE CHAT OR THROUGH JUST SPEAKING UP. DESPITE SOME TECHNICAL DIFFICULTIES. AND THANK YOU KEN FOR YOUR GREAT PRESENTATION. ANYTHING ELSE FROM THERESA OR RALPH THAT YOU WOULD LIKE TO MENTION AS WE WRAP UP. >> I JUST WANT TO--I MEAN WE HAVE THIS TREMENDOUS ENERGY WHEN WE COME TOGETHER AND YOU FOLKS DO GIVE US YOUR FULL ATTENTION. I JUCHT WANT TO MAINTAIN THAT, NOT JUST TWICE A YEAR BUT AS YOU HAVE OTHER IDEAS IN YOUR REGULAR LIVES, FEEL FREE TO KIND OF STAY IN TOUCH EITHER GRAB AN E-MAIL FROM THE GROUP AND E-MAIL BACK THE WHOLE GROUP OR E-MAIL THERESA AND I BECAUSE WE SHOULDN'T ONLY THINK OF THIS ENERGY TWICE A YEAR, THIS SHOULD BE A CONTINUOUS PROCESS, SO AS YOU THINK OF OTHER THINGS AND SAY YOU WANT TO GROW UP IN THE MEETING, LET US KNOW, OKAY? AND THANK YOU ALL. THIS IS GREAT. >> ALL RIGHT, THANK YOU. LOOK FORWARD TO SEEING YOU, NEXT TIME OR SOMEWHERE ELSE. PROBABLY ON VIDEO. AND CONGRATULATIONS AGAIN TO YOU THERESA, WE LOOK FORWARD TO ALL THE GREAT WORK THAT YOU HAVE COMING IN THE FUTURE. >> THANK YOU EVERYONE EVERYONE. THIS IS A REALLY GREAT MEETING AND I LOOK FORWARD TO SEEING YOU AT OUR CONFERENCE IN OCTOBER. IF NOT SOONER. >> BYE, ALL. >> THANK YOU.